{"id":7246,"date":"2026-06-17T13:39:00","date_gmt":"2026-06-17T10:39:00","guid":{"rendered":"https:\/\/oncomsi.com\/ekibimiz\/prof-dr-mustafa-oral-oncul\/"},"modified":"2026-09-28T16:29:06","modified_gmt":"2026-09-28T13:29:06","slug":"prof-dr-mustafa-oral-oncul","status":"publish","type":"team","link":"https:\/\/oncomsi.com\/en\/team\/prof-dr-mustafa-oral-oncul\/","title":{"rendered":"Prof. Dr. Mustafa Oral \u00d6NC\u00dcL"},"content":{"rendered":"\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\r\n
\r\n\r\n

Prof. Dr. Mustafa Oral \u00d6NC\u00dcL<\/h1> \r\n\r\n <\/div>\r\n\r\n \t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Prof. Dr. Mustafa Oral \u00d6nc\u00fcl<\/b> is a physician who has combined patient care, academic teaching, and scientific research in infectious diseases and clinical microbiology for more than thirty years. He is recognized nationally and internationally for his expertise in managing difficult-to-treat infections, particularly hospital-acquired infections, antibacterial resistance, and infections in intensive care settings.<\/p>\n\n

Prof. Dr. \u00d6nc\u00fcl completed his medical education at the G\u00fclhane Military Medical Academy, G\u00fclhane Faculty of Medicine (1984\u20131990)<\/strong>, followed by residency training in the Department of Infectious Diseases and Clinical Microbiology at GATA Haydarpa\u015fa Training Hospital (1993\u20131997)<\/strong>, where he wrote his specialty thesis on penicillin resistance rates and epidemiology in Streptococcus pneumoniae<\/em>. He began his academic career as an assistant professor in 1999, was appointed associate professor in 2004 and full professor in 2010<\/strong>. In 2012 he completed an observership in transplant infectious diseases at the Mayo Clinic in the United States<\/strong>.<\/p>\n\n

During the 1999 Marmara Earthquake he served with the Turkish Armed Forces Search and Rescue Medical Team, working as a field physician in G\u00f6lc\u00fck, Adapazar\u0131, and D\u00fczce. He carried that experience into widely cited international research on hospital infections in the aftermath of disasters. After retiring from the Turkish Armed Forces in 2014, he was appointed to the faculty of the Department of Infectious Diseases and Clinical Microbiology at Istanbul University, Istanbul Faculty of Medicine<\/strong>.<\/p>\n\n

At Istanbul Faculty of Medicine he served as a consulting physician for intensive care and transplantation, as a member of the hospital infection control committee, and as coordinator of scientific research projects. He went on to serve as Vice Dean of Istanbul Faculty of Medicine (2015\u20132018)<\/strong>, Chief Physician of Istanbul Faculty of Medicine Hospital (2018\u20132019)<\/strong>, and Vice Rector of Istanbul University (2019\u20132023)<\/strong>. As vice rector he played an active role in establishing the university’s International Project Office, securing European Union grants, and advancing technology transfer and university\u2013industry partnerships. In 2021 he was appointed Founding Dean of the Istanbul University Faculty of Nursing<\/strong>, and as a member of the Istanbul Teknopark Board of Directors<\/strong> he contributed to the development of its incubation center and to the commercial success of companies within the technology park.<\/p>\n\n

During the COVID-19 pandemic he took part in vaccine and drug development efforts, directing the research team behind the immunomodulatory compound C-Vx<\/strong> and contributing scientific and administrative expertise to its licensing as a domestically developed pharmaceutical.<\/p>\n\n

In recent years Prof. Dr. \u00d6nc\u00fcl has expanded his scientific interests to microbiota, cancer immunology, nanosensor technologies, biotechnology, and smart health systems<\/strong>. He leads numerous projects under T\u00dcB\u0130TAK, \u0130STKA, Y\u00d6K-ADEP, and European Union Horizon programs, and holds a number of patent applications and registered patents. He speaks English and Spanish, and is married with two children.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\r\n
\r\n\r\n

Specialties<\/h3> \r\n\r\n <\/div>\r\n\r\n \t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
    \n \t
  • Infectious Diseases and Clinical Microbiology<\/strong><\/li>\n \t
  • Hospital-Acquired (Nosocomial) Infections and Infection Control<\/li>\n \t
  • Antibacterial Resistance and Antimicrobial Stewardship<\/li>\n \t
  • Intensive Care Infections and Sepsis<\/li>\n \t
  • Community-Acquired Infections<\/li>\n \t
  • Burn and Wound Infections<\/li>\n \t
  • Diabetic Foot Infections<\/li>\n \t
  • Transplant Infections and Febrile Neutropenia<\/li>\n \t
  • Viral Hepatitis and HIV<\/li>\n \t
  • Tuberculosis and Central Nervous System Infections<\/li>\n \t
  • Microbiota and Cancer Immunology<\/strong><\/li>\n \t
  • Nanosensors, Biotechnology, and Medical Applications<\/li>\n \t
  • Drug and Vaccine Development<\/li>\n<\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t\r\n
    \r\n\r\n

    Education<\/h3> \r\n\r\n <\/div>\r\n\r\n \t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
    \n\t\t\t\t\t\t\t\t\t
      \n \t
    • Doctor of Medicine (MD)<\/strong>: G\u00fclhane Military Medical Academy, G\u00fclhane Faculty of Medicine, Ankara (1984 \u2013 1990)<\/li>\n \t
    • Internship<\/strong>: GATA Haydarpa\u015fa Training Hospital, Infectious Diseases and Clinical Microbiology, Istanbul (July 1990 \u2013 March 1991)<\/li>\n \t
    • Residency (Infectious Diseases and Clinical Microbiology)<\/strong>: GATA Haydarpa\u015fa Training Hospital, Istanbul (August 1993 \u2013 November 1997)<\/li>\n \t
    • Specialty Thesis<\/strong>: “Investigation of Penicillin Resistance Among Pneumococcal Strains,” 1997, Istanbul<\/li>\n \t
    • International Observership<\/strong>: Mayo Clinic, Rochester, Minnesota, USA \u2013 Transplant Infectious Diseases (2012)<\/li>\n \t
    • Intensive Care Program<\/strong>: GATA Haydarpa\u015fa Training Hospital, Istanbul (2012)<\/li>\n \t
    • Oncology \u2013 Immunology Program<\/strong> (2024)<\/li>\n<\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t
      \n\t\t\t\t
      \n\t\t\t\t\t\r\n
      \r\n\r\n

      Academic Titles<\/h3> \r\n\r\n <\/div>\r\n\r\n \t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
      \n\t\t\t\t\t\t\t\t\t
        \n \t
      • Specialist Physician<\/strong>: Infectious Diseases and Clinical Microbiology (1997)<\/li>\n \t
      • Assistant Professor<\/strong>: GATA Haydarpa\u015fa Training Hospital (1999 \u2013 2004)<\/li>\n \t
      • Associate Professor<\/strong>: GATA Haydarpa\u015fa Training Hospital (2004 \u2013 2010)<\/li>\n \t
      • Professor<\/strong>: GATA Haydarpa\u015fa Training Hospital (2010 \u2013 2014)<\/li>\n \t
      • Professor<\/strong>: Istanbul University, Istanbul Faculty of Medicine (2014 \u2013 Present)<\/li>\n<\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t
        \n\t\t\t\t
        \n\t\t\t\t\t\r\n
        \r\n\r\n

        Professional Appointments<\/h3> \r\n\r\n <\/div>\r\n\r\n \t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t
          \n \t
        • 1991 \u2013 1993: 2nd Army 400-Bed Field Hospital \u2013 Chief Physician<\/li>\n \t
        • 1992 \u2013 1993: Malatya Military Hospital<\/li>\n \t
        • 1993 \u2013 1997: GATA Haydarpa\u015fa Training Hospital \u2013 Residency Training<\/li>\n \t
        • 1997 \u2013 1999: A\u011fr\u0131 Military Hospital \u2013 Specialist in Infectious Diseases and Clinical Microbiology<\/li>\n \t
        • 1999 \u2013 2014: GATA Haydarpa\u015fa Training Hospital \u2013 Faculty Member (Assistant Professor \/ Associate Professor \/ Professor)<\/li>\n \t
        • 2014 \u2013 Present: Istanbul University, Istanbul Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology \u2013 Professor<\/li>\n<\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t
          \n\t\t\t\t
          \n\t\t\t\t\t\r\n
          \r\n\r\n

          Administrative and Leadership Roles<\/h3> \r\n\r\n <\/div>\r\n\r\n \t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
          \n\t\t\t\t\t\t\t\t\t
            \n \t
          • Chief Physician, 2nd Army 400-Bed Field Hospital (1991 \u2013 1993)<\/li>\n \t
          • Head of Infectious Diseases Service and Laboratory, A\u011fr\u0131 Military Hospital (1997 \u2013 1999)<\/li>\n \t
          • Director, GATA Haydarpa\u015fa Blood Bank (1999 \u2013 2002)<\/li>\n \t
          • Deputy Head of Infectious Diseases Service, GATA Haydarpa\u015fa (2002 \u2013 2014)<\/li>\n \t
          • Chair, Infection Control Committee, GATA Haydarpa\u015fa Training Hospital<\/li>\n \t
          • Chair, NBC (Nuclear, Biological, Chemical) Board, GATA Haydarpa\u015fa Training Hospital<\/li>\n \t
          • Chair, Project Coordination Board, GATA Haydarpa\u015fa Training Hospital<\/li>\n \t
          • Chair, Febrile Neutropenia and Immunosuppression Board, GATA Haydarpa\u015fa Training Hospital<\/li>\n \t
          • Chair, Diabetic Foot Board, GATA Haydarpa\u015fa Training Hospital<\/li>\n \t
          • Board Member and Proficiency Board Member, Turkish Society of Clinical Microbiology and Infectious Diseases (KL\u0130M\u0130K) (2011 \u2013 2015)<\/li>\n \t
          • Vice Dean, Istanbul University, Istanbul Faculty of Medicine (2015 \u2013 2018)<\/strong><\/li>\n \t
          • Chief Physician, Istanbul University, Istanbul Faculty of Medicine Hospital (2018 \u2013 2019)<\/strong><\/li>\n \t
          • Vice Rector for Research and Projects, Istanbul University (2019 \u2013 2023)<\/strong><\/li>\n \t
          • Founding Dean, Istanbul University Faculty of Nursing (2021)<\/strong><\/li>\n \t
          • Member, Turkish Scientific Board on Public Health and Communicable Diseases<\/li>\n \t
          • Member, Health Ethics Board, Council of Higher Education (Y\u00d6K) (2018 \u2013 )<\/li>\n \t
          • Board Member, Istanbul Teknopark<\/li>\n \t
          • Board Member, Istanbul Development Agency (\u0130STKA)<\/li>\n \t
          • Board Member, Istanbul University Technology Transfer Center<\/li>\n \t
          • Board Member, Istanbul University CEOTEKMER<\/li>\n \t
          • Board Member, Istanbul University Center of Excellence for Clinical Research<\/li>\n \t
          • Board Member, Istanbul University Center of Excellence for Drug Research<\/li>\n \t
          • Member, Istanbul University Patent Board, Scientific Policies Board, Animal Ethics Board, and European Union Board<\/li>\n<\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t
            \n\t\t\t\t
            \n\t\t\t\t\t\r\n
            \r\n\r\n

            Research Interests<\/h3> \r\n\r\n <\/div>\r\n\r\n \t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
            \n\t\t\t\t\t\t\t\t\t
              \n \t
            • Hospital-Acquired Infections<\/li>\n \t
            • Antibacterial Resistance<\/li>\n \t
            • Community-Acquired Infections<\/li>\n \t
            • Infection Control<\/li>\n \t
            • Intensive Care<\/li>\n \t
            • Microbiota and Cancer<\/li>\n \t
            • Cancer Immunology<\/li>\n \t
            • Nanosensors in Medicine<\/li>\n \t
            • Biotechnology in Medicine<\/li>\n \t
            • Drug and Vaccine Development<\/li>\n<\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t
              \n\t\t\t\t
              \n\t\t\t\t\t\r\n
              \r\n\r\n

              Research and Projects<\/h3> \r\n\r\n <\/div>\r\n\r\n \t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
              \n\t\t\t\t\t\t\t\t\t
                \n \t
              • HeKDisco \u2013 Healthcare Knowledge Discovery<\/strong>, European Union Horizon Project (2022 \u2013 2025) \u2013 Development of a clinical decision support system for sepsis and septic shock; collaboration between T\u00fcrkiye, Slovenia, Spain, and Belgium. Researcher<\/li>\n \t
              • HeKDisco<\/strong>, T\u00dcB\u0130TAK 1509 Project (Project No: 9210016), 2022 \u2013 2025. Researcher<\/li>\n \t
              • Development of a gold nanorod\/polymer-based carrier system with potential use in hyperthermia-supported chemotherapy for cancer, T\u00dcB\u0130TAK 1001<\/strong> (2023 \u2013 2025). Researcher<\/li>\n \t
              • Development of a mobile hyperthermia device and in vitro testing of its efficacy on cancer cells, Y\u00d6K ADEP<\/strong> (2023 \u2013 2025). Researcher<\/li>\n \t
              • Geometric modeling of aortic valve morphology and 3D bioprinting of patient-specific aortic valve prostheses for pediatric patients, T\u00dcB\u0130TAK 1001<\/strong> (2022 \u2013 2024). Researcher<\/li>\n \t
              • Evaluation of the interaction between mesenchymal stem cells expanded from human umbilical cord blood and cancer cells (2019 \u2013 2021, completed)<\/li>\n \t
              • Innovation Leader Istanbul<\/strong>, Istanbul Development Agency (\u0130STKA) Infrastructure Project (2015 \u2013 2016). Project Coordinator<\/li>\n \t
              • Development of molecularly imprinted nanoparticles (plastic antibodies) targeting diphtheria toxoid, T\u00dcB\u0130TAK<\/strong> (2017 \u2013 2020)<\/li>\n \t
              • Evaluation of the immunomodulatory effects of the compound C-Vx on the innate and adaptive immune systems (2019 \u2013 )<\/li>\n \t
              • Early administration of low-molecular-weight heparin via soft mist inhaler in COVID-19-related hypoxemia: a Phase IIb study, T\u00dcB\u0130TAK<\/strong> (2022)<\/li>\n \t
              • In vitro efficacy of antibiotic combinations against mature biofilms of ventilator-associated pneumonia isolates, Istanbul University Research Center (2022)<\/li>\n \t
              • Adaptation of PVDF-based polymers for wearable sensor applications in healthcare devices, T\u00dcB\u0130TAK \u2013 Pakistan Science Foundation International Collaboration Project<\/strong> (2022)<\/li>\n \t
              • Microbiota and KEGG analysis following allogeneic stem cell transplantation in hematologic malignancies, T\u00dcB\u0130TAK<\/strong> (2018)<\/li>\n \t
              • Phage therapy in carbapenem-resistant Klebsiella pneumoniae<\/em> infections (animal model), Istanbul University Research Center (2024). Project Coordinator<\/li>\n \t
              • INICC (International Nosocomial Infection Control Consortium) multinational surveillance studies (2004 \u2013 2017)<\/li>\n<\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t
                \n\t\t\t\t
                \n\t\t\t\t\t\r\n
                \r\n\r\n

                Patents and Patent Applications<\/h3> \r\n\r\n <\/div>\r\n\r\n \t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
                \n\t\t\t\t\t\t\t\t\t
                  \n \t
                • 2024\/017262 \u2013 Portable Re-Based Device for Healthcare Applications<\/li>\n \t
                • 2022\/014289 \u2013 Novel 3-Arylidene 2-Indolinone Derivatives for Therapeutic Use<\/li>\n \t
                • 2019\/23084 \u2013 An Aortic Piezoelectric Respiratory Stimulator<\/li>\n \t
                • 2019\/23098 \u2013 Geometric Modeling of Aortic Valve Morphology and Production of Patient-Specific Aortic Autografts via Stem Cell Implantation<\/li>\n \t
                • 2019\/22577 \u2013 Wearable Device for Telemedicine-Based Monitoring of Mechanical Heart Valve Risk<\/li>\n \t
                • 2019\/568 \u2013 Polymer-Based Antibody Application<\/li>\n \t
                • 2018\/08516 \u2013 Innovation in Eco-Friendly Antibacterial Fabric Production<\/li>\n \t
                • 2018\/06651 \u2013 Viscous Isotonic Solution with Antimicrobial Properties<\/li>\n \t
                • 2017\/23140 \u2013 Virtual Licensing System<\/li>\n \t
                • 2017\/18186 \u2013 Smart Diabetes Management System and Method<\/li>\n \t
                • 2017\/12529 \u2013 Production of Polymer-Based Antibodies<\/li>\n \t
                • 2017\/12532 \u2013 Implantable Biosensor and Nanocapsule Application Containing Antibacterial Agents<\/li>\n \t
                • 2017\/07156 \u2013 Gastric Bypass Tube for Bariatric Use<\/li>\n \t
                • 2016\/17478 \u2013 Surgical Procedure Optimization Through Preoperative 3D Modeling<\/li>\n \t
                • 2016\/13696 \u2013 Automated Checkerboard Synergy Testing Device and Method<\/li>\n \t
                • 2016\/13699 \u2013 Bionanosensor-Equipped Heart Rhythm Monitoring Garments and Early Warning System<\/li>\n \t
                • 2016\/13682 \u2013 Bionanosensor-Equipped Blood Pressure Monitoring Garments and Early Warning System<\/li>\n \t
                • 2016\/125 \u2013 Medical Procedure Optimization Through 3D Modeling in Medical Education<\/li>\n<\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t
                  \n\t\t\t\t
                  \n\t\t\t\t\t\r\n
                  \r\n\r\n

                  Awards<\/h3> \r\n\r\n <\/div>\r\n\r\n \t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
                  \n\t\t\t\t
                  \n\t\t\t\t\t\r\n
                  \r\n\r\n

                  T\u00dcB\u0130TAK Scientific Publication Incentive Awards<\/h4> \r\n\r\n <\/div>\r\n\r\n \t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
                  \n\t\t\t\t\t\t\t\t\t
                    \n \t
                  • T\u00dcB\u0130TAK Scientific Publication Incentive Award \u2013 “Cutaneous Anthrax in Turkey: A Review of 32 Cases” (November 15, 2002)<\/li>\n \t
                  • T\u00dcB\u0130TAK Scientific Publication Incentive Award \u2013 “Hospital-Acquired Infections Following the 1999 Marmara Earthquake” (November 15, 2002)<\/li>\n \t
                  • T\u00dcB\u0130TAK Scientific Publication Incentive Award \u2013 “Serum Interleukin-2 Levels in Patients with Rheumatoid Arthritis and Correlation with Insulin Sensitivity” (November 15, 2002)<\/li>\n \t
                  • T\u00dcB\u0130TAK Scientific Publication Incentive Award \u2013 “Serum Interleukin-1 Alpha and Interleukin-2 Levels in Patients with Schizophrenia” (November 15, 2002)<\/li>\n \t
                  • T\u00dcB\u0130TAK Scientific Publication Incentive Award \u2013 “Seroprevalences of Hepatitis B and C Among Health Care Workers in Turkey” (August 1, 2002)<\/li>\n \t
                  • T\u00dcB\u0130TAK Scientific Publication Incentive Award \u2013 “Comparison of Silver Sulfadiazine 1%, Mupirocin 2% and Fusidic Acid 2% for Topical Antibacterial Effect in MRSA-Infected Full-Skin Thickness Rat Burn Wounds” (December 22, 2003)<\/li>\n \t
                  • T\u00dcB\u0130TAK Scientific Publication Incentive Award \u2013 “Seroprevalence of Tetanus Antibody in Turkish Population and Effectiveness of Single-Dose Tetanus Toxoid” (December 22, 2003)<\/li>\n \t
                  • T\u00dcB\u0130TAK Scientific Publication Incentive Award \u2013 “Does N-Acetyl Cysteine Affect the Sensitivity and Specificity of Helicobacter pylori<\/em> Stool Antigen Test?” (December 30, 2003)<\/li>\n \t
                  • T\u00dcB\u0130TAK Scientific Publication Incentive Award \u2013 “The Evaluation of Nosocomial Infection During 1-Year Period in the Burn Unit of a Training Hospital in Istanbul, Turkey” (December 30, 2003)<\/li>\n \t
                  • T\u00dcB\u0130TAK Scientific Publication Incentive Award \u2013 “Splenic Complications in Malaria: Report of Two Cases from Turkey” (February 2005)<\/li>\n<\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t
                    \n\t\t\t\t
                    \n\t\t\t\t\t\r\n
                    \r\n\r\n

                    Awards Received at National Congresses<\/h4> \r\n\r\n <\/div>\r\n\r\n \t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
                    \n\t\t\t\t\t\t\t\t\t
                      \n \t
                    • \u0130lhan H, \u00d6nc\u00fcl O, G\u00fcltepe M, \u00d6zsoy MF, \u00c7avu\u015flu \u015e. Can various biochemical tests serve as an alternative to liver needle biopsy in evaluating fibrotic and histological activity in the liver tissue of patients with chronic hepatitis B virus infection? 12th Turkish Congress of Clinical Microbiology and Infectious Diseases, November 12\u201316, 2005, Antalya. (First Prize, Oral Presentation)<\/li>\n \t
                    • Temelatan \u015e, \u00d6nc\u00fcl O, Haznedaro\u011flu T, \u00c7avu\u015flu \u015e. Trends in nasal Staphylococcus aureus<\/em> carriage among healthcare workers in intensive care units. 2nd National\/International Turkish Armed Forces Nursing Congress, May 25\u201327, 2005, Istanbul. (Third Prize, Poster)<\/li>\n \t
                    • Kavruk U, \u00d6nc\u00fcl O, \u00d6zyurt M, Acar A, Haznedaro\u011flu T, \u00c7avu\u015flu \u015e. Epidemiological and clinical dimensions of carbapenem resistance in gram-negative non-fermentative bacteria causing hospital infections: a prospective study. 13th Turkish Congress of Clinical Microbiology and Infectious Diseases, March 14\u201318, 2007, Belek, Antalya. (Second Prize, Oral Presentation)<\/li>\n \t
                    • Acar A, Uygur F, Dikta\u015f H, Evin\u00e7 R, \u00dclk\u00fcr E, \u00d6nc\u00fcl O. Comparison of silver-containing dressing (Acticoat), 0.5% chlorhexidine acetate (Bactigrass), and nystatin in the treatment of rats with experimental full-thickness burns and Candida albicans<\/em> infection. 14th Turkish Congress of Clinical Microbiology and Infectious Diseases, March 25\u201329, 2009, Lara, Antalya. (Third Prize, Oral Presentation)<\/li>\n \t
                    • Congress of Plastic Surgery, February 20, 2011, Antalya. (First Prize, Oral Presentation)<\/li>\n \t
                    • KL\u0130M\u0130K Congress, March 23\u201327, 2011, Antalya. (First Prize, Oral Presentation)<\/li>\n \t
                    • Alkanl\u0131 SS, Y\u00f6ntem FD, Ya\u015far M, et al. Development of Molecular Imprinting Technology and the Effective Use of Molecular Imprinted Polymers. Congress on Biological and Medical Sciences, October 31 \u2013 November 3, 2018, Ni\u011fde. (First Prize, Oral Presentation)<\/li>\n<\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t
                      \n\t\t\t\t
                      \n\t\t\t\t\t\r\n
                      \r\n\r\n

                      Memberships<\/h3> \r\n\r\n <\/div>\r\n\r\n \t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
                      \n\t\t\t\t\t\t\t\t\t
                        \n \t
                      • American Society for Microbiology (ASM)<\/li>\n \t
                      • Infectious Diseases Society of America (IDSA)<\/li>\n \t
                      • European Society of Clinical Microbiology and Infectious Diseases (ESCMID)<\/li>\n \t
                      • Turkish Society of Clinical Microbiology and Infectious Diseases (KL\u0130M\u0130K)<\/li>\n \t
                      • Viral Hepatitis Prevention Society<\/li>\n \t
                      • Turkish Society of Intensive Care<\/li>\n \t
                      • Society of Hospital Infections and Control<\/li>\n \t
                      • Health Institutes of T\u00fcrkiye (T\u00dcSEB)<\/li>\n \t
                      • Scientific and Technological Research Council of T\u00fcrkiye (T\u00dcB\u0130TAK)<\/li>\n \t
                      • Turkish Society of Oncologic Innovation<\/li>\n \t
                      • The World Health Summit<\/li>\n \t
                      • M8 Alliance<\/li>\n \t
                      • Istanbul Development Agency (\u0130STKA)<\/li>\n<\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t
                        \n\t\t\t\t
                        \n\t\t\t\t\t\r\n
                        \r\n\r\n

                        Certifications<\/h3> \r\n\r\n <\/div>\r\n\r\n \t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
                        \n\t\t\t\t\t\t\t\t\t
                          \n \t
                        • Chief Physician Training Certificate<\/li>\n \t
                        • First Aid and Advanced First Aid Certificates<\/li>\n \t
                        • Blood Banking Certificate<\/li>\n \t
                        • Immunofluorescence Course Certificate<\/li>\n \t
                        • Molecular Biology and PCR Certificate<\/li>\n \t
                        • Infection Control Committee Physician Certificate<\/li>\n \t
                        • NBC (Nuclear, Biological, Chemical) Course Certificate<\/li>\n \t
                        • Immunology Certificate<\/li>\n \t
                        • Transplant Infections Certificate<\/li>\n \t
                        • Animal Experimentation Certificate<\/li>\n \t
                        • Diabetic Foot Infections Course Certificate<\/li>\n \t
                        • Vaccination and Immunization Certificate<\/li>\n \t
                        • Epidemiology Course Certificate<\/li>\n \t
                        • Medicine and Informatics Certificate<\/li>\n \t
                        • Biotechnology and Nanomolecules Certificate<\/li>\n \t
                        • Monoclonal Antibody Course Certificate<\/li>\n \t
                        • Febrile Neutropenia Certificate<\/li>\n \t
                        • Intensive Care Course Certificate<\/li>\n<\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t
                          \n\t\t\t\t
                          \n\t\t\t\t\t\r\n
                          \r\n\r\n

                          International Scientific Publications<\/h3> \r\n\r\n <\/div>\r\n\r\n \t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
                          \n\t\t\t\t\t\t\t\t\t
                          • Oncul O, K. Keskin, H.V. Acar, Y. Kucukardali, R. Evrenkaya, E.M. Atasoyu, C. Top, S. Nalbant, S. Ozkan, G. Emekdas, S. Cavuslu, M.H. Us, A. Pahsa ve M. Gokben, “Hospital-acquired infections following the 1999 Marmara earthquake”, J Hosp Infect, 51 (1); 47-51 (2002).<\/li>
                          • Oncul O, C. Top ve S. Cavuslu, “Correlation of serum leptin levels with Insulin sensitivity in patients with chronic hepatitis C infection”, Diabetes Care, 25 (5); 937 (2002).<\/li>
                          • Oncul O, C. Top ve S. Cavuslu, “Response to Fukui et al (Insulin sensitivity in patients with chronic hepatitis C infection)”. Diabetes Care. 25 (10); 1901 -1902 (2002).<\/li>
                          • Ebrinc S, C. Top, O. Oncul, C. Basoglu, S. Cavuslu ve M. Cetin,”Serum Interleukin 1 and Interleukin-2 levels in patients with Schizophrenia”, J of International Medical Research, 30; 314-317 (2002).<\/li>
                          • Top C, O. Oncul, S. Cavuslu, E. Elb\u00fcken, M. Saracoglu ve M. Danac\u0131, “The efficacy of hyperbaric oxygen theraphy for the threatment of diabetic autonomic neuropathy”. The Internet Journal of Neurology, 1 (2): 1-9 (2002).<\/li>
                          • Top C, A. Tuncel, O. Oncul, S. Ozkan, N. Kocak, S. Cavuslu ve M. Danac\u0131, “The correlation of insulin resistance with serum TNF- levels in patients with rheumatoid artritis”. The Internet Journal of Rheumatology, 1 (1): 1-10 (2002).<\/li>
                          • Oncul O, M.F. Ozsoy, H.C. Gul, N. Kocak, S. Cavuslu ve A. Pahsa, “Cutaneous Anthrax in Turkey: A review of 32 cases”. Scand.J of Infection, 34 (6): 413-416 (2002).<\/li>
                          • Oncul O, C. Top, S. Ozkan, S. Cavuslu ve M. Danac\u0131, “Serum interleukin 2 levels in patients with rheumatoid arthritis and correlation with insulin sensitivity”. J of International Medical Research, 30: 386-390 (2002).<\/li>
                          • Oncul O, F. Yuksel, H. Altunay, C. Ac\u0131kel, B. Celikoz ve S. Cavuslu, “The evaluation of nosocomial infection during one-year period in the Burn Unit of a training hospital in Istanbul-Turkey”. Burns, 28 (8): 738-744 (2002).<\/li>
                          • Keskin O, H.V. Acar, O. Oncul, S. Ozkan, M.H. Us ve M. G\u00f6kben, “Experience in an emergency department after the Marmara earthquake”. Isr Med Assoc , 4 (1): 474-475 (2002).<\/li>
                          • Kucukardali Y, Z. Cankir, C. Top, S. Nalbant, O. Oncul, H. Baloglu ve M. Danaci, “Kiguchi’s disease: report of one case and an overview”. The Internet Journal of Emergency and Intensive Care Medicine, 6 (2): 1-7 (2002).<\/li>
                          • Ac\u0131kel C, O. Oncul, E. Ulkur, I. Bayram, B. Celikoz ve S. Cavuslu, “Comparison of silver sulfadiazine 1 per cent, mupirocin 2 per cent and fusidic acid 2 per cent for topical antibacterial effect in methicillin-resistant staphylococci-infected full skin thickness rat burn wounds”. Journal of Burn Care and Rehabilitation, 24 (1): 37-41 (2003).<\/li>
                          • Ozsoy MF, O. Oncul, S. Cavuslu, A. Erdemoglu, G. Emekdas ve A. Pahsa, “Seroprevalences of hepatitis B and C among health care workers in Turkey”. J Viral Hepatitis, 10: 150-156 (2003).<\/li>
                          • Cavuslu S, I. Birinci, O. Oncul, G. Emekdas ve A. Erdemoglu, “The Comparison of different recombinant hepatitis B vaccines”. Internet J Infect Dis, 2: 1-11 (2003).<\/li>
                          • L. Demirturk, Yazgan Y, O. Tarc\u0131n, M. Ozel, M. Diler, O. Oncul ve S. Yildirim, “Does N-acetyl cystein affect the sensitivity and specifity of Helicobacter pylori stool antigen test”. Helicobacter, 8: 120-123 (2003).<\/li>
                          • Oncul O, H. Erdem, H. Altunay, M.F. Ozsoy, A. Pahsa ve S. Cavuslu, “The trends of penicillin resistant Streptococcus pneumoniae in Turkey”. Internet J Infect Dis, 3: 1-10 (2003).<\/li>
                          • Cavuslu S, O. Oncul, H. Altunay, M.F.Ozsoy ve N. Kocak, “The seroprevalence of Tetanus antibody in Turkish population and effectiveness of single dose tetanus toxoid”. -European Journal of Clinical Microbiology & Infectious Diseases, 22: 431-433 (2003).<\/li>
                          • Keskin O, Us MH, Ozkan S, Acar HV, Top C, Oncul O. The Role Of Ketanserin, A Serotonin Receptor Blocker, InThe Treatment Of Ischemic Acute Renal Failure. Internet Journal of Thoracic & Cardiovascular Surgery, 6: 66-75 (2003).<\/li>
                          • Esen E, Leblecioglu, and Study Group, “Prevalence of nosocomial infections at intensive care units in Turkey: A multicenter one-day point prevalence study”. Scand J Infect Dis, 36: 144-148 (2004).<\/li>
                          • Cavuslu S, Oncul O, Gungor A, Ebrin\u00e7 S, Kizilkaya E, Candan H, Recurrant subcutaneous emphysema: an untoward complication of endotracheal intubation, Ear Nose Throat Journal. 83: 485-488 (2004).<\/li>
                          • M. F. Ozsoy, Oncul O, Z. Pekkafali, A. Pahsa and O. S. Yenen Splenic complications in malaria: report of two cases from Turkey, Journal of Medical Microbiology, 2004; 53: 1255-8.<\/li>
                          • S\u00f6nmezoglu M, Kocak N, Oncul O, Ozbayburtlu S, Hepgul Z, Kosan E, Aksu Y, Bay\u0131k M. Effects of a major earthquake on blood donor types and infectious diseases marker rates. Transfus Med. 2005; 15: 93-7.<\/li>
                          • Ulkur E, Oncul O, Karagoz H, Yeniz E, Celikoz B. Comparison of silver-coated dressing (Acticoattrade mark), chlorhexidine acetate 0.5% (Bactigrass(R)), and fusidic acid 2% (Fucidin(R)) for topical antibacterial effect in methicillin-resistant Staphylococci-contaminated, full-skin thickness rat burn wounds. Burns. 2005; 31: 874-7.<\/li>
                          • Oncul O, Cavuslu S. The other side of the coin in disaster management. Lancet Infect Dis. 2005; 5: 532-3.<\/li>
                          • Ulkur E, Oncul O, Karagoz H, Celikoz B, Cavuslu S. Comparison of Silver-Coated Dressing (Acticoattrade mark), Chlorhexidine Acetate 0.5% (Bactigrass(R)), and Silver Sulfadiazine 1% (Silverdin(R)) for Topical Antibacterial Effect in Pseudomonas Aeruginosa-Contaminated, Full-Skin Thickness Burn Wounds in Rats. J Burn Care Rehabil. 2005; 26: 430-3.<\/li>
                          • Oncul O, Baylan O, Mutlu H, Cavuslu S, Doganci L. Tuberculous meningitis with multiple intracranial tuberculomas mimicking neurocysticercosis clinical and raidiological findings. Jpn J Infect Dis. 2005; 58: 387-9.<\/li>
                          • Gaye Usluer, Ilhan Ozgunes, Hakan Leblebicioglu, and the Turkish Antibiotic Utilization Study Group. (Turkish Antibiotic Utilization Study Group: Halis Akal\u0131n, Celal Ayaz, Rahmet Caylan, Yesim Cetinkaya Sardan, Nese Demirturk, Ilknur Erdem, Funda Ergin, Serpil Erol, Saban Esen, Sibel G\u00fcndes, Iftihar Koksal, Oral Oncul, Kazim Ozdamar, Recep Ozturk, Fatma Sirmatel, Irfan Sencan, Yesim Tasova, Gunay Tuncer, Sercan Ulusoy, Serhat Unal, Haluk Vahaboglu, Tansu Yamazhan (In alphabetical order) A multicenter point-prevalence study: antimicrobial prescription frequencies in hospitalized patients in Turkey. Ann Clin Microbiol Antimicrob. 2005; 4: 16.<\/li>
                          • Ardic N, Oncul O, Ilga U, Turhan V, Haznedaroglu T, Ozyurt M. Investigation of the Frequency And Antibiotic Susceptibility of Mycoplasma\/Ureaplasma in Urine Samples With Leukocyturia by Different Commercial Methods. The Internet J Infect Dis. 2005; 4: 1-9.<\/li>
                          • Leblebicioglu H, Yilmaz H, Tasova Y, Alp E, Saba R, Caylan R, Bakir M, Akbulut A, Arda B, Esen S and Study Group (Atahan Cagatay, Funda Ergin, Hurrem Bodur, Gulsen Ozkaya Sahin, Irfan Sencan, Saban Gurcan, Elif Doyuk, Bilgiul Mete, Oral Oncul). Characteristics and analysis of risk factors for mortality in Infective Endocarditis. European Journal of Epidemiology. 2006; 21: 25-31.<\/li>
                          • Kucukardali Y, Solmazgul E, Kunter E, Oncul O, Yildirim S, Kaplan M. Kikuchi-Fujimoto Disease: analysis of 244 cases. Clin Rheumatol. 2007; 26: 50-4.<\/li>
                          • Oncul O, Turhan V, Cavuslu S. H5N1 avian influenza: the Turkish dimension. Lancet Infect Dis. 2006; 6: 186-7.<\/li>
                          • Turhan V, Senol MG, Sonmez G, Oncul O, Cavuslu S, Tanridag O. Cerebral venous thrombosis as a complication of leptospirosis. J Infect. 2006; 53: 247-9.<\/li>
                          • Oncul O, Yildiz S, Gurer US, Yeniiz E, Qydedi T, Top C, Gocer P, Akarsu B, Cevikbas A, Cavuslu S. Effect of the function of polymorphonuclear leukocytes and interleukin-1 beta on wound healing in patients with diabetic foot infections. J Infect. 2007; 54 (3): 250-6.<\/li>
                          • Onde E, Top C, Oncul O. The Correlation of Insulin Resistance With Serum Tumor Necrosis Factor-Alpha Levels in Patients With Rheumatoid Arthritis. Endocrinologist: 2008;18(4):178-81.<\/li>
                          • Emekdas G, Cavuslu S, Oncul O, Atuk C; Aksoy A. Trends in hepatitis B and hepatitis C virus among blood donors over 16 years in Turkey. Eur J Epidemiol. 2006;21(4):299-305.<\/li>
                          • Kucukardali Y, Oncul O, Cavuslu S, Danaci M, Calangu S, et al. The spectrum of diseases causing fever of unknown origin in Turkey: a multicenter study. Int J Infect Dis. 2008; 12(1):71-9.<\/li>
                          • Oncul O. Antimicrobial resistance pattern of extended spectrum beta-lactamase producing Klebsiella spp. Indian J Med Res. 2007 May;125(5):699-700.<\/li>
                          • Top C, Yildiz S, Oncul O, Qydedi T, Cevikbas A, Soyogul T, Cavuslu S. Phagocytic activity of neutrophils improves over the course of therapy of diabetic foot infections. J Infect. 2007; 55 (4): 399-73.<\/li>
                          • Ersanli D, Top C, Oncul O, Aydin A, Terekeci H. Relationship between serum soluble E-selectin levels and development of diabetic retinopathy in patients with type 2 diabetes. Scand J Clin Lab Invest. 2007; 67(5): 474-9.<\/li>
                          • Oncul O. Treatment of ventilator-associated pneumonia. Journal of The Turkish Society of Intensive Care.1(1): 2007.<\/li>
                          • Turhan V, Dogru S, Coban M, Oncul O, Nalbant S. Relapsing Polychondritis presenting with FUO. Case Rep Clin Pract Rev, 2007; 67 (5): 474-9.<\/li>
                          • Erdem H, Oncul O. A review of the Current place of glycopeptides in Turkish Clinical Practice. Current Therapeutic Research, 2007; 68: 49-66.<\/li>
                          • Oncul O, Erenoglu C, Top C, Kucukardali Y, Karabudak O, Kurt Y, Akin ML, Cavuslu S, Celenk T. Necrotizing fasciitis: A life-threatining clinical disorder in uncontrolled type-2 diabetic patients. Diabetes Research and Clinical Practice, December 2008; 80: 218-23.<\/li>
                          • Oncul O, Emekdas G, Cavuslu S, Artuk C, Aksoy A. The Sixteen-Year Trend of Syphilis in Turkey: Data from Blood Donors. Tropical Doctor, 2008; 38: 181-2..<\/li>
                          • Kucukardali Y, Solmazgul E, Terekeci H, Oncul O, Turhan V. Herpes zoster ophthalmicus and syndrome of inappropriate antidiuretic hormone secretion. Intern Med. 2008;47(5):463-5.<\/li>
                          • Turhan V, Coban M, Oncul O, Cavuslu S. Strongyloidiosis and Loeffler’s Syndrome Detected in a Patient Who Used a Short Term Steroid Treatment. Turkiye Parazitol Derg, 2008; 32: 48-50.<\/li>
                          • \u00d6zyurt M, \u00d6nc\u00fcl O, Ceylan S, Haznedaroglu T, Sahiner F, Ardic N. Cross resistance and Associated resistance in Escherichia coli isolates from nosocomial urinary tract infections between 2004-2006 in a Turkish Hospital. Central European Journal of Medicine, 2008, in pres.<\/li>
                          • Oncul O, Acar A. Bacterial infections in burn patients. Indian J Med Res, 2008; 127: 415-6.<\/li>
                          • Ozyurt M, Haznedaroglu T, Sahiner F, Oncul O, Ceylan S, Ardic N, Erdemoglu A. Antimicrobial Resistance profiles of community-acquired uropathogenic Escherichia coli isolates during 2004-2006 in a Training Hospital in \u0130stanbul. Mikrobiyol Bul, 2008; 42: 231-43.<\/li>
                          • Acar A, Oncul O, Kucukardali Y, Ozyurt M, Haznedaroglu T, Cavuslu S. Epdemiological Features of Candida Infections Detected in Intensive Care Units and Risk Factors Affecting Mortality. Mikrobiyol Bul, 2008; 42: 451-61.<\/li>
                          • Suleymanoglu S, Karademir F, Aydinoz S, Meral C, Cavuslu S, Oncul O, Ardic N, Gocmen I. Relapsed Nocomial Neonatal Salmonella enterica sv. Typhi Meningitis: A case report. The Internet Journal of Infectious Diseases, 2008: 1-5.<\/li>
                          • Top C, Terekeci H, Oncul O, Demirel F, Ozkan S. The relationship between Platelet Morhpology Neutrophil Beta-2 (CD18) Integrins in patients with diabetes. The Internet Journal of Endocrinology, 2008: 1-9.<\/li>
                          • Uygur F, Oncul O, Evinc R, Diktas H, Acar A, Ulkur E. Effects of three different topical antibacterial dressing on Acinetobacter baumannii contaminated full-thickness burns in rats. Burns 2009; 35: 270-3.<\/li>
                          • Acar A, Turhan V, Diktas H, Oncul O, Cavuslu S. A case of brucellosis complicated with endocarditis, pyelonephritis, sacroileitis and thyroiditis. Mikrobiol Bul, 2009; 43 (1): 140-5.<\/li>
                          • Turhan V, Sacar S, Uzun G, Sacar M, Yildiz S, Ceran N, Gorur R, Oncul O. Hyperbaric Oxygen as adjunctive Therapy in Experimental Mediastinitis. Journal of Surgical Research, 2009; 10: 1-5. A<\/li>
                          • H. Erdem, S. Kilic, O. Coskun, Y. Ersoy, A. Cagatay, P. Onguru, S. Alp and Members of the Turkish Bacterial Meningitis in the Elderly Study Group Community-acquired acute bacterial meningitis in the elderly in Turkey. Clinical Microbiology and Infection. 2009; In pres.<\/li>
                          • Acar A, Kemahli S, Altunay H, Kosan E, Oncul O, Gorenek L, Cavuslu S. The significance of repeat testing in Turkish blood donors screened with HBV, HCV and HIV immunoassays and the importance of S\/CO ratios in the interpretation of HCV\/HIV screening test results and as a determinant for further confirmatory testing. Transfus Med. 2010 Jan 5. [Epub ahead of print].<\/li>
                          • Oncul O, Ulkur E, Acar A, Turhan V, Yeniz E, Karacaer Z, Yildiz F. Prospective analysis of nosocomial infections in a Burn Care Unit, Turkey. Indian J Med Res. 2009;130(6):758-64.<\/li>
                          • Rosenthal VD, Maki DG, Jamulitrat S, et al. International Nosocomial Infection Control Consortium (INICC) report, data summary for 2003-2008, issued June 2009. Am J Infect Control. 2010 Mar;38(2):95-104.e2.<\/li>
                          • Acar A, Kemahli S, Altunay H, Kosan E, Oncul O, Gorenek L, Cavuslu S. HBV, HCV and HIV seroprevalence among blood donors in \u0130stanbul, Turkey: how effective are the changes in the national blood transfusion policies. Braz J Infect Dis, 2010; 14 (1): 41-6.<\/li>
                          • Yeniz E, Oncul O, Cavuslu S. \u0130shalli hastalar\u0131n d\u0131\u015fk\u0131lar\u0131nda Escherichia coli 0157 H7 varl\u0131\u011f\u0131n\u0131n ara\u015ft\u0131r\u0131lmas\u0131, Turkiye Klinikleri J Med Sci 2009;29(6):1398-405.<\/li>
                          • Turhan V, Acar A, K\u0131l\u0131\u00e7 A, Budak S, Onc\u00fcl O, Haznedaro\u011flu T, G\u00f6renek L. Meningococcemia and meningitis due to Neisseria meningitidis W135 developed in two cases vaccinated with bivalent (A\/C) meningococcal vaccine.] Mikrobiyol Bul. 2010 Jul;44(3):473-8.<\/li>
                          • Oncul O, Atalay Y, Onem Y, Turhan V, Acar A, Uyar Y, Caglayik DY, Ozkan S, Gorenek L. Hantavirus infection in Istanbul, Turkey. Emerg Infect Dis. 2011 Feb;17(2):303-4.<\/li>
                          • Acar A, Uygur F, Dikta\u015f H, Evin\u00e7 R, Ulk\u00fcr E, Onc\u00fcl O, G\u00f6renek L. Comparison of silver-coated dressing (Acticoat(\u00ae)), chlorhexidine acetate 0.5% (Bactigrass(\u00ae)) and nystatin for topical antifungal effect in Candida albicans-contaminated, full-skin-thickness rat burn wounds. Burns. 2011 Feb 26. [Epub ahead of print]<\/li>
                          • Oncul O. Tertiary Trauma Care Centre & Antimicrobial Resistance. Indian J Med. Res. 2011; 1134: 238.<\/li>
                          • Orhan Y\u0131ld\u0131z, Bilgehan Aygen, Nese Demirt\u00fcrk, Tuna Demirdal, Dilara Inan, Taner Y\u0131ld\u0131rmak, Arzu Kant\u00fcrk, Ediz T\u00fct\u00fcnc\u00fc, Hepatitis B Study Group. lLamivudine resistance mutations in patients infected with hepatitis B virus genotype D. World J Gastroenterol 2011 December 7; 17(45): 4987-4992<\/li>
                          • Akta\u015f Z, Kayacan C, Oncul O. In vitro activity of avibactam (NXL104) in combination with \u03b2-lactams against Gram-negative bacteria, including OXA-48 \u03b2-lactamase-producing Klebsiella pneumoniae. Int J Antimicrob Agents. 2012: 39(1):86-9.<\/li>
                          • Erdem H, Tekin-Koruk S, Koruk I, Tozlu-Keten D, Ulu-K\u0131l\u0131c A, Oncul O, Guner R, Birengel S, Mert G, Nayman-Alpat S, Eren-Tulek N, Demirdal T, Elaldi N, Ataman-Hatipoglu C, Yilmaz E, Mete B, Kurtaran B, Ceran N, Karabay O, Inan D, Cengiz M, Sacar S, Yucesoy-Dede B, Yilmaz S, Agalar C, Bayindir Y, Alpay Y, Tosun S, Yilmaz H, Bodur H, Erdem HA, Dikici N, Dizbay M, Oncu S, Sezak N, Sari T, Sipahi OR, Uysal S, Yeniiz E, Kaya S, Ulcay A, Kurt H, Besirbellioglu BA, Vahaboglu H, Tasova Y, Usluer G, Arman D, Diktas H, Ulusoy S, Leblebicioglu H. Assessment of the requisites of microbiology based infectious disease training under the pressure of consultation needs. Ann Clin Microbiol Antimicrob. 2011; 16;10(1):38.<\/li>
                          • Ertugrul BM, Oncul O, Tulek N, et al. A prospective, multi-center study: factors related to the management of diabetic foot infections. Eur J Clin Microbiol Infect Dis. 2012 Sep;31(9):2345-52.<\/li>
                          • Koruk ST, Erdem H, Koruk I, Erbay A, Tezer-Tekce Y, Erbay AR, Dayan S, Deveci O, Inan A, Engin DO, Guner R, Dikici N, Doyuk-Kartal E, Kurtaran B, Pehlivanoglu F, Sipahi OR, Yalci A, Yemisen M, Alp-Cavus S, Gencer S, Guzel G, Oncul O, Parlak M, Kazak E, Tulek N, Ulcay A, Savasci U. Management of K endocarditis: results of the Gulhane study. Int J Antimicrob Agents. 2012 ; 40(2):145-50.<\/li>
                          • Oks\u00fcz S, Ulk\u00fcr E, Onc\u00fcl O, K\u00f6se GT, K\u00fc\u00e7\u00fckodaci Z, Urhan M.. The effect of subcutaneous mesenchymal stem cell infection on stasis zone and apoptrosis in an experimental burn model. Plast Reconstr Surg. 2013: 131(3):463-471<\/li>
                          • Rosenthal VD, Bijie H, Maki DG, Mehta Y, Apisarnthanarak A, Medeiros EA, Leblebicioglu H, Fisher D, \u00c1lvarez-Moreno C, Khader IA, Del Roc\u00edo Gonz\u00e1lez Mart\u00ednez M, Cuellar LE, Navoa-Ng JA, Abouqal R, Guanche Garcell H, Mitrev Z, Pirez Garc\u00eda MC, Hamdi A, Due\u00f1as L, Cancel E, Gurskis V, Rasslan O, Ahmed A, Kanj SS, Ugalde OC, Mapp T, Raka L, Yuet Meng C, Thu le TA, Ghazal S, Gikas A, Narv\u00e1ez LP, Mej\u00eda N, Hadjieva N, Gamar Elanbya MO, Guzm\u00e1n Siritt ME, Jayatilleke K; INICC members. International Nosocomial Infection Control Consortium (INICC) report, data summary of 36 countries, for 2004-2009. Am J Infect Control. 2012 Jun;40(5):396-407. doi: 10.1016\/j.ajic.2011.05.020. Epub 2011 Sep 10.<\/li>
                          • Temizkan V, Ugur M, Arslan G, Ucak A, Selcuk A, Oncul O, Yilmaz AT. Complete Healing of the Diabetic Ulcerative Osteomyelitis with Atherectomy and Flexible Stent. Archives of Clinical Experimental Surgery. DOI: 10:5455\/ACES.20120802123704.<\/li>
                          • Diktas H, Gulec B, Baylan O, Oncul O, Turhan V, Acar A, Gorenek L. Intraabdominal abscess related fungaemia caused by Rhodotorula glutinis in a non-neutropenic cancer patient. Acta Clin Belg. 2013 Jan-Feb;68(1):62-4.<\/li>
                          • Erdem H, Dizbay M, Karabey S, Kaya S, Demirdal T, Koksal I, Inan A, Erayman I, Ak O, Ulu-Kilic A, Karasahin O, Akbulut A, Elaldi N, Yilmaz G, Candevir A, Gul HC, Gonen I, Oncul O, Aslan T, Azak E, Tekin R, Kocak Tufan Z, Yenilmez E, Arda B, Gungor G, Cetin B, Kose S, Turan H, Akalin H, Karabay O, Dogan-Celik A, Albayrak A, Guven T, Celebi G, Ozgunes N, Ersoy Y, Sirmatel F, Oztoprak N, Balkan II, Bayazit FN, Ucmak H, Oncu S, Ozdemir D, Ozturk-Engin D, Bitirgen M, Tabak F, Akata F, Willke A, Gorenek L, Ahmed SS, Tasova Y, Ulcay A, Dayan S, Esen S, Leblebicioglu H, Altun B, Unal S. Withdrawal of Staphylococcus aureus from intensive care units in Turkey. Am J Infect Control. 2013 May 7. doi:pii: S0196-6553(13)00226-5. 10.1016\/j.ajic.2013.01.041. [Epub ahead of print].<\/li>
                          • Erdem H, Turkan H, Cilli A, Karakas A, Karakurt Z, Bilge U, Yazicioglu-Mocin O, Elaldi N, Ad\u0131guzel N, Gungor G, Ta\u015fc\u0131 C, Yilmaz G, Oncul O, Dogan-Celik A, Erdemli O, Oztoprak N, Tomak Y, Inan A, Karabo\u011fa B, Tok D, Temur S, Oksuz H, Senturk O, Buyukkocak U, Yilmaz-Karadag F, Ozcengiz D, Turker T, Afyon M, Samur AA, Ulcay A, Savasci U, Diktas H, Ozgen-Alpayd\u0131n A, Kilic E, Bilgic H, Leblebicioglu H, Unal S, Sonmez G, Gorenek L. Mortality indicators in community-acquired pneumonia requiring intensive care in Turkey. Int J Infect Dis. 2013 May 8. doi:pii: S1201-9712(13)00144-6. 10.1016\/j.ijid.2013.03.015. [Epub ahead of print].<\/li>
                          • Surgical site infections, International Nosocomial Infection Control Consortium (INICC) report, data summary of 30 countries, 2005-2010. Rosenthal VD, Richtmann R, Singh S, Apisarnthanarak A, K\u00fcbler A, Viet-Hung N, Ram\u00edrez-Wong FM, Portillo-Gallo JH, Toscani J, Gikas A, Due\u00f1as L, El-Kholy A, Ghazal S, Fisher D, Mitrev Z, Gamar-Elanbya MO, Kanj SS, Arreza-Galapia Y, Leblebicioglu H, Hlinkov\u00e1 S, Memon BA, Guanche-Garcell H, Gurskis V, Alvarez-Moreno C, Barkat A, Mej\u00eda N, Rojas-Bonilla M, Ristic G, Raka L, Yuet-Meng C; International Nosocomial Infection Control Consortiuma. Infect Control Hosp Epidemiol. 2013 Jun;34(6):597-604. doi: 10.1086\/670626. Epub 2013 Apr 18.<\/li>
                          • Birgand G, Lapelletier D, Baron G, et al. Agreement among healthcare Professional in ten European Countries in diagnosing case-vignettes of surgical-site infections. PLOS One. 2013; 8(7): 1-9.<\/li>
                          • Turhan V, Mutluoglu M, Acar A, Hatipoglu M, Onem Y, Uzun G, Ay H, Oncul O, Gorenek L. Increasing incidence of Gram-negative organisms in bacterial agents isolated from diabetic foot ulcers. J Infect Dev Ctries. 2013 Oct 15;7(10):707-12.<\/li>
                          • Erdem H, Elaldi N, Oztoprak N, Sengoz G, Ak O, Kaya S, Inan A, Nayman-Alpat S, Ulu-Kilic A, Pekok AU, Gunduz A, Gozel MG, Pehlivanoglu F, Yasar K, Y\u0131lmaz H, Hatipoglu M, Cicek-Senturk G, Akcam FZ, Inkaya AC, Kazak E, Sagmak-Tartar A, Tekin R, Ozturk-Engin D, Ersoy Y, Sipahi OR, Guven T, Tuncer-Ertem G, Alabay S, Akbulut A, Balkan II, Oncul O, Cetin B, Dayan S, Ersoz G, Karakas A, Ozgunes N, Sener A, Yesilkaya A, Erturk A, Gundes S, Karabay O, Sirmatel F, Tosun S, Turhan V, Yalci A, Akkoyunlu Y, Ayd\u0131n E, Diktas H, Kose S, Ulcay A, Seyman D, Savasci U, Leblebicioglu H, Vahaboglu H. Mortality indicators in pneumococcal meningitis: therapeutic implications. Int J Infect Dis. 2013 Oct 30. doi:pii: S1201-9712(13)00304-4.<\/li>
                          • Cilli A, Erdem H, Karakurt Z, Turkan H, Yazicioglu-Mocin O, Adiguzel N, Gungor G, Bilge U, Tasci C, Yilmaz G, Oncul O, Dogan-Celik A, Erdemli O, Oztoprak N, Samur AA, Tomak Y, Inan A, Karaboga B, Tok D, Temur S, Oksuz H, Senturk O, Buyukkocak U, Yilmaz-Karadag F, Ozcengiz D, Karakas A, Savasci U, Ozgen-Alpayd\u0131n A, Kilic E, Elaldi N, Bilgic H. Community-acquired pneumonia in patients with chronic obstructive pulmonary disease requiring admission to the intensive care unit: risk factors for mortality. J Crit Care. 2013 Dec;28(6):975-9. doi: 10.1016\/j.jcrc.2013.08.004. Epub 2013 Sep 24.<\/li>
                          • Onc\u00fcl O, Oks\u00fcz S, Acar A, Ulk\u00fcr E, Turhan V, Uygur F, Ul\u00e7ay A, Erdem H, Ozyurt M, G\u00f6renek L. Nosocomial infection characteristics in a burn intensive care unit: Analysis of an eleven-year active surveillance. Burns. 2013 Nov 29. doi:pii: S0305-4179(13)00362-8. 10.1016\/j.burns.2013.11.003. [Epub ahead of print].<\/li>
                          • Kapmaz M, Erdem F, Abulaila A, Yeniaras E, Oncul O, Aktas Z. First detection of NDM-1 with CTX-M-9, TEM, SHV and rmtC in Escherichia coli ST471 carrying IncI2, A\/C and Y plasmids from clinical isolates in Turkey. J Glob Antimicrob Resist. 2016 Dec;7:152-153.<\/li>
                          • Cag Y, Ozturk-Engin D, Gencer S, Hasbun R, Sengoz G, Crisan A, Ceran N, Savic B, Yasar K, Pehlivanoglu F, Kilicoglu G, Tireli H, Inal AS, Civljak R, Tekin R, Elaldi N, Ulu-Kilic A, Ozguler M, Namiduru M, Sunbul M, Sipahi OR, Dulovic O, Alabay S, Akbulut A, Sener A, Lakatos B, Andre K, Yemisen M, Oncu S, Nechifor M, Deveci O, Senbayrak S, Inan A, Dragovac G, G L HC, Mert G, Oncul O, Kandemir B, Erol S, Agalar C, Erdem H. Antituberculosis drug resistance patterns in adults with tuberculous meningitis: results of haydarpasa-iv study .Hydrocephalus and vasculitis delay therapeutic responses in tuberculous meninigitis: Results of Haydarpasa-III study. Neurol India. 2016 Sep-Oct;64(5):896-905.<\/li>
                          • Senbayrak S, Ozkutuk N, Erdem H, Johansen IS, Civljak R, Inal AS, Kayabas U, Kursun E, Elaldi N, Savic B, Simeon S, Yilmaz E, Dulovic O, Ozturk-Engin D, Ceran N, Lakatos B, Sipahi OR, Sunbul M, Yemisen M, Alabay S, Beovic B, Ulu-Kilic A, Cag Y, Catroux M, Inan A, Dragovac G, Deveci O, Tekin R, Gul HC, Sengoz G, Andre K, Harxhi A, Hansmann Y, Oncu S, Kose S, Oncul O, Parlak E, Sener A, Yilmaz G, Savasci U, Vahaboglu H. Antituberculosis drug resistance patterns in adults with tuberculous meningitis: results of haydarpasa-iv study. H. Ann Clin Microbiol Antimicrob. 2015 Nov 4;14:47. doi: 10.1186\/s12941-015-0107-z.<\/li>
                          • Uzun C, Onc\u00fcl O, G\u00fcm\u00fc\u015f D, Alan S, Dayio\u011flu N, K\u00fc\u00e7\u00fcker MA. Virulence Genes and Antibiotic Susceptibilities of Uropathogenic E. coli Strains. Clin Lab. 2015;61(8):941-50.<\/li>
                          • Delibalta G, Seringe\u00e7 M, \u00d6nc\u00fcl O. [A case diagnosed with chronic granulomatous disease after disseminated infection following BCG vaccination]. Mikrobiyol Bul. 2015 Jul;49(3):461-6.<\/li>
                          • Karag\u00f6z E, Selek MB, Ayd\u0131n E, Hatipo\u011flu M, Turhan V, Acar A, \u00d6nc\u00fcl O, G\u00f6renek L. Recurrent toxocariasis due to chronic urticaria and successful treatment with prolonged albendazole therapy.Turkiye Parazitol Derg. 2015;39 (1):83-5.<\/li>
                          • Saltoglu N, Yemisen M, Ergonul O, Kadanali A, Karagoz G, Batirel A, Ak O, Eraksoy H, Cagatay A, Vatan A, Sengoz G, Pehlivanoglu F, Aslan T, Akkoyunlu Y, Engin D, Ceran N, Erturk B, Mulazimoglu L, Oncul O, Ay H, Sargin F, Ozgunes N, Simsek F, Yildirmak T, Tuna N, Karabay O, Yasar K, Uzun N, Kucukardali Y, Sonmezoglu M, Yilmaz F, Tozalgan U, Ozer S, Ozyazar M; KLIMIK Turkish Society, Diabetic Foot Study Group.. Predictors for limb loss among patient with diabetic foot infections: an observational retrospective multicentric study in Turkey. Clin Microbiol Infect. 2015l;21(7):659-64.<\/li>
                          • Erdem H, Ozturk-Engin D, Tireli H, Kilicoglu G, Defres S, Gulsun S, Sengoz G, Crisan A, Johansen IS, Inan A, Nechifor M, Al-Mahdawi A, Civljak R, Ozguler M, Savic B, Ceran N, Cacopardo B, Inal AS, Namiduru M, Dayan S, Kayabas U, Parlak E, Khalifa A, Kursun E, Sipahi OR, Yemisen M, Akbulut A, Bitirgen M, Popovic N, Kandemir B, Luca C, Parlak M, Stahl JP, Pehlivanoglu F, Simeon S, Ulu-Kilic A, Yasar K, Yilmaz G, Yilmaz E, Beovic B, Catroux M, Lakatos B, Sunbul M, Oncul O, Alabay S, Sahin-Horasan E, Kose S, Shehata G, Andre K, Dragovac G, Gul HC, Karakas A, Chadapaud S, Hansmann Y, Harxhi A, Kirova V, Masse-Chabredier I, Oncu S, Sener A, Tekin R, Elaldi N, Deveci O, Ozkaya HD, Karabay O, Senbayrak S, Agalar C, Vahaboglu H. Hamsi scoring in the prediction of unfavorable outcomes from tuberculous meningitis: results of Haydarpasa-II study. J Neurol. 2015;262(4):890-8.<\/li>
                          • Leblebicioglu H, Erben N, Rosenthal VD, Sener A, Uzun C, Senol G, Ersoz G, Demirdal T, Duygu F, Willke A, Sirmatel F, Oztoprak N, Koksal I, Oncul O, Gurbuz Y, G\u00fc\u00e7l\u00fc E, Turgut H, Yalcin AN, Ozdemir D, Kendirli T, Aslan T, Esen S, Ulger F, Dilek A, Yilmaz H, Sunbul M, Ozgunes I, Usluer G, Otkun M, Kaya A, Kuyucu N, Kaya Z, Meric M, Azak E, Y\u00fdlmaz G, Kaya S, Ulusoy H, Haznedaroglu T, Gorenek L, Acar A, Tutuncu E, Karabay O, Kaya G, Sacar S, Sungurtekin H, U\u011furcan D, Turhan O, Kaya S, Gumus E, Dursun O, Geyik MF, \u015eahin A, Erdogan S, Ince E, Karbuz A, \u00c7ift\u00e7i E, Ta\u015fyapar N, G\u00fcne\u015f M. Surgical site infection rates in 16 cities in Turkey: findings of the International Nosocomial Infection Control Consortium (INICC). Am J Infect Control. 2015 Jan;43(1):48-52.<\/li>
                          • Leblebicioglu H, Erben N, Rosenthal VD, Atasay B, Erbay A, Unal S, Senol G, Willke A, \u00d6zg\u00fcltekin A, Altin N, Bakir M, Oncul O, Ers\u00f6z G, Ozdemir D, Yalcin AN, \u00d6zdemir H, Y\u0131ld\u0131zda\u015f D, Koksal I, Aygun C, Sirmatel F, Sener A, Tuna N, Akan \u00d6A, Turgut H, Demiroz AP, Kendirli T, Alp E, Uzun C, Ulusoy S, Arman D. International Nosocomial Infection Control Consortium (INICC) national report on device-associated infection rates in 19 cities of Turkey, data summary for 2003-2012. Ann Clin Microbiol Antimicrob. 2014 Nov 18;13:51.<\/li>
                          • Karagoz E, Ulcay A, Tanoglu A, Kara M, Turhan V, Erdem H, Oncul O, Gorenek L. Clinical usefulness of mean platelet volume and red blood cell distribution width to platelet ratio for predicting the severity of hepatic fibrosis in chronic hepatitis B virus patients. Eur J Gastroenterol Hepatol. 2014 ;26(12):1320-4.<\/li>
                          • Rosenthal VD, Maki DG, Mehta Y, Leblebicioglu H, Memish ZA, Al-Mousa HH, Balkhy H, Hu B, Alvarez-Moreno C, Medeiros EA, Apisarnthanarak A, Raka L, Cuellar LE, Ahmed A, Navoa-Ng JA, El-Kholy AA, Kanj SS, Bat-Erdene I, Duszynska W, Van Truong N, Pazmino LN, See-Lum LC, Fern\u00e1ndez-Hidalgo R, Di-Silvestre G, Zand F, Hlinkova S, Belskiy V, Al-Rahma H, Luque-Torres MT, Bayraktar N, Mitrev Z, Gurskis V, Fisher D, Abu-Khader IB, Berechid K, Rodr\u00edguez-S\u00e1nchez A, Horhat FG, Requejo-Pino O, Hadjieva N, Ben-Jaballah N, Garc\u00eda-Mayorca E, Kushner-D\u00e1valos L, Pasic S, Pedrozo-Ortiz LE, Apostolopoulou E, Mej\u00eda N, Gamar-Elanbya MO, Jayatilleke K, de Lourdes-Due\u00f1as M, Aguirre-Avalos G; International Nosocomial Infection Control Consortium.. International Nosocomial Infection Control Consortium (INICC) report, data summary of 43 countries for 2007-2012. Device-associated module. Am J Infect Control. 2014 Sep;42(9):942-56.<\/li>
                          • Hatipo\u011flu M, Ul\u00e7ay A, Turhan V, Karag\u00f6z E, Erdem H, Acar A, Onc\u00fcl O, G\u00f6renek L. [Two imported and relapsed of Plasmodium vivax malaria cases and primaquine prophylaxis]. Turkiye Parazitol Derg. 2014 Jun;38(2):120-3.<\/li>
                          • Budak S, Oncul O, Aktas Z, Acar A, Ozyurt M, Turhan V, Erdem H, Gorenek L. The determination of carbapenem resistance in Escherichia coli and Pneumoniae isolates related to nosocomial infections and the evaluation of risk factors. Southeast Asian J Trop Med Public Health. 2014 Jan;45(1):113-22.<\/li>
                          • Erg\u00f6n\u00fcl \u00d6, Alan S, Ak \u00d6, Sarg\u0131n F, Kant\u00fcrk A, G\u00fcnd\u00fcz A, Engin D, \u00d6nc\u00fcl O, Balkan II, Ceylan B, Benzonana N, Yaz\u0131c\u0131 S, \u015eim\u015fek F, Uzun N, Inan A, Gulhan E, Ciblak M, Midilli K, Ozyurt M, Badur S, Gencer S, Nazl\u0131can O, \u00d6zer S, \u00d6zg\u00fcne\u015f N, Y\u0131ld\u0131rmak T, Aslan T, G\u00f6kta\u015f P, Salto\u011flu N, Fincanc\u0131 M, Dokucu AI, Eraksoy H; Turkish Society of Clinical Microbiology and Infectious Diseases (KLIMIK).; Pandemic Influenza Study Group.. Predictors of fatality in pandemic influenza A (H1N1) virus infection among adults. BMC Infect Dis. 2014 Jun 10;14:317.<\/li>
                          • Erdem H, Ozturk-Engin D, Elaldi N, Gulsun S, Sengoz G, Crisan A, Johansen IS, Inan A, Nechifor M, Al-Mahdawi A, Civljak R, Ozguler M, Savic B, Ceran N, Cacopardo B, Inal AS, Namiduru M, Dayan S, Kayabas U, Parlak E, Khalifa A, Kursun E, Sipahi OR, Yemisen M, Akbulut A, Bitirgen M, Dulovic O, Kandemir B, Luca C, Parlak M, Stahl JP, Pehlivanoglu F, Simeon S, Ulu-Kilic A, Yasar K, Yilmaz G, Yilmaz E, Beovic B, Catroux M, Lakatos B, Sunbul M, Oncul O, Alabay S, Sahin-Horasan E, Kose S, Shehata G, Andre K, Alp A, Cosi\u0107 G, Cem Gul H, Karakas A, Chadapaud S, Hansmann Y, Harxhi A, Kirova V, Masse-Chabredier I, Oncu S, Sener A, Tekin R, Deveci O, Karabay O, Agalar C. The microbiological diagnosis of tuberculous meningitis: results of Haydarpasa-1 study. Clin Microbiol Infect. 2014;20(10):O600-8.<\/li>
                          • Turhan V, Acar A, Ates F, Diktas H, Haholu A, Oncul O, Gorenek L. Orchiectomy performed in wo patients with Brucella orchitis mimicking testicular tumour. West Indian Med J. 2013;62(6):557-60.<\/li>
                          • \u00dcl\u00e7ay A, Karaahmeto\u011flu G, Turhan V, Erdem H, Acar A, \u00d6nc\u00fcl O, G\u00f6renek L. [The management of therapeutic failure in a falciparum malaria patient under oral arthemether-lumefantrine therapy]. Turkiye Parazitol Derg. 2014;38(1):61-7.<\/li>
                          • Erdem H, Kocak-Tufan Z, Yilmaz O, Karakurt Z, Cilli A, Turkan H, Yazicioglu-Mocin O, Ad\u0131guzel N, Gungor G, Ta\u015fc\u0131 C, Yilmaz G, Oncul O, Dogan-Celik A, Erdemli O, Oztoprak N, Tomak Y, Inan A, Tok D, Temur S, Oksuz H, Senturk O, Buyukkocak U, Yilmaz-Karadag F, Ozturk-Engin D, Ozcengiz D, Karakas A, Bilgic H, Leblebicioglu H. The interrelations of radiologic findings and mechanical ventilation in community acquired pneumonia patients admitted to the intensive care unit: a multicentre retrospective study. Ann Clin Microbiol Antimicrob. 2014: 8;13:5.<\/li>
                          • Karacaer Z, Oncul O, Turhan V, Gorenek L, Ozyurt M. A surveillance of nosocomial candida infections: epidemiology and influences on mortalty in intensive care units. Pan Afr Med J. 2014: 22;19:398.<\/li>
                          • Karagoz E, Gorenek L, Ulcay A, Turhan V, Erdem H, Oncul O. A case considering utilization of potent antiviral agents in a hepatitis B virus-infected patient with high viral load receiving immunosuppressive therapy. Disease and Molecular Medicine. 2016:4: 6-8.<\/li>
                          • Erdem F, Abulaila A, Aktas Z, Oncul O. Comparison of the Novel Oxa-48 and Kpc K-SeT Assay, and Blue-Carba Test for the Detection of Carbapenemase-Producing Enterobacteriaceae Using PCR as a Reference Method. Clin Lab. 2017;63(3):515-522.<\/li>
                          • Saltoglu N, Ergonul O, Tulek N, Yemisen M, Kadanali A, Karagoz G, Batirel A, Ak O, Sonmezer C, Eraksoy H, Cagatay A, Surme S, Nemli SA, Demirdal T, Coskun O, Ozturk D, Ceran N, Pehlivanoglu F, Sengoz G, Aslan T, Akkoyunlu Y, Oncul O, Ay H, Mulaz\u0131moglu L, Erturk B, Yilmaz F, Yoruk G, Uzun N, Simsek F, Yildirmak T, Ya\u015far KK, Sonmezoglu M, K\u00fc\u00e7\u00fckardali Y, Tuna N, Karabay O, Ozgunes N, Sarg\u0131n F; Turkish Clinic Microbiology and Infectious Diseases Society, Diabetic Foot Infections Study Group. Influence of multidrug resistant organism on the outcome of diabetic foot infection. Int J Infect Dis. 2018: 21.<\/li>
                          • Karagoz E, Simsek H, Erdem H, Oncul O, Ulcay A, Turhan V, Acar A, Gorenek L. A Rare Case of Brucella Spondylodiscitis Mimicking Lumbar Disc Herniation. July 2015 DOI: 10.5455\/medscience.2015.04.8316.<\/li>
                          • Erdem H, Ozturk Engin D, Tireli H, Kilicoglu G, Oncul O, Vahaboglu H. 1475 Hamsi scoring in the prediction of unfavorable outcomes in tuberculous meningtis: Results of multinational Haydarpasa-2 Study. Open Forum Infectious Diseases, 2014: 1(suppl-1):S390.<\/li>
                          • Ulcay A, Hatipoglu M, Oncul O, Gokce DE, Turhan V, Erdem H, Gorenek L. Compliance of rabies post exposure prophylaxis and rabies vaccine application problems. Open Forum Infectious Diseases, 2014: 1(suppl-1):S344-5.<\/li>
                          • Aydin M, Aygen B, Mistik R, Oncul O, Tuna N, Tuncer Ertem G, Yildiz O, Yulugkural Z. Management of Fulminant Hepatitis B: A Consensus Report of the Study Group for Viral Hepatitis of the Turkish Society of Clinical Microbiology and Infectious Diseases. September 2014. DOI: 10.5152\/kd.2013.13.<\/li>
                          • Karaahmetoglu G, Atabey C, Oncul O, Topuz AK, Turhan V, Acar A, Gorenek L. Successful Treatment of Ventriculitis Caused by Extensively Drug-resistant Acinetobacter Baumannii with Intraventricular Colistin Administration: Report of Two Cases. Dis Mol Med. 2014:2:65-9.<\/li>
                          • Temizkan V, Ugur M, Arslan G, Ucak A, Selcuk A, Oncul O, Yilmaz A. Complete Healing of the Diabetic Ulcerative Osteomyelitis with Atherectomy and Flexible Stent. Archives of Clinical Experimental Surgery. 2014:3:195-6.<\/li>
                          • Budak S, Aktas Z, Oncul O, Acar A, Ozyurt M, Turhan V, Gorenek L. Detection of OXA-51 Carbapenemase Gene in Klebsiella pneumoniae: A Case Report and a New Dimension on Carbapenem Resistance. Journal of molecular and genetic medicine: an international journal of biomedical research. 2013:7(63):1-4 \u00b7<\/li>
                          • Erdem H, Ergunay K, Yilmaz AT, Nez H, Akata F, \u0130nan AS, Ulcay A, Gunay F, Ozkul A, Alten B, Turhan V, Oncul O, Gorenek L. Emergence and co-infections of West Nile virus and Toscana virus in Eastern Thrace, Turkey. Clinical Microbiology and Infection. 2013:57(4): DOI: 10.1111\/1469-0691.12310.<\/li>
                          • G\u00fcndo\u011fan A, Aydogan M, Ozk\u0131sa T, et al. A case of Thalidomide induced organizing pneumoniae. Chest, 2013: 144 (4): 440 A.<\/li>
                          • Acar A, S\u00fcc\u00fcl\u00fc \u00dc, Baylan O, et al. Coexistence of pancreatic tuberculosis with systemic brucellosis: a case report. Central European Journal of Medicine. 2010:5 (5): 573-6.<\/li>
                          • Acar A, Dikta\u015f H, \u00d6nc\u00fcl O, \u00c7avu\u015flu \u015e. Steroid Kullanan ve Salmonella enteritidis Bakteriyemisi Geli\u015fen bir Olguda Femur Ba\u015f\u0131 Avask\u00fcler Nekrozu. Nobel Med 2012: 8(1):103-6.<\/li>
                          • Baylan O, Selek MB, Alay S, Oncul O, Ozyurt M, Haznedaroglu T. Burkholderia cepacia sepsis observed in a hospitalized patient. Core:2011:135:439.<\/li>
                          • Karagoz E, Ulcay A, Suer BT, Turhan V, Acar A, Erdem H, Oncul O, Gorenek L. Recurrent Fever of Unknown Origin Associated with Forgotten Dental Root Infection in a Geriatric Patient. West Indian Medical Journal. 2017: DOI: 10.7727\/wimj.2017.012<\/li>
                          • Turhan V, Acar A, Coban M, Oncul O, Cavuslu S. Recurrent Gastrointestinal Bleeding, Intraabdominal Abscesses and Synchronous Candidemia and Meningitis Due to Leflunomide Therapy: Case Report. Turkiye Klinikleri J Med Sci 2010:30(6):2027-30.<\/li>
                          • Acar A, Oncul O, Kucukardali Y, Ozyurt M, Haznedaroglu T, Cavuslu S. Yo\u011fun bak\u0131m \u00fcnitelerinde saptanan Candida enfeksiyonlar\u0131n\u0131n epidemiyolojik \u00f6zellikleri ve mortaliteye etki eden risk fakt\u00f6rleri. Mikrobiyol Bul 42 (3), 451-61.<\/li>
                          • S Cavuslu, O Oncul, A Gungor, E Kizilkaya, H Candan. A case of recurrent subcutaneous emphysema as a complication of endotracheal intubation. ENT: Ear, Nose & Throat Journal 83:(7):2004.<\/li>
                          • A Acar, O Onc\u00fcl, Y Kuecuekardali, M Ozyurt, T Haznedaro\u011flu, S Cavu\u015flu. Epidemiological features of Candida infections detected in intensive care units and risk factors affecting mortality. Mikrobiyoloji bulteni 42 (3), 451-461. 2008.<\/li>
                          • S Budak, Z Aktas, O Oncul, A Acar, M Ozyurt, V Turhan, L Gorenek. detection of: p1235acinetobacter baumannii: p1235derived oxa-51 and oxa-58 carbapenemase genes in enteric bacteria: a new dimension on carbapenemase resistance: p1235. Clinical Microbiology & Infection 18, 311: 2012.<\/li>
                          • V.Turhan, A.Acar, A. K\u0131l\u0131\u00e7, S. Budak, O. Oncul, T. Haznedaroglu. Bivalan (A\/C) Meningokok a\u015f\u0131s\u0131 ile a\u015f\u0131lanm\u0131\u015f iki olguda Neisseria meningitidis W 135’e ba\u011fl\u0131 geli\u015fen meningokoksemi ve menenjit. Mikrobiyol Bul 44, 473-478: 2010.<\/li>
                          • E Yen\u0130\u0130z, O \u00d6nc\u00fcl, \u0218 \u00c7avu\u0219lu. Investigation of Escherichia coli O157: H7 in fecal samples of patients with diarrhea. T\u00fcrkiye Klinikleri t\u0131p Bilimleri Dergisi 29 (6), 1398-1405: 2009.<\/li>
                          • Y Kucukardali, O Oncul, S Cavuslu, M Danaci, S Calangu The changing spectrum of diseases causing fever of unknown origin in Turkey. Clinical Microbiology & Infection Supplement 11, 560-561: 2005.<\/li>
                          • O \u00d6nc\u00fcl, C Top, S Cavuslu. Response to Fukui et al. Diabetes Care 25 (10), 1901-1902: 2002.<\/li>
                          • A Erdemo\u011flu, MF \u00d6zsoy, G Emekda\u015f, O \u00d6nc\u00fcl, A Pahsa The resistance of Staphylococci isolated from urine to fusidic acid and other antimicrobials. T\u00fcrk Mikrobiol Cem Derg 30 (1), 6-12: 2000.<\/li>
                          • A Acar, H Diktas, O Oncul, S Cavuslu. Avasculer Necrosis of the femur head in a case using steroid and with Salmonella enteritidis bacteremia. Nobel Medicus 8 (1), 103-106: 2012.<\/li>
                          • F Erdem, O Oncul, Z Aktas. Characterization of Resistance Genes and Polymerase Chain Reaction-Based Replicon Typing in Carbapenem-Resistant Klebsiella pneumoniae Microbial Drug Resistance: 2018.<\/li>
                          • Atabey C, Koc A, Eroglu A, Topuz AK, Colak A, et al. Nosocomial Infections Caused by Jugular Central Venous Catheterization in Brain Surgery Intensive Care Unit. Journal of Neurological Sciences 31 (3): 2014.<\/li>
                          • E Karag\u00f6z, M Hatipo\u011flu, V Turhan, A \u00dcl\u00e7ay, A Acar, M Al\u0131s, O \u00d6nc\u00fcl. Cortisone Acetate Induced Acute Flare-Up of HBV Infection in a Growth Hormone Deficient Patient. Disease and Molecular Medicine 2 (2), 41-44: 2014.<\/li>
                          • V Turhan, A Acar, F Ates, H Diktas, A Haholu, O \u00d6nc\u00fcl, L G\u00f6renek. Orquiectom\u00eda realizada en dos pacientes con orquitis brucelosa semejante a un tumor testicular. West Indian Medical Journal 62 (6), 557-560: 2013.<\/li>
                          • H Erdem, O Oncul. Background: Graft infections are severe complications of vascular surgery that may result in amputation or mortality. Staphylococci are the most frequent cause of vascular .Current Therapeutic Research 68 (1), 23-31: 2007.<\/li>
                          • Basaran S, Yavuz SS, Bali EA, Cagatay A, Oncul O, Ozsut H, Eraksoy H. Hyponatremia Is Predictive of HSV-1 Encephalitis among Patients with Viral Encephalitis. Tohoku J Exp Med. 2019 Mar;247(3):189-195. doi: 10.1620\/tjem.247.189.<\/li>
                          • Rosenthal VD, Bat-Erdene I, Gupta D, Belkebir S, Rajhans P, Zand F, Myatra SN, Afeef M, Tanzi VL, Muralidharan S, Gurskis V, Al-Abdely HM, El-Kholy A, AlKhawaja SAA, Sen S, Mehta Y, Rai V, Hung NV, Sayed AF, Guerrero-Toapanta FM, Elahi N, Morfin-Otero MDR, Somabutr S, De-Carvalho BM, Magdarao MS, Velinova VA, Quesada-Mora AM, Anguseva T, Ikram A, Aguilar-de-Moros D, Duszynska W, Mejia N, Horhat FG, Belskiy V, Mioljevic V, Di-Silvestre G, Furova K, Gamar-Elanbya MO, Gupta U, Abidi K, Raka L, Guo X, Luque-Torres MT, Jayatilleke K, Ben-Jaballah N, Gikas A, Sandoval-Castillo HR, Trotter A, Valderrama-Beltr\u00e1n SL, Leblebicioglu H; International Nosocomial Infection Control Consortium. International Nosocomial Infection Control Consortium (INICC) report, data summary of 45 countries for 2012-2017: Device-associated module. Am J Infect Control. 2020 Apr;48(4):423-432. doi: 10.1016\/j.ajic.2019.08.023. Epub 2019 Oct 29.<\/li>
                          • Erdem F, Oncul O, Aktas Z. Characterization of Resistance Genes and Polymerase Chain Reaction-Based Replicon Typing in Carbapenem-Resistant Klebsiella pneumoniae. Microb Drug Resist. 2019 May;25(4):551-557. doi: 10.1089\/mdr.2018.0231. Epub 2018 Nov 20.<\/li>
                          • Yasar M, Yontem FD, Kahraman MV, et al. Polymeric nanoparticles for selective protein recognition by using thiol-ene miniemulsion photopolymerization. J Biomater Sci Polym Ed. 2020; 31(16): 2044-59.<\/li>
                          • Abulaila A, Erdem F, Oncul O, Aktas Z. Comparison of Four Phenotypic Assays and Check-Direct CPE for Detection of Carbapenemases-Producing Enterobacterales.Clin Lab. 2021 Jul 1;67(7). doi: 10.7754\/Clin.Lab.2020.201002.<\/li>
                          • Ba\u015faran S, \u015eim\u015fek-Yavuz S, Me\u015fe S, \u00c7a\u011fatay A, Medetalibeyo\u011flu A, \u00d6nc\u00fcl O, \u00d6zs\u00fct H, A\u011fa\u00e7fidan A, G\u00fcl A, Eraksoy H. The effect of tocilizumab, anakinra and prednisolone on antibody response to SARS-CoV-2 in patients with COVID-19: A prospective cohort study with multivariate analysis of factors affecting the antibody response. Int J Infect Dis. 2021 Apr;105:756-762. doi: 10.1016\/j.ijid.2021.03.031. Epub 2021 Mar 15. PMID: 33737128.<\/li>
                          • Erdem F, Kayacan C, Oncul O, Karagoz A, Aktas Z. Clonal distribution of vancomycin-resistant Enterococcus faecium in Turkey and the new singleton ST733. J Clin Lab Anal. 2020 Dec;34(12):e23541. doi: 10.1002\/jcla.23541. Epub 2020 Oct 6. PMID: 33025699.<\/li>
                          • Erdem F, Abulaila A, Aktas Z, Oncul O. In vitro evaluation of double carbapenem and colistin combinations against OXA-48, NDM carbapenemase-producing colistin-resistant Klebsiella pneumoniae strains. Antimicrob Resist Infect Control. 2020 May 19;9(1):70. doi: 10.1186\/s13756-020-00727-4. PMID: 32430058.<\/li>
                          • Sulaiman T, Medi S, Erdem H, Senbayrak S, Ozturk-Engin D, Inan A, Civljak R, Nechifor M, Akbulut A, Crisan A, Ozguler M, Namiduru M, Savic B, Dulovic O, Pehlivanoglu F, Sengoz G, Yasar K, Inal AS, Parlak E, Johansen IS, Kursun E, Parlak M, Yilmaz E, Yilmaz G, Gul HC, Oncul O, Sim\u00e9on S, Tattevin P, Ulu-Kilic A, Alabay S, Beovic B, Catroux M, Hansmann Y, Harxhi A, Sener A, Ozkaya HD, Ca\u011f Y, Agalar C, Vahaboglu H, Ugur BK, Hasbun R. The diagnostic utility of the “Thwaites’ system” and “lancet consensus scoring system” in tuberculous vs. non-tuberculous subacute and chronic meningitis: multicenter analysis of 395 adult patients. BMC Infect Dis. 2020 Oct 23;20(1):788. doi: 10.1186\/s12879-020-05502-9. PMID: 33096990.<\/li>
                          • Yasar M, Yontem FD, Kahraman MV, Apohan NK, Aktas Z, Oncul MO, Akcakaya H. Polymeric nanoparticles for selective protein recognition by using thiol-ene miniemulsion photopolymerization J Biomater Sci Polym Ed. 2020 Nov;31(16):2044-2059. doi: 10.1080\/09205063.2020.1793705. Epub 2020 Jul 22.<\/li>
                          • M Can, C Bairam, S Aksoy, S Kuruca, Z Akta\u015f, M \u00d6nc\u00fcl. Enhancement of Neel Relaxation at Magnetic Heating Performance of Iron Oxide Nanoparticles. Research Square. 2021. : https:\/\/doi.org\/10.21203\/rs.3.rs-149474\/v1.<\/li>
                          • Basaran S , Yilmaz E. , Yavuz S. S. , Cagatay A. , Oncul O. , Ozsut H et al. Nocardiosis Cases and Risk Factors for Infection in a Tertiary Care Hospital. FLORA INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI, cilt.26, sa.2, ss.285-294, 2021.<\/li>
                          • Can MM, Bairam C, S Aksoy, DS Kuruca, S Kaneko, Z Akta\u015f, MO \u00d6nc\u00fcl. Effect of Ti Atoms on N\u00e9el Relaxation Mechanism at Magnetic Heating Performance of Iron Oxide Nanoparticles. Coatings 2022, 12, 481. https:\/\/doi.org\/10.3390\/coatings12040481.<\/li>
                          • Erdem F, Agullar MD, L Oksuz, C Kayacan, A Abulaila, O Oncul, et al. Time kill-assays of antibiotic combinations for multidrug resistant clinical isolates of OXA- 48 carbapenemase producing Klebsiella pneumoniae. Acta Microbiologica et Immunologica Hungarica. 2022; Volume 69: Issue 3: 215-9.<\/li>
                          • F Erdem, G Gunel, Z Aktas, O Oncul. PHAGE THERAPY: AN ALTERNATIVE TREATMENT OPTION FOR MULTI-DRUG RESISTANT KLEBSIELLA PNEUMONIAE STRAINS. In: Advances in Health and Disease, Editor: Lowell T.Duncan, ISBN: 798-1-53619-788-4.<\/li>
                          • Basaran S, Evlice O, A Benli, S Simsek-Yavuz, A Cagatay, O Oncul, et al.. Skull Base Osteomyelitis and Long Term Outcome\/Kafa Tabani Osteomyelitleri ve Uzun Donem Sonuclari.2021; KLIMIK Journal(Vol. 34, Issue 2): pp. 129+.<\/li>
                          • Shawuti S, Bairam C, \u0130A Kariper, IN Korkut, Z Akta\u015f, MO \u00d6nc\u00fcl. Kuruca S. Green synthesis and characterization of silver and iron nanoparticles using Nerium oleander extracts and their antibacterial and anticancer activities. Plant J, 2021: https:\/\/doi.org\/10.46341\/PI2021010.<\/li>
                          • Oktelik FB, Civelek DO, Okyar A, Aktas EC, Kucuksezer UC, Akdeniz N, Solakoglu S, Cevik A, Oncul O, Deniz G. Evaluation of the Immunomodulatory Effects of C-Vx on the Innate and Adaptive System; Preliminary Results. Journal of Complenentary Medicine Research. 2022; 13 (3): 138-145.<\/li>
                          • Tahrali I, Akdeniz N, Yilmaz V, Kucuksezer UC, Oktelik FB, Ozdemir O, Cetin-Aktas E, Ogutmen Y, Ergen A, Abaci N, Tuzun E, Oncul O, Deniz G. The Modulatory Action of C-Vx Substance on the Immune System in COVID-19. Emerg Microbes Infect. 2022; 15:1-28.<\/li>
                          • Medetalibeyoglu A, Senkal N, Kose M, Catma Y, Caparali EB, Erelel M, Oncul O. The Journal of Nutrition, Health & Aging. 2020; 24, 928-37.<\/li>
                          • Alkanli SS, Dal Yontem F, Yasar M, Guven C, Kahraman MV, Apohan NK, Aktas Z, Oncul MO, Unlu A, Akcakaya H. Molecularly imprinted nanoparticles with recognition properties towards diphtheria toxin for ELISA applications. J Biomater Sci Polym Ed. 2022; 17;1-15.. doi: 10.1080\/09205063.2022.2145866. 156. Ya\u015far M, Y\u00f6ntem FD, Kahraman MV, Apohan NK, Akta\u015f Z, \u00d6nc\u00fcl MO, Ak\u00e7akaya H.J Polymeric nanoparticles for selective protein recognition by using thiol-ene miniemulsion photopolymerization. Biomater Sci Polym Ed. 2020 ;31(16):2044-2059. doi: 10.1080\/09205063.2020.1793705. Epub 2020 Jul 22.<\/li>
                          • Erelel M, Kaskal M, Akbal-Dagistan O, Issever H, Dagistanli AS, Balkanci H, Oguz MS, Qarayeva A, Culha M, Erturk A, Basarir NS, Sahin G, Uresin AY, Araman AO, Medetalibeyoglu A, Tukek T, Oncul MO, Yildiz-Pekoz A. Early Effects of Low Molekcular Weight Heparin Therapy with Soft Mist Inhaler for COVID-19 Induced Hypoxeia: A Phase IIb Trial. Pharmaceutics. 2021 Oct 22;13(11):1768. doi: 10.3390\/pharmaceutics13111768. 158.Basaran S, Simsek-Yavuz S, Mese S, Cagatay A, Medetalibeyoglu A, Oncul O, et al. The effect of tocilizumab, anakinra and prednisolone on antibody response to SARS-CoV-2 in patients with COVID-19: A prospective cohort study with multivariate analysis of factors affecting the antibody response. International Journal of Infectious Diseases, 2021; 105:: 756-62<\/li>
                          • Medetalibeyoglu A, Senkal AN, Kose M, Catma Y, Caparli EB, Erelel M, Oncul MO, Bahat G, Tukek T. Older adults hospitalized with COVID-19: clinical characteristics and early outcomes from a single center in Istanbul, Turkey. The journal of nutrition, health & aging 24, 928-37.<\/li>
                          • Can MM, Bairam C, Aksoy S, Kuruca DS, Kaneko S, Akta\u015f Z, Oncul MO. Effect of Ti atoms on neel relaxation mechanism at magnetic heating performance of iron oxide nanoparticles. Coatings, 2022; 12 (4): 481.<\/li>
                          • Karaka\u015f A, \u00d6nc\u00fcl O, Acar A, Turhan V, \u00c7avu\u015flu \u015e, G\u00f6renek L. The effect of day care centres to nasopharyngeal Streptococcus pneumoniae colonization and penicillin resistancey. Anatolian Journal of Clinical Investigation. Anatolian Journal of Clinical Investigation, 2010; 4 (1): 1-30.<\/li>
                          • Unver S, Atasoyu EM, Evrenkaya T, Ardic N, Ozyurt M. The importance of body flora in catheter-related bacteremia. Dialysis and Transplantation. 2006; 35(2): 72-83.<\/li>
                          • B Copur, S Dosler, Z Aktas, S Basaran, S Simsek-Yavuz, A Cagatay, et al. In vitro activities of antibiotic combinations against mature biofilms of ventilator associated pneumonia isolates. Future Microbiology. 2022; 17 (13): 1027-42.<\/li>
                          • Erdem F, D\u00edez-Aguilar M, Oksuz L, Kayacan C, Abulaila A, Oncul O. Time kill assays of antibiotic combinations for multidrug resistant clinical isolates of OXA-48 carbapenemase producing Klebsiella pneumoniae. Acta Microbiologica et Immunologica Hungarica, 2022; 14: 215-9. https:\/\/doi.org\/10.1556\/030.2022.01785.<\/li>
                          • Medetalibeyoglu A, Kaytaz M, Senkal N, Genc S, Aktar I, Omer B, Oncul O. Would Tracking Coagulation Together with inflamation markers be a prospect for Covid-19 Disease Prognosis? Clinical Laboratory. 2022; 68 (6).<\/li>
                          • Gurer EE, Oguz FS, Aktas Z, Besisik SK, Sezerman U, Oncul O, Gulbas Z. Microbiota and Kegg analysis after allogeneic stem cell transplantation for hematological malignancies. HLA 99 (5), 495-9.<\/li>
                          • Erdem H, Engin DO, Gencer S, Oncul O, Gul HC, Vahaboglu H. 1477 Factors affecting the early clinical response in due course of tuberculous meningitis treatment: Results of Haydarpasa-3 Study. Open Forum Infectious Diseases 1 (suppl-1). 2014; s390.<\/li>
                          • Can MM, Shawuti S, Kalindemirtas FD, Erdemir G, Kuruca DS, Kaneko S et al. Anticancer drug doxorubicin (DOX) loading performance of functionalized polyaniline (PANI) surface with active carbonJournal of Materials Science, 2023: 1-13.<\/li>
                          • Erdem H, Engin DO, Gencer S, Oncul O, Gul HC, Vahaboglu H. 1477 Factors affecting the early clinical response in due course of tuberculous meningitis treatment: Results of Haydarpasa-3 Study. Open Forum Infectious Diseases 1 (suppl-1). 2014; s390.<\/li>
                          • Can MM, Shawuti S, Kalindemirtas FD, Erdemir G, Kuruca DS, Kaneko S et al. Anticancer drug doxorubicin (DOX) loading performance of functionalized polyaniline (PANI) surface with active carbonJournal of Materials Science, 2023: 1-13.<\/li>
                          • Kalemoglu M, Oncul O, Keskin O. The Evaluation of Traumatize Open Wound Culture Results. Scand J Trauma Resusc Emerg Med 2006; 14; 1-4.<\/li>
                          • Sneider MS, Solorzano CC, Monano RE, et al. Sporadic primary hyperparathyroidism in young individuals: different disease and treatment? J Surg Res. 2009;155(1):100-3.doi: 10.1016\/j.jss.2008.07.041. Epub 2008 Sep 4.<\/li>
                          • Karaahmetoglu G, Atabey C, Oncul O, et al. Successful Treatment of Ventriculitis Caused by Extensively Drug-resistant Acinetobacter Baumannii with Intraventricular Colistin Administration: Report of Two Cases. Dis Mol Med 2014;2: 65-9.<\/li>
                          • Yeniiz E, Oncul O, Cavuslu S. Investigation of Escherichia coli O157: H7 in fecal samples of patients with diarrhea. T\u00fcrkiye Klinikleri T\u0131p Bilimleri Dergisi. 2009; 29 (6): 1398-1405.<\/li>
                          • Aktas Z, Sonmez N, Oksuz L, Boral O, Issever H, Oncul O. Efficacy of antibiotic combinations in an experimental sepsis model with Pseudomonas aeruginosa. Braz J Microbiol. DOI: 10.1007\/s42770-023-01141-9, 2023.<\/li>
                          • Hivda Ulbegi Polat, Irem Abaci Arzu Tas Ekiz Ozge Aksoy Fatma Betul Oktelik Vuslat Yilmaz Saban Tekin Alper Okyar,Oral Oncul and Gunnur Deniz. Therapeutic Effect of C-Vx Substance in K18-hACE2 Transgenic Mice Infected with SARS-CoV-2. International Journal of Medical Science. 2023;34(6):753-767.<\/li>
                          • Suleymanoglu M, Bozkurt AE, Sel FA, Ozdemir IA, Oguz FS, Kuruca DS, Aktas Z, Karakas Z, Oncul MO. In vitro anti-leukemic effect of Wharton’s jelly derived mezenchymal stem cell. Mol Biol Rep. 2024, 5(1): 595. 178. Savran M, Y\u0131lmaz MY, Oncul MO, Sever K. Manufacturing and Modeling of Polypropylene-based Hybrid Composites by Using Multiple-Nonlinear Regression Analysis. 2022; 2 (1): 1-15.<\/li>
                          • Gurer EE, Besisik SK, Sezerman U, et al. HL-122 Microbiota Changes in Hodgkin and Non-Hodgkin Lymphoma Treatment: Assessment With II-17 and II-12 Levels. Clinical Leukemia, Myeloma and Lymphoma. 2023, Vol 23, Suppl 1.<\/li>
                          • Shawuti S, Bairam C, Beyatli A, Kariper A, Korkut I, Aktas Z, Oncul MO, Kuruca S. Green Synthesis and Characterization of Silver and Iron Nanoparticles Using Nerium Oleander Extracts and their Antibacterial and Anticancer Activities. Plant Introduction, 2021. DOI:10.46341\/pi2021010.<\/li>
                          • Y\u0131lmaz E, Benli A, Ba\u015faran S, \u015eim\u015fek-Yavuz S, Cagatay A, Oncul MO, \u00d6zs\u00fct H, Eraksoy H. Community-Acquired Pneumonia in the Immunocompromised Patients: An Observational Study from a Single Center, TURKEY. Infection and Drug Resistance 2024, 17:4875-85.<\/li>
                          • Budak S, Acar A, Karacaer Z, Diktas H, Turhan V, Oncul O, Gorenek L. Compliance of health care workers with suggested pandemic influenza and vaccine side effects. Tropical Medicine & International Health. 2011; 16: 366-8.<\/li>
                          • Erdem H, Ozturk-Engin D, Gencer S, Oncul O, Gul HC, Vahaboglu H. Factors Affecting the Early Clinical Response in due course of Tuberculosis Meningitis Treatment: Results of Haydarpasa-3 Study, 2014; 1 (Suppl 1): 390. https:\/\/doi.org\/10.1093\/ofid\/ofu052.1023. 184. Oncul MO. The clinic of COVID-19, Turkiye Klinikleri \u00d6zel Say\u0131s\u0131, 2023. (https:\/\/www.turkiyeklinikleri.com\/upload\/issueauthors\/covid-19yazarlar1-37.pdf).<\/li>
                          • Rosenthal VD, Richtmann R, Singh S,at al. INICC Members.(Oncul O).Surgical site infections, International Nosocomial Infection Control Consortium (INICC) report, data summary of 30 countries, 2005-2010. Infect Control Hosp Epidemiol. 2013 Jun; 34(6): 597-604. PMID: 23651890 DOI: 10.1086\/670626<\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t
                            \n\t\t\t\t
                            \n\t\t\t\t\t\r\n
                            \r\n\r\n

                            National Scientific Publications<\/h3> \r\n\r\n <\/div>\r\n\r\n \t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
                            \n\t\t\t\t\t\t\t\t\t
                            • Keskin K, O. \u00d6nc\u00fcl, H. Germeyan ve O.\u015e. Yenen, “Klinik \u00f6rneklerden izole edilen Pseudomonas aeruginosa su\u015flar\u0131n\u0131n \u00e7e\u015fitli antibiyotiklere duyarl\u0131l\u0131klar\u0131n\u0131n E Testi ile ara\u015ft\u0131r\u0131lmas\u0131”, T\u00fcrk Mikrobiyoloji ve \u0130nfeksiyon Hastal\u0131klar\u0131 KL\u0130M\u0130K Dergisi 2: 89-90 (1996).<\/li>
                            • \u00d6nc\u00fcl O, \u015e. \u00c7avu\u015flu, M.F. \u00d6zsoy, H. Altunay ve O.\u015e. Yenen, “Pn\u00f6mokok su\u015flar\u0131nda penisilin direncinin ara\u015ft\u0131r\u0131lmas\u0131”, T\u00fcrk Mikrobiyoloji ve \u0130nfeksiyon Hastal\u0131klar\u0131 KL\u0130M\u0130K Dergisi 12 (1): 3-8 (1999).<\/li>
                            • \u00d6nc\u00fcl O, M.F. \u00d6zsoy, A. Pahsa ve H. Erdem, “Salmonelloz: 71 olgunun de\u011ferlendirilmesi”, T\u00fcrk Mikrobiyol Cem Derg 29 (3-4):127-132 (1999).<\/li>
                            • \u00d6nc\u00fcl O, M.F. \u00d6zsoy, N. Ko\u00e7ak ve A. Pahsa, “\u015earbon: 27 olgunun de\u011ferlendirilmesi*”, Flora \u0130nfeksiyon Hastal\u0131klar\u0131 ve Klinik Mikrobiyoloji Dergisi* 5 (3):195-198 (2000).<\/li>
                            • Pahsa A, M.F. \u00d6zsoy, O. \u00d6nc\u00fcl, H. Erdem ve N. Ko\u00e7ak, “GATA Haydarpa\u015fa E\u011fitim Hastanesi’nde 1993-1998 y\u0131llar\u0131 aras\u0131nda incelenen kan k\u00fclt\u00fcrlerinin irdelenmesi”, Hastane \u0130nfeksiyonlar\u0131 Dergisi 4: 51-57 (2000).<\/li>
                            • Erdemo\u011flu A, M.F. \u00d6zsoy, G. Emekda\u015f, O. \u00d6nc\u00fcl ve A. Pahsa, “\u0130drardan izole edilen oksasilin duyarl\u0131 ve diren\u00e7li stafilokok su\u015flar\u0131n\u0131n fusidik asit ve di\u011fer antimikrobik maddelere duyarl\u0131kl\u0131klar\u0131”, T\u00fcrk Mikrobiyoloji Cemiyeti Dergisi 30 (1-2): 6-12 (2000).<\/li>
                            • \u00d6zsoy MF, G. Emekda\u015f, A. Pahsa, A. Erdemo\u011flu, M.T. \u00d6zer, T. Bozb\u0131y\u0131k, O. \u00d6nc\u00fcl ve \u00d6. Kocabeyo\u011flu, “Sa\u011fl\u0131k \u00e7al\u0131\u015fanlar\u0131nda Hepatit B ve Hepatit C Seroprevalans\u0131”, Viral Hepatit Dergisi 6 (2): 71-74 (2000).<\/li>
                            • \u00c7avu\u015flu \u015e, O. \u00d6nc\u00fcl, A Erdemo\u011flu, M.F. \u00d6zsoy ve G. Emekda\u015f, “\u00c7ocuk ve eri\u015fkin serum \u00f6rneklerinde Rubella seroprevalans\u0131”, \u0130nfeksiyon Dergisi (Turkish Journal of Infection) 15: 419-424 (2001).<\/li>
                            • \u00d6zkan S, O. \u00d6nc\u00fcl, C. Demirkol ve M.G\u00f6kben, “Yo\u011fun bak\u0131m \u00fcnitesinde kar\u015f\u0131la\u015f\u0131lan nozokomiyal infeksiyon etkenleri ve s\u0131kl\u0131klar\u0131”, Anestezi Dergisi 9: 43-47 (2001).<\/li>
                            • \u00d6zsoy MF, A. Pahsa, A. Y\u0131ld\u0131r\u0131m, A. Erdemo\u011flu, G. Emekda\u015f ve O.\u00d6nc\u00fcl, “Klebsiella ve Escherichia coli su\u015flar\u0131nda beta-laktam antibiyotiklere diren\u00e7 ve “Geni\u015flemi\u015f Spektrumlu Beta Laktamaz” s\u0131kl\u0131\u011f\u0131”, T\u00fcrk Mikrobiyoloji Cemiyeti Dergisi 31 (1-2): 46-53 (2001).<\/li>
                            • K\u00fc\u00e7\u00fckardal\u0131 Y, O. \u00d6nc\u00fcl, S. Nalbant, Z. \u00c7ank\u0131r, C. Top, \u015e. A\u011fda\u015f, E. \u015eilt ve M. Danac\u0131 “Ya\u015fl\u0131 pop\u00fclasyonda toplum k\u00f6kenli pn\u00f6moni olgular\u0131”, T\u00fcrk Geriatri Dergisi 4: 59-62 (2001).<\/li>
                            • \u00d6nc\u00fcl O, M.F. \u00d6zsoy, E. \u0130nci ve A. Pahsa, “Rek\u00fcrren akut tonsillit olgular\u0131nda tonsil y\u00fczey, \u00e7ekirdek ve arka y\u00fcz mikrofloras\u0131n\u0131n kar\u015f\u0131la\u015ft\u0131r\u0131lmas\u0131”, Flora \u0130nfeksiyon Hastal\u0131klar\u0131 ve Klinik Mikrobiyoloji Dergisi 6 (2) : 101-107 (2001).<\/li>
                            • \u00d6zsoy MF, O. \u00d6nc\u00fcl, A. Pahsa, H. Erdem ve G.Emekda\u015f, “Etil alkol, povidon iyot ve benzalkonyum klor\u00fcr\u00fcn Pseudomonas aeruginosa su\u015flar\u0131na kar\u015f\u0131 etkinli\u011fi”, T\u00fcrk Mikrobiyoloji ve \u0130nfeksiyon Hastal\u0131klar\u0131 KL\u0130M\u0130K Dergisi 14: 30-32 (2001).<\/li>
                            • \u00d6nc\u00fcl O, C. Top ve \u015e. \u00c7avu\u015flu, “Tip-2 diyabet geli\u015fiminde kronik HCV infeksiyonu bir risk fakt\u00f6r\u00fc m\u00fcd\u00fcr?”, Viral Hepatit Dergisi 1: 436-440 (2002).<\/li>
                            • \u00d6nc\u00fcl O, G. Emekda\u015f, H. Altunay, O. Sezer ve \u015e. \u00c7avu\u015flu, “G\u00fclhane Askeri T\u0131p Akademisi Haydarpa\u015fa E\u011fitim Hastanesi’nde Yatan Hastalardan \u0130zole Edilen Mikroorganizmalar\u0131n 1999 Y\u0131l\u0131 Analizi”, Hastane \u0130nfeksiyonlar\u0131 Dergisi 4: 195-201 (2002).<\/li>
                            • \u00c7avu\u015flu \u015e, O. \u00d6nc\u00fcl, Y. K\u00fc\u00e7\u00fckardal\u0131, E. G\u00f6nc\u00fco\u011flu ve M. Danac\u0131, “Hastane infksiyonlar\u0131n\u0131n \u00f6nlenmesinde infeksiyon kontrol komitesi ne kadar etkili?”, \u0130nfeksiyon Dergisi (Turkish Journal of Infection) 16: 443-449 (2002).<\/li>
                            • Erdem H, O. \u00d6nc\u00fcl, \u015e. \u00c7avu\u015flu ve A. Pahsa, “Sivas b\u00f6lgesinde hastal\u0131k etkeni pn\u00f6mokoklarda diren\u00e7”, T\u00fcrk Mikrobiyoloji ve \u0130nfeksiyon Hastal\u0131klar\u0131 KL\u0130M\u0130K Dergisi 15: 46-48 (2002).<\/li>
                            • \u00d6nc\u00fcl O, M.F. \u00d6zsoy, V. Cimin, H. Altunay ve \u015e.\u00c7avu\u015flu, “Hastane ortam\u0131ndan izole edilen bakterilerde antibiyotik duyarl\u0131l\u0131\u011f\u0131: \u0130ki y\u0131ll\u0131k verilerin kar\u015f\u0131la\u015ft\u0131r\u0131lmas\u0131*”, Haydarpa\u015fa Numune Dergisi,* 42: 33-38 (2002).<\/li>
                            • \u00d6nc\u00fcl O, A. Erdemo\u011flu, M.F. \u00d6zsoy, H. Altunay, Z. Ertem ve \u015e. \u00c7avu\u015flu, “Hastane personelinde nazal Staphylococcus aureus ta\u015f\u0131y\u0131c\u0131l\u0131\u011f\u0131”, T\u00fcrk Mikrobiyoloji ve \u0130nfeksiyon Hastal\u0131klar\u0131 KL\u0130M\u0130K Dergisi 15: 74-77 (2002).<\/li>
                            • \u00d6nc\u00fcl O, H. Erdem, H. Altunay, M.F. \u00d6zsoy, A. Pahsa ve \u015e. \u00c7avu\u015flu, “Pn\u00f6mokoklarda penisiline diren\u00e7 trendi”, T\u00fcrk Mikrobiyoloji Cemiyeti Dergisi, 33: 109-114 (2003).<\/li>
                            • \u00d6zkan S, M.G\u00f6kben, M. \u00d6zsoy, V. Acar, O. \u00d6nc\u00fcl ve S. Po\u00e7an, “Major abdominal cerrahide standart ve immunon\u00fctrisyonun, n\u00fctrisyon ve imm\u00fcnoloji parametrelerine etkilerinin kar\u015f\u0131la\u015ft\u0131r\u0131lmas\u0131”, T\u00fcrk Anesteziyoloji ve Reanimasyon Cemiyeti Mecmuas\u0131 30 (10): 473-479 (2002).<\/li>
                            • Ozsoy MF, Ozyurt M, Oncul O, Cavuslu S. BSE ve insan prion hastal\u0131klar\u0131. Sendrom; 2003; 1: 97-107.<\/li>
                            • Erdem H, M. Cetin, T. Timuroglu, A. Cetin, O. Yanar, O. Oncul, S. Cavuslu ve A. Pahsa, “Vaginal Yeasts: Identification and antifungal resistance”, Gynecology, Obstetrics & Reproductive Medicine (GORM) 9: 29-32 (2003).<\/li>
                            • Ereno\u011flu C, O. \u00d6nc\u00fcl, \u015e. Y\u0131ld\u0131z, T. \u00c7elenk ve \u015e. \u00c7avu\u015flu, “Fournier Gangreni: 5 y\u0131ll\u0131k klinik deneyimlerimiz”. \u00c7a\u011fda\u015f Cerrahi Dergisi, 17 (2):91-95 (2003)<\/li>
                            • \u00d6nc\u00fcl O, A, Bahar, F. Karademir ve \u015e. \u00c7avu\u015flu, “Akut gastroenteritli \u00e7ocuk ya\u015f grubunda Rotavirus ve Adenovirus s\u0131kl\u0131\u011f\u0131n\u0131n saptanmas\u0131” Haydarpa\u015fa Numune Dergisi. 43(3):133-137 (2003)<\/li>
                            • \u00d6zkan S, M. Metin, M. G\u00f6kben, O. \u00d6nc\u00fcl, V. Acar, S. Po\u00e7an ve O. \u00c7ak\u0131r, “Helikobakter pilori nozokomiyal bir infeksiyon etkeni midir?”, T\u00fcrk Anesteziyoloji ve Reanimasyon Cemiyeti Mecmuas\u0131.2003; 31: 409-14.<\/li>
                            • Kalemo\u011flu M, O. \u00d6nc\u00fcl, \u00d6. Keskin ve \u015e. \u00c7avu\u015flu, “GATA Haydarpa\u015fa E\u011fitim Hastanesi \u0130lk Yard\u0131m Servisi’ne ba\u015fvuran a\u00e7\u0131k yaralanma olgularar\u0131n\u0131n yara k\u00fclt\u00fcr sonu\u00e7lar\u0131n\u0131n irdelenmesi”, Haydarpa\u015fa Numune Dergisi 2002; 42: 25-9.<\/li>
                            • \u00d6zsoy MF, \u015e. \u00c7avu\u015flu, O. \u00d6nc\u00fcl, N. Ko\u00e7ak ve O.\u015e. Yenen, “Splenik komplikasyonlu iki s\u0131tma olgusu”, T\u00fcrk Mikrobiyoloji ve \u0130nfeksiyon Hastal\u0131klar\u0131 KL\u0130M\u0130K Dergisi 11: 45-47 (1998).<\/li>
                            • Yi\u011fitler C, N. Bulut ve O. \u00d6nc\u00fcl, “\u0130nguinal herniografi sonras\u0131 nadir bir komplikasyon: Fornier Gangreni”, GATA B\u00fclteni 40: 396-398 (1998).<\/li>
                            • \u00d6nc\u00fcl O, M.F. \u00d6zsoy, T. Sar\u0131\u00e7am ve A. Pahsa, “Tifoya ba\u011fl\u0131 terminal ileum perforasyonu: 4 olgu nedeni ile”, Ege T\u0131p Dergisi. 40 (2): 137-140 (2001).<\/li>
                            • Altunay H, O. \u00d6nc\u00fcl ve \u015e. \u00c7avu\u015flu, “Rek\u00fcrren Menenjitler: 14 olgu nedeniyle T\u00fcrk Mikrobiyoloji ve \u0130nfeksiyon Hastal\u0131klar\u0131 KL\u0130M\u0130K Dergisi 14: 150-153 (2001).<\/li>
                            • \u00d6zkan S, O. \u00d6nc\u00fcl, C. Demirkol, R. Erg\u00fcr ve M.G\u00f6kben, “Rahim i\u00e7i ara\u00e7 \u00e7\u0131kar\u0131lmas\u0131 ve probe k\u00fcretaj sonras\u0131 septik \u015fok ve multi-organ yetmezli\u011fi geli\u015fimi: (olgu sunumu)”, G\u00fclhane T\u0131p Dergisi 44 (1): 99-102 (2002).<\/li>
                            • Altunay H, O. \u00d6nc\u00fcl, H. Balo\u011flu ve N. Sara\u00e7o\u011flu, “Bir viral deri infeksiyonu olgusu: Orf”, \u0130nfeksiyon Dergisi (Turkish Journal of Infection) 16: 371-376 (2002).<\/li>
                            • \u00d6nc\u00fcl O, \u015e. \u00c7avu\u015flu ve O.\u015e. Yenen, “Penisiline diren\u00e7li pn\u00f6mokoklar \u00fclkemiz i\u00e7in ger\u00e7ekten bir sorun mu?”, Flora \u0130nfeksiyon Hastal\u0131klar\u0131 ve Klinik Mikrobiyoloji Dergisi 4 (Supplement 2):1-23 (1999).<\/li>
                            • \u00d6nc\u00fcl O ve \u015e. \u00c7avu\u015flu, “Hepatit G virus (HGV\/GBV-C) infeksiyonlar\u0131na g\u00fcncel yakla\u015f\u0131m”, Viral Hepatit Dergisi 7: 281-285 (2001).<\/li>
                            • Pahsa A, M.F. \u00d6zsoy, O. \u00d6nc\u00fcl, H. Erdem ve E. Elb\u00fcken, “\u0130nfeksiyon Hastal\u0131klar\u0131nda Hiperbarik Oksijen Tedavisinin Yeri”, Sendrom Dergisi 13 (2): 84-88 (2001).<\/li>
                            • \u00d6zsoy MF, O. \u00d6nc\u00fcl, A. Y\u0131ld\u0131r\u0131m ve A. Pahsa, Geni\u015fletilmi\u015f Spektrumlu Beta-Laktamazlar: Klinik \u00d6nemi ve Getirdi\u011fi Sorunlar. Flora \u0130nfeksiyon Hastal\u0131klar\u0131 ve Klinik Mikrobiyoloji Dergisi 6 (Supplement 1) (2001).<\/li>
                            • \u00d6nc\u00fcl O, “Diyabetik ayak infeksiyonlar\u0131na yakla\u015f\u0131m”, Flora \u0130nfeksiyon Hastal\u0131klar\u0131 ve Klinik Mikrobiyoloji Dergisi 2: 74-80 (2001).<\/li>
                            • Kalemo\u011flu M, \u00d6. Keskin, O.\u00d6nc\u00fcl, “Acil Servislerde \u0130nfeksiyon Hastal\u0131klar\u0131na Tedavi Yakla\u015f\u0131mlar\u0131”, Sendrom Dergisi 14: 36-42 (2002).<\/li>
                            • \u00d6nc\u00fcl O, “Antibiyotikler I”, Tabak F, \u00d6zt\u00fcrk R, Aktu\u011flu Y eds*. Ak\u0131lc\u0131 Antibiyotik Kullan\u0131m\u0131 ve Eri\u015fkinde Toplumdan Edinilmi\u015f Enfeksiyonlar*. \u0130.\u00dc. Cerrahpa\u015fa T\u0131p Fak\u00fcltesi S\u00fcrekli T\u0131p E\u011fitimi Etkinlikleri Sempozyum Dizisi, \u0130stanbul, 23-38 (2002).<\/li>
                            • \u00d6nc\u00fcl O, (Kitap \u00e7evirisi) “Streptococcus pneumoniae”, (B\u00f6l\u00fcm 47) \u00c7eviri Edit\u00f6r\u00fc: D\u00fcndar \u0130.H. In: Current \u0130nfeksiyon Hastal\u0131klar\u0131 Tan\u0131 ve Tedavi. Nobel T\u0131p Kitabevi, \u0130stanbul, 2003; 489-501.<\/li>
                            • \u00d6nc\u00fcl O, (Kitap \u00e7evirisi) “Akut \u0130nfeksiy\u00f6z ishaller ve Besin zehirlenmesi”. In: Harrison \u0130\u00e7 Hastal\u0131klar\u0131 Prensipleri, Cilt 1. B\u00f6l\u00fcm Yazar\u0131: Stephen B. Calderwood. Nobel Matbaac\u0131l\u0131k ve Yay\u0131n & Mc Grow-Hill, s: 834-9, 2001-Istanbul.<\/li>
                            • \u00d6nc\u00fcl O. (Kitap \u00e7evirisi) ” Infections due to Fungi, Actinomyces, and Nocardia”. In: Reese & Bettis’s A Pratical Approach to Infectious Diseases, \u00c7eviri Ed. Prof. Dr. Fehmi Tabak, OHAN Matbaac\u0131l\u0131k, \u0130stanbul Medikal Yay\u0131nc\u0131l\u0131k Ltd. Sti. 5. Bask\u0131, 2005- \u0130stanbul.<\/li>
                            • \u00d6nc\u00fcl O. (Kitap \u00e7evirisi) “Hastane kaynakl\u0131 stafilokok infeksiyonlar\u0131”. Hastane \u0130nfeksiyonlar\u0131 Kitab\u0131, Edit\u00f6rler: Prof. Dr. Mesut Pek\u00e7an, Prof. Dr. Alaaddin Pahsa, Do\u00e7. Dr. Levent G\u00f6renek, Do\u00e7. Dr. B\u00fclent A Be\u015firbellio\u011flu. S: 329-43, GATA Bas\u0131mevi, 2003-Ankara<\/li>
                            • \u00d6nc\u00fcl O. (Kitap \u00e7evirisi) “Travmal\u0131 hastalarda proflaksi”, Afet T\u0131bb\u0131, Ed: Mehmet Ery\u0131lmaz, Ufuk Dizer, s: 565-73, I.Cilt, 1. Bask\u0131, \u00dcnsal Yay\u0131nlar\u0131, 2005-Ankara.<\/li>
                            • \u00d6nc\u00fcl O. (Kitap b\u00f6l\u00fcm\u00fc) “Sepsis tan\u0131m\u0131, etiyoloji ve epidemiyoloji”, Ed. K\u00fc\u00e7\u00fckardal\u0131 Y, GATA Bas\u0131mevi, Ankara 2006.<\/li>
                            • \u00dcnver S, Atasoyu EM, Evrenkaya TR, Ard\u0131\u00e7 N, \u00d6zyurt M, \u00d6nc\u00fcl O, T\u00fclbek MY. Kateterle ili\u015fkili bakteriyemide v\u00fccut floras\u0131n\u0131n \u00f6nemi. \u0130nfekksiyon Dergisi (Turkish Journal of Infection) 2005; 19: 87-90.<\/li>
                            • \u00d6nc\u00fcl O. Clostridium difficile infeksiyonlar\u0131ndan korunma. Yeni ve Yeniden G\u00fcndeme Gelen \u0130nfeksiyonlar. Ed. Prof. Dr. Recep \u00d6zt\u00fcrk. Bilimsel T\u0131p Yay\u0131nevi, Ankara-2005.<\/li>
                            • Berdan ME, Top C, \u00d6nde ME, \u00d6nc\u00fcl O, Er\u015fanl\u0131 D, Danac\u0131 M. Vask\u00fcler endoteliyal b\u00fcy\u00fcme fakt\u00f6r\u00fc (VEGF)’n\u00fcn diyabetik retinopati geli\u015fimindeki rol\u00fc ve ins\u00fclin direnci, beta-h\u00fccre indeksi ile ili\u015fkisi. Endokrinolojide Diyalog 2005; 2: 81-9.<\/li>
                            • Gul HC, Kurnaz A, Turhan V, Oncul O, Pahsa A. Microorganisms isolated from middle ear cultures and their antibacterial susceptibility in patients with chronic suppurative otitis media. Kulak Burun Bogaz \u0130htisas Derg. 2006; 16: 164-8.<\/li>
                            • Top C, Demirci M, \u00d6nc\u00fcl O, Terekeci H. Tip 2 diyabette inflamasyon, adipoz doku ve adipositokinler. Folia Hipertansiyon Diyabet Ateroskleroz Dergisi, 2006; 4: 8-11.<\/li>
                            • Kavruk U, \u00d6nc\u00fcl O. Yan\u0131k ve apopitoz. Sendrom Dergisi, 2006; 18: 36-43.<\/li>
                            • Kucukardali Y, Oncul O, Kunter E, Solmazgul E, Turhan V, et al. Fever of unknown origin –are there predictors of outcome: a multicenter study. Anatol J Clin Invest, 2007; 1(2): 111-7.<\/li>
                            • Acar A, \u00d6nc\u00fcl O. Toplum k\u00f6kenli pn\u00f6moniler. KL\u0130M\u0130K Dergisi, 2007; 20: 1-6.<\/li>
                            • \u00d6nc\u00fcl O. (Kitap B\u00f6l\u00fcm\u00fc) Hastane enfeksiyonlar\u0131n\u0131n kontrol\u00fc. Enfeksiyon Hastal\u0131klar\u0131 ve Mikrobiyoloji. Edit\u00f6rler:Prof. Dr. Ay\u015fe Willke-Topcu, Prof. Dr. G\u00fcner S\u00f6yletir, Prof. Dr. Mehmet Do\u011fanay. 3. Bask\u0131, s: 1039-47 Nobel T\u0131p Yay\u0131nevi, \u0130stanbul-2007.<\/li>
                            • \u00d6nc\u00fcl O, Keskin O, Turhan V, \u0130lhan H, Kalemoglu M, \u00c7avuslu S. \u0130lk yard\u0131m servisine mening kirritasyon bulgular\u0131 ile ba\u015fvuran ve lomber ponsiyon uygulanan ellid\u00f6rt eri\u015fkin olgunun irdelenmesi. Haydarpa\u015fa Numune E\u011fitim ve Ara\u015ft\u0131rma Hastanesi T\u0131p Dergisi, 2007; 47 (2): 286-92.<\/li>
                            • \u00d6nc\u00fcl O. Yan\u0131k infeksiyonlar\u0131. T\u00fcrkiye Klinikleri Cerrahi T\u0131p Bilimleri Dergisi. 2007; 3: 41-6.<\/li>
                            • \u00d6nc\u00fcl O. Hepatit B Virus\u00fc Epidemiyolojisi. A\u015f\u0131 Serisi, Ed. Prof. Dr. Selim Badur, Bilimsel T\u0131p Yay\u0131nevi, Ankara 2007; 7-18.<\/li>
                            • \u00d6nc\u00fcl O. Yan\u0131k Enfeksiyonlar\u0131, Korunma ve Kontrol. Hastane Enfeksiyonlar\u0131: Korunma ve Kontrol. Ed: Prof. Dr. Recep \u00d6zt\u00fcrk, Prof. Dr. Ne\u015fe Salto\u011flu, Do\u00e7. Dr. G\u00f6khan Ayg\u00fcn, Aksu Bas\u0131m Yay\u0131n, Ocak 2008; 105-21.<\/li>
                            • Turhan V, \u00c7oban M, \u00d6nc\u00fcl O, \u00c7avu\u015flu \u015e. K\u0131sa s\u00fcreli Steroid kullanan bir hastada saptanan Strongyloidoz ve Loeffler Sendrom tablosu. T\u00fcrkiye Parazitoloji Dergisi. 2008; 32 (1): 48-50.<\/li>
                            • Acar A, \u00d6nc\u00fcl O. Cerrahi Alan \u0130nfeksiyonlar\u0131. KL\u0130M\u0130K Dergisi, 2007; 20: 35-46.<\/li>
                            • \u00d6nc\u00fcl O. Ventilat\u00f6rle ili\u015fkili pn\u00f6moni. III. Ulusal Yo\u011fun Bak\u0131m \u0130nfeksiyonlar\u0131 Sempozyumu. Sempozyum Kitab\u0131, Edit\u00f6r, Prof. Dr. Haluk Eraksoy, 2007; 35-8.<\/li>
                            • \u00d6nc\u00fcl O. Diyabette n\u00f6trofil fonksiyon bozukluklar\u0131. I. Ulusal Diyabetik Ayak \u0130nfeksiyonlar\u0131 Sempozyumu. Sempozyum Kitab\u0131, Edit\u00f6rler, Yrd. Do\u00e7. Dr. M.B\u00fclent Ertu\u011frul, Do\u00e7. Dr. Nur Yapar, 2008; 4-5.<\/li>
                            • Turhan V, Dikta\u015f H, \u00d6nc\u00fcl O. Akut kar\u0131n ve pansitopeni tablosu ile seyreden Bruselloz: Bir olgu sunumu. Klimik Dergisi, 2008; 21: 31-3.<\/li>
                            • \u00d6nc\u00fcl O. Yo\u011fun bak\u0131mda infeksiyonu olan ya\u015fl\u0131 hastalarda sorunlar. Yo\u011fun Bak\u0131mda Ya\u015fl\u0131 Hasta Sorunlar\u0131, Ed. Do\u00e7. Dr. Ya\u015far K\u00fc\u00e7\u00fckardal\u0131, Yrd. Do\u00e7. Dr. Hakan Terekeci, 55-69, Nobel T\u0131p Kitabevi, \u0130stanbul, 2008.<\/li>
                            • \u00d6nc\u00fcl O: Antibiyotik direnci ile ilgili ulusal ve uluslar aras\u0131 \u00e7al\u0131\u015fmalar. XXXIII. T\u00fcrk Mikrobiyoloji Kongre Kitab\u0131, 2008-Istanbul: 423-9.<\/li>
                            • \u00d6nc\u00fcl O. Yan\u0131k \u0130nfeksiyonlar\u0131. Yara Bak\u0131m\u0131 ve Tedavisi Kitab\u0131. Edit\u00f6rler: Kartal Erdost \u015e, \u00c7etinkale O. \u0130stanbul \u00dcniversitesi Cerrahpa\u015fa T\u0131p Fak\u00fclteasi S\u00fcrekli T\u0131p E\u011fitimi Etkinlikleri, s: 129-144, Aksu Bas\u0131m, 2008- \u0130stanbul.<\/li>
                            • \u00d6nc\u00fcl O. Sepsis ve imm\u00fcn yan\u0131t. T\u00fcrkiye Klinikleri Enfeksiyon Hastal\u0131klar\u0131 Dergisi. 2008; 1: 23-30.<\/li>
                            • Turhan V, \u00c7arpraz H, Karacaer Z, \u00d6nc\u00fcl O. N\u00f6roburuselloz; \u00fc\u00e7 olgu nedeniyle. Flora Dergisi. 2008; 13: 146-149.<\/li>
                            • K\u00fc\u00e7\u00fckardali Y, Karag\u00f6z B, Solmazg\u00fcl E, Bilgi O, Terekeci H, \u00d6nc\u00fcl O, \u00d6ktenli \u00c7. Secondary Pulmonary Arterial Hypertension in a Patient with Common Variable Immunodeiciency : Treatment with low dose Sildenafil. Anatol J Clin Investig; 2009; 3(1): 97-9.<\/li>
                            • Oncul O, Mert A. Nedeni bilinmeyen ate\u015fli bir olguya yakl\u0131\u015f\u0131m. 14. T\u00fcrk Klinik Mikrobiyoloji ve Infeksiyon Hastal\u0131klar\u0131 Kongre Kitab\u0131. 2009-Istanbul: 12-5.<\/li>
                            • Oncul O. Nozokomiyal Viral Hepatit Sorunu. 3.Ulusal Viroloji Kongresi \u00f6zet kitab\u0131, 2008-Istanbul.<\/li>
                            • \u00d6nc\u00fcl O, G\u00fcl HC, Turhan V, Ard\u0131\u00e7 N, Diler M, Haznedaro\u011flu T, \u00c7avu\u015flu \u015e. A comparison of Hepatitis Seroprevalance in various age groups over a 10 years interval. The Anatolian Journal of Clinical Investigation. 2007; 1(3): 151-4.<\/li>
                            • Acar A, Rodop O, Yenilmez E, Baylan O, \u00d6nc\u00fcl O. Case Report: Primary Localization of a Hydatid Cyst in the Adductor Brevis Muscle. Turkiye Parazitol Derg, 2009; 33 (2): 174-6.<\/li>
                            • \u00d6nc\u00fcl O. Yo\u011fun Bak\u0131m \u00fcnitesinde ate\u015fli hastaya yakla\u015f\u0131m. Yo\u011fun Bak\u0131m \u00dcnitesinde \u0130nfeksiyonlar. Eds. Prof. Dr. Ata Nevzat Yal\u00e7\u0131n, Do\u00e7. Dr. R\u0131za Hakan Erbay, Nobel Matbaac\u0131l\u0131k, \u0130stanbul, 2009.<\/li>
                            • Acar A, \u00d6nc\u00fcl O, \u00c7avu\u015flu \u015e, Okutan O, Kartalo\u011flu Z. Olgu Sunumu: Akut Bakteriyel Toplum K\u00f6kenli Pn\u00f6moni Klini\u011fini Taklit Eden Ascaris Lumbricoides’e Ba\u011fl\u0131 bir L\u00f6ffler’s Sendromu. T\u00fcrkiye Parazitoloji Dergisi, 2009; 33 (3): 239-41.<\/li>
                            • \u00d6nc\u00fcl O. Hepatit B Virus infeksiyonlar\u0131ndan korunma. Eri\u015fkin A\u015f\u0131lama El Kitab\u0131, Ed: Prof. Dr. Selim Badur. Mart\u0131 Ofset, \u015ei\u015fli \u0130stanbul, 2009.<\/li>
                            • Acar A, Turhan V, Karacaer Z, \u00d6nc\u00fcl O, G\u00f6renek L. Gen\u00e7 yeti\u015fkin HBV hastalar\u0131nda HBeAg\/Anti-HBe Durumunun ALT\/AST D\u00fczeyi ve karaci\u011fer histolojisi ile korelasyonu. Anatol J Clin Investig, 2009; 3(4): 231-4.<\/li>
                            • Karakas A, \u00d6nc\u00fcl O, Acar A, Turhan V, \u00c7avu\u015flu \u015e, G\u00f6renek L. The effect of day care centres to nasopharyngeal Streptococcus pneumoniae colonization and penicilin resistancy. Anatol J Clin Investig 2010; 4(!): 11-4.<\/li>
                            • Turhan V, Acar A, K\u00fc\u00e7\u00fckodaci Z, \u00c7oban M, Karacaer Z, Budak S, Dikta\u015f H, Yenilmez E, Ar\u0131can K, \u00d6nc\u00fcl O, G\u00f6renek L. Kronik Viral hepatiti bulunan 1380 hastada uygulanan perk\u00fctan k\u00f6r karaci\u011fer i\u011fne biyopsisinin irdelenmesi. Viral Hepatit Dergisi, 2009; 14(2): 57-62.<\/li>
                            • \u00d6nc\u00fcl O, Vankomisin ve Teikoplanin Hikayesi. ANKEM Dergisi, 2010; 24 (Ek-2): 100-109.<\/li>
                            • Diktas H, \u00c7akmak S, Turhan V, Antemir A, G\u00fcle\u00e7 B, Oncul O, Rodop O, \u00d6zt\u00fcrk E, G\u00f6renek L. Multepile rek\u00fcrrensle seyreden pelvik tutulumlu hidatik kist: Olgu Sunumu. T\u00fcrkiye Parazitoloji Dergisi, 2011; 35 (3): 178-80.<\/li>
                            • Sinem Budak, Ali Acar, Zehra Karacaer, H\u00fcsrev Dikta\u015f, Vedat Turhan, Oral \u00d6nc\u00fcl, Levent G\u00f6renek GATA Haydarpa\u015fa E\u011fitim Hastanesi’ndeki sa\u011fl\u0131k \u00e7al\u0131\u015fanlar\u0131n\u0131n pandemik influenza A\/H1N1 a\u015f\u0131lamas\u0131 ve a\u015f\u0131ya ba\u011fl\u0131 yan etkiler TurkHijyen.2011.78055 :185 — 190<\/li>
                            • Orhan Baylan, Mehmet Burak Selek, Semih Alay, Oral \u00d6nc\u00fcl, Mustafa \u00d6zyurt, Tun\u00e7er Haznedaro\u011flu Guillain-Barre sendromu nedeniyle hastanede yatan bir hastada geli\u015fen Burkholderia cepacia sepsisi TurkHijyen.2011.78055 : 197 — 202<\/li>
                            • \u00d6nc\u00fcl O. Kolitsin: Endikasyonlar\u0131 ve Klinik Kullan\u0131m\u0131. Aknem Dergisi, 2012; 26 (Ek-2): 12-8.<\/li>
                            • \u00d6nc\u00fcl O. HCV A\u015f\u0131s\u0131. Eds, Badur S, Bak\u0131r M. A\u015f\u0131 Kitab\u0131, Akademi Yay\u0131nlar\u0131, 2012, \u0130stanbul, 406-418.<\/li>
                            • Karag\u00f6z E, Karaahmeto\u011flu G, Acar A, Turhan V, Onc\u00fcl O, G\u00f6renek L. A case report: elephantiasis. Turkiye Parazitol Derg. 2012;36(3):188-90. doi: 10.5152\/tpd.2012.45.<\/li>
                            • Ba\u015faran S, \u015eim\u015fek-Yavuz S, \u00c7a\u011fatay A, Oncul O, Ozsut H, Eraksoy H. Yurtd\u0131\u015f\u0131 Kaynakl\u0131 Plasmodium falciparum’a Ba\u011fl\u0131 S\u0131tma: K\u00fcresel Bir Sorun. Klimik Dergisi. 2017: 30(3): 120-5.<\/li>
                            • Karacaer Z, Oncul O, Turhan V, Gorenek L, Karagoz E, Odabasi Z, Ozyurt M. Antifungal susceptibilities of Candida spp. cause of nosocomial infections determined in intensive care units. Gulhane Medical Journal, 2016: DOI: 10.5455\/gulhane.182769.<\/li>
                            • Karaahmetoglu G, Acar A, Oncul O, Ozyurt M, Gorenek L. Zona zoster associated with aseptic menengitis and hepatitis in two immunocompetent cases after emotional stress. Turkish bulletin of hygiene and experimental biology. 2013: 70(3):157-62.<\/li>
                            • Haznedaroglu T, Oncul O, Hosbul T, Cavuslu S, Baylan O, Ozyurt M. Methicillin Resistance in Staphylococcus aureus Strains Isolated from Hospitalized Patients: Three-Year Trend. TAF Prev Med Bull 2010; 9(6):585-90.<\/li>
                            • Baylan O, Selek MB, Alay S, Oncul O, Ozyurt M, Haznedaro\u011flu T. Turk Hij Den Biyol Derg. 2011; 68(4): 197-202 | DOI: 10.5505\/TurkHijyen.2011.67799.<\/li>
                            • Benli A, Ba\u015faran S, \u015eim\u015fek Yavuz S, \u00c7a\u011fatay A, \u00d6nc\u00fcl O, \u00d6zs\u00fct H, Eraksoy H. Daha \u00d6nce Tedavi G\u00f6rmemi\u015f HIV-Pozitif Hastalarda Kullan\u0131lan Antiretroviral Tedavi Rejimlerinin Virolojik Yan\u0131t, \u0130mmunolojik Yan\u0131t ve \u0130stenmeyen Etkiler A\u00e7\u0131s\u0131ndan Kar\u015f\u0131la\u015ft\u0131r\u0131lmas\u0131. Klimik Dergisi 2018: 31(2):94-100.<\/li>
                            • Dikta\u015f H, \u00d6nc\u00fcl O. A\u00e7\u0131k K\u0131r\u0131klarda Enfeksiyondan Korunma ve Antibiyotik Tedavisi. T\u00fcrkiye Klinikleri J Orthop and Traumatol-Special Topics 2014:7(1):22-6.<\/li>
                            • N Salto\u011flu, \u00d6 K\u0131l\u0131\u00e7o\u011flu, S Bakt\u0131ro\u011flu, Z O\u015far-Siva, \u015e Akta\u015f, M Alt\u0131nda\u015f ve ark. Diyabetik ayak yaras\u0131 ve infeksiyonunun tan\u0131s\u0131, tedavisi ve \u00f6nlenmesi: ulusal uzla\u015f\u0131 raporu. Klimik Derg 28 (Suppl 1), 2-34:2015.<\/li>
                            • M Hatipo\u011flu, A \u00dcl\u00e7ay, V Turhan, E Karag\u00f6z, H Erdem, A Acar, O \u00d6nc\u00fcl ve ark. D\u0131\u015f kaynakl\u0131 \u0130ki Relaps Plasmodium vivax Olgusu ve Proflakside Primakin. Turkiye Parazitol Derg 38 (2), 120-3: 2014.<\/li>
                            • T Haznedaro\u011flu, O \u00d6nc\u00fcl, T Ho\u015fbul, \u015e \u00c7avu\u015flu, O Baylan, M \u00d6zyurt. Yatan Hastalardan Soyutlanan Staphylococcus aureus Su\u015flar\u0131nda Metisilin Direnci: \u00dc\u00e7 Y\u0131ll\u0131k Trend. TAF Preventive Medicine Bulletin 9 (6): 2010.<\/li>
                            • M Aydin, B Aygen, R Mistik, O \u00d6nc\u00fcl, N Tuna, G Tuncer-Ertem, O Yildiz ve ark. F\u00fclminan Hepatit B Tedavisi: T\u00fcrk Klinik Mikrobiyoloji ve Infeksiyon Hastaliklari Dernegi Viral Hepatit \u00c7alisma Grubu Uzlasi Raporu\/Management of Fulminant Hepatitis B: A …KLIMIK Dergisi 26, 2: 2013.<\/li>
                            • A Acar, E Yenilmez, V Turhan, O \u00d6nc\u00fcl, S \u00c7avuslu, L G\u00f6renek. Kizamik-Kabakulak-Kizamik\u00e7ik Asisina Bagli Parotit Olgulari\/Parotitis Cases Due to Measles-Mumps-Rubella Vaccine. Klimik Dergisi 23 (2), 60: 2010.<\/li>
                            • V Turhan, A Acar, M \u00c7oban, O \u00d6nc\u00fcl, \u015e \u00c7avu\u015flu. Recurrent Gastrointestinal Bleeding, Intraabdominal Abscesses and Synchronous Candidemia and Meningitis Due to Leflunomide Therapy: Case Report. Turkiye Klinikleri Journal of Medical Sciences 30 (6), 2027-2030: 2010.<\/li>
                            • A Akcali, E Ozkaya, D Yilmaz, Y Uyar, O Onc\u00fcl. Investigation of herpes simplex virus in viral meningoencephalitis suspected cases using molecular and serological methods. Mikrobiyoloji bulteni 42 (3), 421-428: 2008.<\/li>
                            • Oncul O. Karbapenemler ve Monobaktamlar. Turkiye Klinikleri Journal of Infectious Diseases Special Topics 10 (1), 50-59: 2017.<\/li>
                            • Oncul O. Antibiyotik Kullan\u0131m\u0131n\u0131n \u0130yile\u015ftirilmesi. Klimik Dergisi 27(3), 83: 2014.<\/li>
                            • Dikta\u015f H, Hatipoglu M, Turhan V, Acar A, Oncul O, Kocak N, et al. Akut Bakteriyel Menenjit Tan\u0131s\u0131 ile Takip edilen olgular\u0131n 33 y\u0131ll\u0131k verilerinin retrospektif olarak irdelenmesi. FLORA 17 (4), 161-166: 2012.<\/li>
                            • O Baylan, MB Selek, S Alay, O \u00d6nc\u00fcl, M \u00d6zyurt, T Haznedaro\u011flu. Guillain-Barre sendromu nedeniyle hastanede yatan bir hastada geli\u015fen Burkholderia cepacia sepsisi. T\u00fcrk Hijyen ve Deneysel Biyoloji Dergisi 68 (4), 197-202: 2011.<\/li>
                            • H \u0130lhan, A Acar, A Karaka\u015f, V Turhan, O \u00d6nc\u00fcl, M G\u00fcltepe, M Fevzi \u00d6zsoy ve ark. Can Various Biochemical Tests (Hyaluronic Acid, Haptoglobulin, Apolipoprotein A1 and Alpha-2 Macroglobulin) be an alternative for liver needle biopsies in chronic Hepatitis B. Anatolian Journal of Clinical Investigation 5 (1): 2011.<\/li>
                            • Oncul O. Antibacterial Resistance in Nosocomial Infections: Epidemiology. Turkiye Klinikleri Journal of Infection Diseases-Special Topics 4 (1), 56: 2011.<\/li>
                            • H Dikta\u015f, S \u00c7akmak, V Turhan, A Kantemir, B G\u00fcle\u00e7, O \u00d6nc\u00fcl, O Rodop ve ark. Multiple Rek\u00fcrrensle Seyreden Pelvik Tutulumlu Hidatik Kist: Olgu Sunumu. Turkiye Parazitol Derg 35, 178-80: 2011.<\/li>
                            • Ali A, Karabudak \u00d6, K\u00fc\u00e7\u00fckodac\u0131 Z, Dikta\u015f H, \u00d6nc\u00fcl O ve ark. Giardiasise ba\u011fl\u0131 geli\u015fen bir Wells Sendromu (Eozinofilik Sell\u00fclit) Olgusu. AJCI 4 (4), 215-217: 2010.<\/li>
                            • Turhan V, Ali A, K\u00fc\u00e7\u00fckodac\u0131 Z, et al. Evaluation of 1380 Percutaneous Blind Liver Needle Biopsies Performed in Patients With Chronic Viral Hepatitis. Viral Hepatit Dergisis 14 (2): 2009.<\/li>
                            • Acar A, Turhan V, Dikta\u015f H, Oncul O, \u00c7avu\u015flu \u015e. Endokardit, piyelonefrit, sakroileit ve troidit komplikasyonlar\u0131 geli\u015fen bir bruselloz olgusu. Mikrobiyol Bul 43, 141-145: 2009.<\/li>
                            • Oncul O. Treatment of ventilator-associated pneumonia. Journal of The Turkish Society of Intensive Care.1(1): 2007.<\/li>
                            • Oncul O, Aktas Z. M\u00fcsilajda bulunan mikroorganizmalar\u0131n Klinik A\u00e7\u0131dan Potansiyel Tehlikeleri. Ed. Albay M, Alkan H. Marmara Denizi’nin Musilaj Sorunu. Istanbul University Press, 2023.<\/li>
                            • K\u00f6ksal \u0130, Oncul O, Korten V, Ulusoy S, \u00dcnal S. G\u00fcncel Bilgiler I\u015f\u0131\u011f\u0131nda Kolistin. Flora. 2017; 17 (4): 156-60.<\/li>
                            • Turhan V, Acar A, K\u0131l\u0131\u00e7 A, Budak S, Oncul O, Haznedaroglu T, et al. Bilvalan (A\/C) Meningokok a\u015f\u0131s\u0131 ile a\u015f\u0131lanm\u0131\u015f iki olguda Neisseria meningtidis W135’e ba\u011fl\u0131 geli\u015fen Meningokoksemi ve Menenjit. Mikrobiyoloji B\u00fclteni. 2010; 44: 473-8.<\/li>
                            • Diktas H, \u00c7akmak S, Turhan V, Kantemir A, G\u00fcle\u00e7 B, \u00d6nc\u00fcl O, Rodop O. Hydatid cyst presentign with multiple recurrence and pelvic involvement case report. Turkiye Parazitoloji Dergisi. 2011; 35 (3): 178.<\/li>
                            • Ul\u00e7ay A, Karaahmetoglu G, Turhan V, ErdemH, Oncul O, et al. Falsiparum s\u0131tmal\u0131 bir vakada oral artemisin-l\u00fcmefantrin tedavi ba\u015far\u0131s\u0131zl\u0131\u011f\u0131n\u0131n y\u00f6netimi. T\u00fcrkiye Parazitoloji Dergisi. 2014; 38 (1): 61-7.<\/li>
                            • Diktas H, Hatipoglu M, Turhan V, Ali A, Oncul O, Kocak N. Retrospective Evaluation of cases with the diagnosis of Acute Bacterial Meningitids over a 33-year period. Flora Infeksiyon Hastal\u0131klar ve Klinik Mikrobiyoloji Dergisi.<\/li>
                            • Oren MM, Ozgulnar N, Canbaz S, Karabey S, Onal AE, Oncul MO. An integrated care moled based on hospital and home during the Covid-19 Pandemic: Telehealth. Journal of Istanbul Faculty of Medicine. 2022; 85(1): 9-14.<\/li>
                            • Evlice O, Ba\u015faran S, \u015eim\u015fek-Yavuz S, \u00c7a\u011fatay A, \u00d6nc\u00fcl O, \u00d6zs\u00fct H. Comorbidities, Antiretroviral Therapy Switches, and Drug Side-Effects Among HIV-Infected Patients. Klimik Journal\/Klimik Dergisi. 2020; 33 (3).<\/li>
                            • Ba\u015faran S, Yavuz SS, \u00c7opur BS, Yir A, Ca\u011fatay A, Oncul O, et al. Analysis of Risk factors for mortality in methicillin sensitive Staphylococcus aureus bacteremia: Cefazolin is associated with better outcome. Journal of Istanbul Faculty of Medicine. 2019; 82 (3): 131-8.<\/li>
                            • Delibalta G, Timura\u011fao\u011flu A, Oncul O. Otolog K\u00f6k H\u00fccre Nakli Sonras\u0131 Geli\u015fen Dissemine Herpes Zoster: Olgu Sunumu. 2015; FLORA 20 (4), 203-5.<\/li>
                            • Oncul O. Antibiyotik kullan\u0131m\u0131n\u0131n iyile\u015ftirilmesi. Klimik Dergisi, 2014; 27 (3): 83.<\/li>
                            • \u0130nci E, Erisir F, Oncul O. Kronik Tonsilitte Bakteriyolojik \u00c7al\u0131\u015fma. Cerrahpa\u015fa T\u0131p Dergisi. 2014; 32 (4): 23.<\/li>
                            • Oren MM, Ozgulnar N, Canbaz S, Karabey S, Onal AE, Oncul MO. An integrated care model b ased on hospital and home during the Covid-19 pandemic telehealth. Journal of Istanbul Faculty of Medicine. 2022; 85(1): 9-14.<\/li>
                            • Basaran, Simsek-Yavuz S, Cagatay A, Oncul O, Ozsut H, Eraksoy H Imported Malaria Caused by Plasmodium falciparum; A Global Problem\/Yurtdisi Kaynakli Plasmodium falciparum’a Bagli Sitma: Kuresel Bir Sorun. KLIMIK Journal 2016; 30 (3), 120-6.<\/li>
                            • Karaahmeto\u011flu G, Ali A, \u00d6nc\u00fcl O, \u00d6zyurt M, G\u00f6renek L \u0130mmun sa\u011flam fakat yo\u011fun emosyonel stres alt\u0131nda olan iki olguda Zona zoster sonras\u0131 geli\u015fen aseptik menenjit ve hepatit tablosu T\u00fcrk Hijyen ve Deneysel Biyoloji Dergisi . 2013;70 (3), 157-62.<\/li>
                            • Gurer EE, Savran Oguz F, Kalaycioglu SB, Akta\u015f Z, Gulba\u015f Z, Oncul MO, Sezerman U. Gut Microbiota Effects in Hematopoetic Stem Cell Transplant Patients. J Ist Faculty Med 2022;85(3):296-304.<\/li>
                            • Baba S, Akta\u015f Z, Oncul MO. Investigation of the Susceptibility of Carbapenem-Resistant Klebsiella pneumoniae Isolates to Apramycin. Journal of Advanced Research in Health Sciences – Sa\u011fl\u0131k Bilimlerinde \u0130leri Ara\u015ft\u0131rmalar Dergisi 2022;5(1): 00-00.<\/li>
                            • Gurer EE, Aktas Z, Savran Oguz F, Oncul MO. Ba\u011f\u0131rsak Mikrobiyotas\u0131 ve \u0130mmunogenetik. Flora \u0130nfeksiyon Hastal\u0131klar\u0131 ve Klinik Mikrobiyoloji Dergisi, 2021; 26(4):573-83.<\/li>
                            • Oncul O. Antibiyotik kullan\u0131m\u0131n\u0131n iyile\u015ftirilmesi. KL\u0130M\u0130K Dergisi, 2015. DOI: 10.5152\/kd.2014.21.<\/li>
                            • Oncul O, Emekdas G, Altunay H, Sezer O, \u00c7avu\u015flu \u015e. G\u00fclhane Askeri T\u0131p Akademisi Haydarpa\u015fa E\u011fitim Hastanesi’nde Yatan Hastalardan \u0130zole Edilen Mikroorganizmalar\u0131n 1999 Y\u0131l\u0131 Analizi. Klimik Dergisi, 2001.<\/li>
                            • Oncul O. Yan\u0131k Enfeksiyonlar\u0131. Hastane \u2039nfeksiyonlar\u203a Dergisi 2005; 9: 136-50.<\/li>
                            • Acar A, Turhan V, Cing\u00f6zbay Y, et al. Right-Side Infective Endocarditis Mimicking A Ventricular Myxoma. Haydarpasa Numune Med J. 2010; 50(2): 98-100.<\/li>
                            • Oncul O. Kolistin Endikasyonlar\u0131 ve Klinik Kullan\u0131m\u0131. ANKEM Derg 2012;26(Ek 2):12-18.<\/li>
                            • Sevin\u00e7 B, Aktas Z, Oncul O. Karbapenemlere diren\u00e7li Klebsiella pneumoniae izolatlar\u0131n\u0131n Apramisine duyarl\u0131l\u0131klar\u0131n\u0131n ara\u015ft\u0131r\u0131lmas\u0131. Sa\u011fl\u0131k Bilimlerinde \u0130leri Ara\u015ft\u0131rmalar Dergisi 2022;5(1):25-31.<\/li>
                            • Oncul O. Yan\u0131k Hastalar\u0131na Yakla\u015f\u0131m ve Yara Bak\u0131m\u0131. \u0130stanbul \u00dcniversitesi Cerrahpa\u015fa S\u00fcrekli T\u0131p Yay\u0131nlar\u0131. Yara Bak\u00fdm\u00fd ve Tedavisi Sempozyum Dizisi No:67 s.129-143.<\/li>
                            • Ozkan S, Metin M, Gokben G, Oncul O, et al. Is Helicobacter pylori a Nosocomial Infection Reason? T\u00fcrk Anestiyoloji ve Reanimasyon Derne\u011fi Dergisi, 2003; 31 (8): 409-14.<\/li>
                            • Karagoz E, Karaahmetoglu G, Acar A, Turhan V, Oncul O, G\u00f6renek L. Olgu Sunumu: Eyefehkiazis. Turkiye Parazitoloji Dergisi. 2012; 36 (3): 188-90.<\/li>
                            • Ilhan H, Acar A, Karaka\u015f A, et al. Can various biochemical tests (Hyaluronic Acid, haptoglubulin, apolipoprotein A1 and Alpha-2 macroblobulin) be an alternative for liver needle biopsies in chronic hepatitis B. Anatol J Clin Investig 2011;5(1):24-32.<\/li>
                            • B \u00c7opur, S Ba\u015faran, G Orhun, S Yavuz, A \u00c7a\u011fatay, MO \u00d6nc\u00fcl, H \u00d6zs\u00fct. neumonia in a Tertiary Care Hospital Risk Factors and Prognostic Predictors of Ventilator Associated Pneumonia in a Tertiary Care Hospital. FLORA \u0130nfeksiyon Hastal\u0131klar\u0131 ve Klinik Mikrobiyoloji Dergisi. 2022; 27:1. B142. Gurer EE, Akta\u015f Z, Savran Oguz F, Oncul O. Ba\u011f\u0131rsak Mikrobiyotas\u0131 ve \u0130mmunogenetik. Flora \u0130nfeksiyon Hastal\u0131klar\u0131 ve Klinik Mikrobiyoloji Dergisi. 2021; 26(4): 573-83. B143. Oncul O. Yan\u0131k Yaralar\u0131nda Yara Bak\u0131m\u0131, Takip ve Tedavi. Infeksiyon Dergisi. Bilimsel Yay\u0131nevi. Ed. Sibel G\u00fcndes, 2020; 111-125. B144. Gurer EE, Savran FO, Kalayoglu S, Akta\u015f Z, Gulbas Z, Oncul MO. Allojenik Kok Hucre Nakillerinde Mikrobiyota Etkisi. Istanbul T\u0131p Fak\u00fcltesi Dergisi, 2022: DOI: 10.26650\/IUITFD.1027106.<\/li>
                            • Canbaz S. \u00d6zg\u00fclnar N, \u00c7elik M\u00d6, et al. The evaluation of telehealth services during the COVID-19 Pandemic on Levels of Psychological Growth. Istanbul T\u0131p Fak\u00fcltesi Dergisi. 2023. DOI :10.26650\/IUITFD.1218085.<\/li>
                            • Oren M, Ozgulnar N, Canbaz S, Onal KA, Oncul MO. An Integrated Care Model Based on Hospital and Home During the COVID-19 Pandemic: Telehealth. Istanbul T\u0131p Fak\u00fcltesi Dergisi, 2021.<\/li>
                            • Yilmaz E, Ba\u015faran S, Yildiz S, Yavuz S, Cagatay A, Oncul O, Ozsut H, Eraksoy H. Comparison of Genotypic and Phenotypic Methods to Identify Carbapenemase Production in Gram-Negative Bacteria. Klimik Dergisi, 2024. DOI: 10.36519\/kd.2024.4581.<\/li>
                            • Ba\u015faran S, Evlice O, Benli A, Yavuz S, Cagatay A, Oncul O, Ozsut H, Eraksoy H. Skull Base Osteomyelitis and Long Term Outcome. Klimik Dergisi, 2021. DOI: 10.36519\/kd.2021.3897.<\/li>
                            • Basaran S, Y\u0131lmaz E, Yavuz S, Cagatay A, Oncul O, Ozsut H, Eraksoy H. \u00dc\u00e7\u00fcnc\u00fc Basamak bir Hastanede Nokardiyoz Olgular\u0131 ve \u0130nfeksiyon Risk Fakt\u00f6rleri. Klimik Dergisi, 2021. DOI: 10.5578\/flora.20219808.<\/li>
                            • Dikta\u015f H, G\u00f6renek L, Ate\u015f F, Haholu A, \u00d6nc\u00fcl O, Turhan V, Acar A. Testik\u00fcler T\u00fcm\u00f6r\u00fc Taklit eden Brucella Or\u015fitli Hasta: Olgu Sunumu. Istanbul T\u0131p Fak\u00fcltesi Dergisi, 2013.<\/li>
                            • Budak S, Acar A, Karacae\u011fr Z, Diktas H, Turhan V, Oncul O, Gorenek L. Pandemic Influenza A\/H1N1 Vaccination and Vaccine-related side effects in Health Care Workers of GATA Haydarpasa Training Hospital. Turkish Bulletein of Hygiene and Experimental Biology, 2011; 68(4): 185-90.<\/li>
                            • Saltoglu N, Yemisen M, Ergonul O, Kadanali A, Karagoz G, Batirel A, Ak O, Eraksoy H, Cagatay A, Vatan A, Sengoz G, Pehlivanoglu F, Aslan T, Akkoyunlu Y, Engin D, Ceran N, Erturk B, Mulazimoglu L, Oncul O, Ay H, Sargin F, Ozgunes N, Simsek F, Yildirmak T, Tuna N, Karabay O, Yasar K, Uzun N, Kucukardali Y, Sonmezoglu M, Yilmaz F, Tozalgan U, Ozer S, Ozyazar M. Predictors for limb loss among patient with diabetic foot infections: an observational retrospective multicentric study in Turkey. KLIMIK Turkish Society, Diabetic Foot Study Group. Clin Microbiol Infect. 2015 Jul;21(7):659-64. doi: 10.1016\/j.cmi.2015.03.018.<\/li>
                            • Ey\u00fcbo\u011flu FE, Bacako\u011flu F, Akal\u0131n H, \u00d6nc\u00fcl O, et al. T\u00fcrk Toraks Derne\u011fi, Eri\u015fkinlerde Hastanede Geli\u015fen Pn\u00f6moni Tan\u0131 ve Tedavi Uzla\u015f\u0131 Raporu. 2018.https:\/\/toraks.org.tr\/site\/sf\/books\/pre_migration\/4500cdf26926c6f5cc9f197b8f8dfa92639c96046aff8b9866b60be3e001a366.pdf.<\/li>
                            • Akdur R, Akta\u015f F, Alt\u0131nta\u015f K, et al. TC Sa\u011fl\u0131k Bakanl\u0131\u011f\u0131 Bula\u015f\u0131c\u0131 Hastal\u0131klar\u0131n \u0130hbar\u0131 ve Bildirim Sistemi Standart Tan\u0131, S\u00fcrveyans ve Laboratuvar Rehberi. T.C Sa\u011fl\u0131k Bakanl\u0131\u011f\u0131 Yay\u0131nlar\u0131, 2004.<\/li>
                            • Evlice O, Ba\u015faran S, \u015eim\u015fek-Yavuz S, \u00c7a\u011fatay A, \u00d6nc\u00fcl O, \u00d6zs\u00fct H, Eraksoy H \u0130nsan \u0130mm\u00fcn Yetmezlik Virusuyla \u0130nfekte Hastalarda E\u015flik Eden Hastal\u0131klar, Antiretroviral Tedavi De\u011fi\u015fiklikleri ve \u0130la\u00e7 Yan Etkileri Comorbidities, Antiretroviral Therapy Switches, and Drug Side-Effects Among HIV-Infected Patients. KLIMIK Dergisi; 2020; 3 (30): 241-9.<\/li>
                            • Acar A, Turhan V, Dikta\u015f H, Sayan \u00d6, Baylan O, \u00d6nc\u00fcl O, Hatipo\u011flu M, Haznedaro\u011flu T, G\u00f6renek L. Hematolojik Maligniteli \u0130ki Hastada Nadir Bir Hastane \u0130nfeksiyonu Etkeni Olarak Sphingomonas paucimobilis Bakteremisi. Flora. 2011; 16(1): 47–50.<\/li>
                            • Gurer EE, Savran F, Be\u015f\u0131\u015f\u0131k SK, Akta\u015f Z, G\u00fclba\u015f Z, \u00d6nc\u00fcl MO, Sezerman U, Gurer-Kluge EE, Savran O, Kalayo\u011flu B. Gut microbiota affect in allogenic stem cell transplant patients. Istanbul T\u0131p Fak\u00fcltesi Dergisi, 2022; DOI: 10.26650\/IUITFD.1027106.<\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t
                              \n\t\t\t\t
                              \n\t\t\t\t\t\r\n
                              \r\n\r\n

                              Presentations at National Scientific Meetings<\/h3> \r\n\r\n <\/div>\r\n\r\n \t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
                              \n\t\t\t\t\t\t\t\t\t
                              • Keskin K, O. \u00d6nc\u00fcl, H. Germeyan ve O.\u015e. Yenen, “Klinik \u00f6rneklerden izole edilen Pseudomonas aeruginosa su\u015flar\u0131n\u0131n \u00e7e\u015fitli antibiyotiklere duyarl\u0131l\u0131klar\u0131n\u0131n E Test y\u00f6ntemiyle ara\u015ft\u0131r\u0131lmas\u0131”, 10. T\u00fcrkiye Antibiyotik ve Kemoterapi Kongresi, Antalya, 6-9 Haziran 1995.<\/li>
                              • \u00c7avu\u015flu \u015e, O. \u00d6nc\u00fcl, M.F. \u00d6zsoy, H. Altunay, N. Ko\u00e7ak ve O.\u015e. Yenen, “Proteus su\u015flar\u0131nda yeni bir antibiyotik duyarl\u0131l\u0131k y\u00f6ntemi olan Dio Sensitest’in disk dif\u00fczyon y\u00f6ntemi ile kar\u015f\u0131la\u015ft\u0131r\u0131lmal\u0131 olarak de\u011ferlendirilmesi*”, 3. T\u00fcrkiye Antimikrobik ve Kemoterapi G\u00fcnleri:* Klinik-laboratuvar Uygulamalar\u0131 ve Yenilikler, Ku\u015fadas\u0131, \u0130zmir, 16-22 May\u0131s 1997.<\/li>
                              • \u00c7avu\u015flu \u015e, N. Ko\u00e7ak, M.F. \u00d6zsoy, H. Altunay ve O. \u00d6nc\u00fcl, “HBsAg, anti-HIV 1-2 ve anti-HCV taramas\u0131nda Immunocomb II EIA test y\u00f6nteminin performans\u0131n\u0131n de\u011ferlendirilmesi”,<\/li>
                              • T\u00fcrk Klinik Mikrobiyoloji ve \u0130nfeksiyon Hastal\u0131klar\u0131 Kongresi*, Antalya, 6-10 Ekim 1997. 4. \u00d6nc\u00fcl O, \u015e. \u00c7avu\u015flu, M.F. \u00d6zsoy, H. Altunay, N. Ko\u00e7ak ve O.\u015e. Yenen, “1993-1996 y\u0131llar\u0131 aras\u0131nda incelenen kan k\u00fclt\u00fcrlerinin retrospektif olarak de\u011ferlendirilmesi”, 8. T\u00fcrk Klinik Mikrobiyoloji ve \u0130nfeksiyon Hastal\u0131klar\u0131 Kongresi, Antalya, 6-10 Ekim 1997. 5. \u00d6zsoy MF, \u015e. \u00c7avu\u015flu, O. \u00d6nc\u00fcl ve O.\u015e. Yenen, “Splenik komplikasyonlu 2 s\u0131tma olgusu”, 8. T\u00fcrk Klinik Mikrobiyoloji ve \u0130nfeksiyon Hastal\u0131klar\u0131 Kongresi, Antalya, 6-10 Ekim 1997. 6. \u00d6nc\u00fcl O, M.F. \u00d6zsoy, H. Altunay, \u015e. \u00c7avu\u015flu \u015e ve O.\u015e. Yenen. “S. aureus su\u015flar\u0131nda vankomisin, teikoplanin, siprofloksasin, TMP\/SMZ, gentamisin ve eritromisin duyarl\u0131l\u0131\u011f\u0131”, 8. T\u00fcrk Klinik Mikrobiyoloji ve \u0130nfeksiyon Hastal\u0131klar\u0131 Kongresi, Antalya, 6-10 Ekim 1997. 7. Altunay H, O. \u00d6nc\u00fcl, \u015e. \u00c7avu\u015flu ve O.\u015e. Yenen, “Kafa travmas\u0131 sonras\u0131 geli\u015fen rek\u00fcrren menenjit: 10 olgu nedeniyle irdeleme”, 8. T\u00fcrk KLIMIK Kongresi, Antalya, 6-10 Ekim 1997. 8. Pahsa A, M.F. \u00d6zsoy, O. \u00d6nc\u00fcl, H. Erdem ve O.\u015e. Yenen, “3377 kan k\u00fclt\u00fcr\u00fcn\u00fcn De\u011ferlendirilmesi”, IV. Hastane \u0130nfeksiyonlar\u0131 Simpozyumu, Ankara, 17-19 Mart 1999.<\/li>
                              • Pahsa A, M.F. \u00d6zsoy, O. \u00d6nc\u00fcl ve E. \u0130nci, “Rek\u00fcrren akut tonsillitlerde tonsil y\u00fczey, \u00e7ekirdek ve arka y\u00fcz floras\u0131n\u0131n kar\u015f\u0131la\u015ft\u0131r\u0131lmas\u0131*”, 9. T\u00fcrk Klinik Mikrobiyoloji ve \u0130nfeksiyon Hastal\u0131klar\u0131 Kongresi,* Cilt I, 173, Antalya, 3-8 Ekim 1999.<\/li>
                              • Pahsa A, M.F. \u00d6zsoy, O. \u00d6nc\u00fcl ve N. Y\u0131lmaz., “T\u00fcberculosis one step” testinin klasik laboratuvar y\u00f6ntemlerle kar\u015f\u0131la\u015ft\u0131r\u0131lmas\u0131”, 9. T\u00fcrk Klinik Mikrobiyoloji ve \u0130nfeksiyon Hastal\u0131klar\u0131 Kongresi, Cilt I, 181, Antalya, 3-8 Ekim 1999.<\/li>
                              • Pahsa A, M.F. \u00d6zsoy ve O. \u00d6nc\u00fcl, “Ta\u015f\u0131y\u0131c\u0131 ve kronik HBV’li hastalarda protein elektroforez sonu\u00e7lar\u0131n\u0131n irdelenmesi”, 9. T\u00fcrk Klinik Mikrobiyoloji ve \u0130nfeksiyon Hastal\u0131klar\u0131 Kongresi, Cilt I, 190, Antalya, 3-8 Ekim 1999.<\/li>
                              • Altunay H, KMTD \u00c7al\u0131\u015fma Grubu, ” T\u00fcrkiye’de Kan merkezlerinde 1995-1999 Y\u0131llar\u0131 aras\u0131nda HBsAg, Anti-HCV, Anti-HIV ve VDRL Seroprevalans\u0131”, 1. Ulusal Kan Merkezleri ve Transf\u00fczyon T\u0131bb\u0131 Kongresi, Kapadokya,4-29 Eyl\u00fcl 2000.<\/li>
                              • Emekda\u015f G, \u015e. \u00c7avu\u015flu, O. \u00d6nc\u00fcl ve \u00c7. Artuk, “K\u0131z\u0131lay Kan Merkezleri don\u00f6r profili”, 1. Ulusal Kan Merkezleri ve Transf\u00fczyon T\u0131bb\u0131 Kongresi, Kapadokya,4-29 Eyl\u00fcl 2000.<\/li>
                              • Ko\u00e7ak N, O. \u00d6nc\u00fcl ve \u015e. \u00c7avu\u015flu, “GATA Haydarpa\u015fa E\u011fitim Hastanesi’nde kan ve kan \u00fcr\u00fcn\u00fc kullan\u0131m\u0131”, 1. Ulusal Kan Merkezleri ve Transf\u00fczyon T\u0131bb\u0131 Kongresi, Kapadokya, 4-29 Eyl\u00fcl 2000.<\/li>
                              • Altunay H, S. Kenar, O. \u00d6nc\u00fcl ve \u015e. \u00c7avu\u015flu, “HBsAg ve anti-HBs serolojisi HBV seroprevalans\u0131n\u0131 ne kadar do\u011fru g\u00f6sterir” 1. Ulusal Kan Merkezleri ve Transf\u00fczyon T\u0131bb\u0131 Kongresi, Kapadokya,4-29 Eyl\u00fcl 2000.<\/li>
                              • Emekda\u015f G, \u015e. \u00c7avu\u015flu, O. \u00d6nc\u00fcl ve \u00c7. Artuk, “K\u0131z\u0131lay Kan Merkezlerinde HBsAg seropozitifli\u011fi: 11 y\u0131ll\u0131k trend”, 1. Ulusal Kan Merkezleri ve Transf\u00fczyon T\u0131bb\u0131 Kongresi, Kapadokya,4-29 Eyl\u00fcl 2000.<\/li>
                              • \u00d6nc\u00fcl O, G. Emekda\u015f, \u015e. \u00c7avu\u015flu ve \u00c7. Artuk, “Kan don\u00f6rlerinde VDRL seropozitifli\u011fi: (11 y\u0131ll\u0131k trend)”, 1. Ulusal Kan Merkezleri ve Transf\u00fczyon T\u0131bb\u0131 Kongresi, Kapadokya,4-29 Eyl\u00fcl 2000.<\/li>
                              • \u00d6nc\u00fcl O, G. Emekda\u015f, \u015e. \u00c7avu\u015flu ve \u00c7. Artuk, “K\u0131z\u0131lay Kan Merkezlerinde anti-HCV seropozitifli\u011fi”, 1. Ulusal Kan Merkezleri ve Transf\u00fczyon T\u0131bb\u0131 Kongresi, Kapadokya,4-29 Eyl\u00fcl 2000.<\/li>
                              • Erdem H, O. \u00d6nc\u00fcl, H. Altunay, M.F. \u00d6zsoy, A. Pahsa ve \u015e. \u00c7avu\u015flu, “GATA Haydarpa\u015fa E\u011fitim Hastanesi’nde izole edilen pn\u00f6mokoklarda penisiline diren\u00e7 trendi”, XXIX. T\u00fcrk Mikrobiyoloji Kongresi, Cilt I, 12-43, Antalya, 8-13 Ekim 2000.<\/li>
                              • \u00c7avu\u015flu \u015e, O. \u00d6nc\u00fcl, A. Erdemo\u011flu, M.F. \u00d6zsoy ve G. Emekda\u015f, “\u00c7ocuk ve eri\u015fkin serum \u00f6rneklerinde Rubella seroprevalans\u0131”, XXIX. T\u00fcrk Mikrobiyoloji Kongresi, Cilt I, 14-24, Antalya, 8-13 Ekim 2000.<\/li>
                              • \u00c7avu\u015flu \u015e, O. \u00d6nc\u00fcl, H. Altunay, M.F. \u00d6zsoy ve N. Ko\u00e7ak, “\u00c7e\u015fitli ya\u015f gruplar\u0131nda Tetanoz toksoid IgG antikor seroprevalans\u0131”, XXIX. T\u00fcrk Mikrobiyoloji Kongresi, Cilt I, 14-25, Antalya, 8-13 Ekim 2000.<\/li>
                              • Zekey T, H. Altunay, O. \u00d6nc\u00fcl ve \u015e, \u00c7avu\u015flu, “Enterokoklarda y\u00fcksek d\u00fczeyde aminoglikozid direnci ara\u015ft\u0131r\u0131lmas\u0131nda kullan\u0131lan \u00e7e\u015fitli test y\u00f6ntemlerinin kar\u015f\u0131la\u015ft\u0131r\u0131lmas\u0131” XXIX. T\u00fcrk Mikrobiyoloji Kongresi, Antalya, 8-13 Ekim 2000.<\/li>
                              • \u00c7avu\u015flu \u015e, Y. K\u00fc\u00e7\u00fckardal\u0131, O. \u00d6nc\u00fcl, E. G\u00f6nc\u00fco\u011flu ve M. Danac\u0131, “Hastane infeksiyonlar\u0131n\u0131n \u00f6nlenmesinde \u0130nfeksiyon Kontrol Komitesi ne kadar etkili”, XXIX. T\u00fcrk Mikrobiyoloji Kongresi, Antalya, 8-13 Ekim 2000.<\/li>
                              • K\u00fc\u00e7\u00fckardal\u0131 Y, O. \u00d6nc\u00fcl, E. G\u00f6nc\u00fco\u011flu, M. Danac\u0131 ve \u015e. \u00c7avu\u015flu, “GATA Haydarpa\u015fa E\u011ftim Hastanesi Dahiliye Yo\u011fun Bak\u0131m \u00dcnitesi’nde Yatan hastalarda g\u00f6r\u00fclen hastane infeksiyonlar\u0131n\u0131n irdelenmesi” XXIX. T\u00fcrk Mikrobiyoloji Kongresi, Antalya, 8-13 Ekim 2000.<\/li>
                              • \u00d6nc\u00fcl O, A. Erdemo\u011flu, C, Kuru, M.F. \u00d6zsoy, H. Altunay ve Z. Ertem, “Hastane personelinde nazal S.aureus ta\u015f\u0131y\u0131c\u0131l\u0131\u011f\u0131” XXIX. T\u00fcrk Mikrobiyoloji Kongresi, Antalya, 8-13 Ekim 2000.<\/li>
                              • Emekda\u015f G, O. \u00d6nc\u00fcl, A. Erdemo\u011flu ve \u015e. \u00c7avu\u015flu, “1999 y\u0131l\u0131 GATA Haydarpa\u015fa E\u011fitim Hastanesi’nde HSV-1 IgM ve IgG sonu\u00e7lar\u0131n\u0131n de\u011ferlendirilmesi.” XXIX. T\u00fcrk Mikrobiyoloji Kongresi, Antalya, 8-13 Ekim 2000.<\/li>
                              • G. Emekda\u015f, O. \u00d6nc\u00fcl, A. Erdemo\u011flu, T. Kurukuyu, T. Bozb\u0131y\u0131k ve \u015e. \u00c7avu\u015flu, “\u0130stanbul’da g\u00f6rev yapan kasaplarda anti-Brusella ve anti-Borrelia antikorlar\u0131n\u0131n ara\u015ft\u0131r\u0131lmas\u0131”, XXIX. T\u00fcrk Mikrobiyoloji Kongresi, Antalya, 8-13 Ekim 2000.<\/li>
                              • \u00d6nc\u00fcl O, G. Emekda\u015f, H. Altunay, O. Sezer ve \u015e. \u00c7avu\u015flu, “Yatan hastalardan izole edilen mikroorganizmalar\u0131n 1999 y\u0131l\u0131 analizi”, XXIX. T\u00fcrk Mikrobiyoloji Kongresi, Antalya, 8-13 Ekim 2000.<\/li>
                              • \u00d6nc\u00fcl O, G. Emekda\u015f, \u015e. \u00c7avu\u015flu, “1999 y\u0131l\u0131 GATA Haydarpa\u015fa E\u011fitim Hastanesi’nde saptanan Toksoplazma IgM ve IgG sonu\u00e7lar\u0131n\u0131n de\u011ferlendirilmesi”, XXIX. T\u00fcrk Mikrobiyoloji Kongresi, Antalya, 8-13 Ekim 2000.<\/li>
                              • \u00c7avu\u015flu \u015e, \u0130. Birinci, O. \u00d6nc\u00fcl, G. Emekda\u015f ve A. Erdemo\u011flu, “\u00c7e\u015fitli ya\u015f gruplar\u0131nda d\u00f6rt farkl\u0131 rekombinan hepatit B a\u015f\u0131s\u0131n\u0131n etkinli\u011finin kar\u015f\u0131la\u015ft\u0131r\u0131lmas\u0131”, V. Ulusal Viral hepatit Simpozyumu, Ankara, 9-11 Kas\u0131m 2000.<\/li>
                              • \u00c7avu\u015flu \u015e, \u0130. Birinci, O. \u00d6nc\u00fcl, G. Emekda\u015f ve A. Erdemo\u011flu, “Rekombinan hepatit B a\u015f\u0131lar\u0131n\u0131n antikor yan\u0131t\u0131n\u0131n ya\u015flara g\u00f6re etkinli\u011fi” V. Ulusal Viral hepatit Simpozyumu, Ankara, 9-11 Kas\u0131m 2000.<\/li>
                              • \u00c7avu\u015flu \u015e, O. \u00d6nc\u00fcl, H. Altunay, M.F. \u00d6zsoy, N. Ko\u00e7ak ve V. Cimin. “Kronik Hepatit B Virus \u0130nfeksiyonu saptanan olgularda serum alanin transferaz d\u00fczeyi ile karaci\u011fer histolojisi ile ili\u015fkisi”, V. Ulusal Viral Hepatit Simpozyumu, Cilt I, P-B69, Ankara, 9-11 Kas\u0131m 2000.<\/li>
                              • \u00c7avu\u015flu \u015e, H. Altunay, O. \u00d6nc\u00fcl, N. Ko\u00e7ak, M.F. \u00d6zsoy ve V. Cimin, “Kronik Hepatit B Virus \u0130nfeksiyonlularda karaci\u011fer histolojisi ile serum HBeAg ve anti-HBe ili\u015fkisi”,V. Ulusal Viral Hepatit Simpozyumu, Cilt I, P-B70, Ankara, 9-11 Kas\u0131m 2000.<\/li>
                              • \u00d6nc\u00fcl O, M.F.\u00d6zsoy ve V. Cimin, “Hastane ortam\u0131ndan izole edilen gram negatif bakterilerde antibiyotik duyarl\u0131l\u0131\u011f\u0131: \u0130ki y\u0131ll\u0131k veriler”, 16. T\u00fcrkiye Antibiyotik ve Kemoterapi Kongresi, Cilt I, 176, Belek-Antalya, 4-9 Haziran 2001.<\/li>
                              • Birinci \u0130, O. \u00d6nc\u00fcl ve \u015e. \u00c7avu\u015flu, “Yeni bir bakteri identifikasyon y\u00f6ntemi olan ID rapid (International Microbio) testin API ve klasik biyo\u015fimik y\u00f6ntemlerle kar\u015f\u0131la\u015ft\u0131r\u0131lmas\u0131”, 16. T\u00fcrkiye Antibiyotik ve Kemoterapi Kongresi, Cilt I, 187, Antalya, 4-9 Haziran 2001.<\/li>
                              • Kalemo\u011flu M, \u00d6. Keskin, O. \u00d6nc\u00fcl, “GATA Haydarpa\u015fa E\u011fitim Hastanesi \u0130lk Yard\u0131m Servisine Yaralanma Nedeniyle Ba\u015fvuran Olgularda Yeni Bir K\u00fclt\u00fcr Alma Y\u00f6ntemi Olan Slide Testin Etkinli\u011finin Ara\u015ft\u0131r\u0131lmas\u0131”, 16. T\u00fcrkiye Antibiyotik ve Kemoterapi Kongresi, Cilt I, 187, Antalya, 4-9 Haziran 2001.<\/li>
                              • Kalemo\u011flu M, \u00d6. Keskin, O. \u00d6nc\u00fcl, “GATA Haydarpa\u015fa E\u011fitim Hstanesi \u0130lk Yard\u0131m Servisine Yaralanma Nedeniyle Ba\u015fvuran A\u00e7\u0131k Yaralanma Olgular\u0131n Yara K\u00fclt\u00fcr Sonu\u00e7lar\u0131n\u0131n \u0130rdelenmesi”, 16. T\u00fcrkiye Antibiyotik ve Kemoterapi Kongresi, Cilt I, 159, Antalya, 4-9 Haziran 2001.<\/li>
                              • \u00d6nc\u00fcl O, H. Altunay, V.Cimin, N. Ko\u00e7ak, ” Yatan Hasta Bakteri Floras\u0131: 1999-2000 Y\u0131l\u0131 Verilerinin Kar\u015f\u0131la\u015ft\u0131r\u0131lmas\u0131”, 16. T\u00fcrkiye Antibiyotik ve Kemoterapi Kongresi, Cilt I, 159, Antalya, 4-9 Haziran 2001.<\/li>
                              • Y\u0131ld\u0131r\u0131m A, O. \u00d6nc\u00fcl, S. G\u00f6kahmeto\u011flu, H. Altunay ve N. Ko\u00e7ak, “Kronik HBV \u0130nfeksiyonlu hastalarda interferon-alfa + lamivudin tedavisinin 12 ayl\u0131k sonu\u00e7lar\u0131”, IV. Ulusal Hepatoloji Kongresi, \u0130stanbul, 14-16 Haziran 2001.<\/li>
                              • Atasoyu EM, O. \u00d6nc\u00fcl, S. Enver, R. Evrenkaya ve M.Y. T\u00fclbek, “S\u00fcrekli ayaktan periton diyalizi uygulanan hastalarda Staphylococcus aureus ta\u015f\u0131y\u0131c\u0131l\u0131\u011f\u0131*”, 18. Ulusal Nefroloji Hipertansiyon Diyaliz ve transplantasyon Kongresi*, Kapadokya, 5-9 Eyl\u00fcl 2001.<\/li>
                              • Erdem H, M.Z. Bak\u0131c\u0131, M. Bak\u0131r, \u015e. \u00c7avu\u015flu, O. \u00d6nc\u00fcl, N. Ko\u00e7ak ve M.F \u00d6zsoy, “Sivas B\u00f6lgesinde infeksiyon etkeni Pn\u00f6mokoklarda diren\u00e7”, X. T\u00fcrk Klinik Mikrobiyoloji ve \u0130nfeksiyon Hastal\u0131klar\u0131 Kongresi, Cilt I, Adana, 15-19 Ekim 2001.<\/li>
                              • Altunay H, O. \u00d6nc\u00fcl, H. Balo\u011flu ve N. Sara\u00e7o\u011flu, “Bir viral deri infeksiyonu olgusu: Orf”, X. T\u00fcrk Klinik Mikrobiyoloji ve \u0130nfeksiyon Hastal\u0131klar\u0131 Kongresi, Cilt I, Adana, 15-19 Ekim 2001.<\/li>
                              • G\u00fcl HC, O. \u00d6nc\u00fcl, M. Dede, \u0130.Y. Avc\u0131, C.P. Eyig\u00fcn ve A. Pahsa, “\u00dc\u00e7\u00fcnc\u00fc Trimestr Hamilelerde Grup B streptokok kolonizasyonu” X. T\u00fcrk Klinik Mikrobiyoloji ve \u0130nfeksiyon Hastal\u0131klar\u0131 Kongresi, Cilt I, Adana, 15-19 Ekim 2001.<\/li>
                              • \u00d6nc\u00fcl O, F, Y\u0131ld\u0131z, H. Altunay, C. A\u00e7\u0131kel, F. Peker ve \u015e. \u00c7avu\u015flu, “Yan\u0131k Servisi’nde izlenen hastane infeksiyonlar\u0131”, X. T\u00fcrk Klinik Mikrobiyoloji ve \u0130nfeksiyon Hastal\u0131klar\u0131 Kongresi, Cilt I, Adana, 15-19 Ekim 2001.<\/li>
                              • \u00d6nc\u00fcl O, R. Evrenkaya, E.M. Atasoyu, \u015e. \u00c7avu\u015flu ve Y. T\u00fclbek, “Kronik ayaktan periton diyalizi uygulanan hastalarda pertonit s\u0131kl\u0131\u011f\u0131 ve bunlar\u0131n bakteri ta\u015f\u0131y\u0131c\u0131l\u0131\u011f\u0131 ile ili\u015fkisi”, XXX. T\u00fcrk Mikrobiyoloji Kongresi, Antalya, 30 Eyl\u00fcl-05 Ekim 2002.<\/li>
                              • \u00d6nc\u00fcl O, F. Y\u00fcskel, H. Altunay, C, A\u00e7\u0131kel, B. \u00c7elik\u00f6z ve \u015e. \u00c7avu\u015flu, “Yan\u0131k \u00fcnitesinde bir y\u0131l s\u00fcresince izlenen hastane infeksiyonlar\u0131n\u0131n irdelenmesi”, XXX. T\u00fcrk Mikrobiyoloji Kongresi, Antalya, 30 Eyl\u00fcl-05 Ekim 2002.<\/li>
                              • \u00d6nc\u00fcl O, \u00d6. Keskin, H.V. Acar, Y. K\u00fc\u00e7\u00fckardal\u0131, R. Evrenkaya, E.M. Atasoyu, C. Top, S. Nalbant, S. \u00d6zkan, G. Emekdas, \u015e. \u00c7avu\u015flu, M.H. Us, A. Pahsa ve M. G\u00f6kben, “1999 Marmara Depremi sonras\u0131 g\u00f6r\u00fclen hastane infeksiyonlar\u0131n\u0131n irdelenmesi”, XXX. T\u00fcrk Mikrobiyoloji Kongresi, Antalya, 30 Eyl\u00fcl-05 Ekim 2002.<\/li>
                              • \u00d6nc\u00fcl O, M.F.\u00d6zsoy, H.C. G\u00fcl, N. Ko\u00e7ak, \u015e. \u00c7avu\u015flu ve A. Pahsa, “Deri \u015farbonu: 32 olgunun irdelenmesi”, XXX. T\u00fcrk Mikrobiyoloji Kongresi, Antalya, 30 Eyl\u00fcl-05 Ekim 2002.<\/li>
                              • Kalemo\u011flu M, O. \u00d6nc\u00fcl, \u00d6, Keskin, \u015e ve \u00c7avu\u015flu, “GATA Haydarpa\u015fa E\u011fitim Hastanesi ilk yard\u0131m servisine ba\u015fvuran a\u00e7\u0131k yaralanma olgular\u0131n\u0131n yara k\u00fclt\u00fcr sonu\u00e7lar\u0131n\u0131n irdelenmesi”, XXX. T\u00fcrk Mikrobiyoloji Kongresi, Antalya, 30 Eyl\u00fcl-05 Ekim 2002.<\/li>
                              • \u00d6nc\u00fcl O, A, Bahar, F. Karademir ve \u015e. \u00c7avu\u015flu, “Akut gastroenteritli \u00e7ocuk ya\u015f grubunda Rotavirus ve Adenovirus s\u0131kl\u0131\u011f\u0131n\u0131n saptanmas\u0131” XXX. T\u00fcrk Mikrobiyoloji Kongresi, Antalya, 30 Eyl\u00fcl-05 Ekim 2002.<\/li>
                              • \u00d6nc\u00fcl O, C. Top ve \u015e. \u00c7avu\u015flu, “Tip-2 Diyabet geli\u015fiminde kronik HCV infeksiyonu bir risk fakt\u00f6r\u00fc m\u00fcd\u00fcr?”, XXX. T\u00fcrk Mikrobiyoloji Kongresi, Antalya, 30 Eyl\u00fcl-05 Ekim 2002.<\/li>
                              • \u00d6nc\u00fcl O, C. Top, S. \u00d6zkan, \u015e. \u00c7avu\u015flu ve M. Danac\u0131, “Romatoid artiritli hastalarda serum interleukin-2 ve ins\u00fclin duyarl\u0131l\u0131\u011f\u0131 aras\u0131ndaki ili\u015fkinin saptanmas\u0131”, XXX. T\u00fcrk Mikrobiyoloji Kongresi, Antalya, 30 Eyl\u00fcl-05 Ekim 2002.<\/li>
                              • \u00d6zkan S, O. \u00d6nc\u00fcl, S. Po\u00e7an, V, Acar, \u00c7. Yard\u0131mc\u0131, A, At\u0131m, \u015e. \u00c7avu\u015flu ve M. G\u00f6kben, “Yo\u011fun bak\u0131m \u00fcnitesinde ventilat\u00f6rlerle ili\u015fkili pn\u00f6moni insidensi ve etkenlerinin saptanmas\u0131”, T\u00fcrk Anesteziyoloji ve Reanimasyon Cemiyeti Kongresi, Belek-Antalya, 26-30 Ekim 2002.<\/li>
                              • \u00d6zkan S, O. \u00d6nc\u00fcl, \u00c7. Yard\u0131mc\u0131, V. Acar, S. Po\u00e7an, M. Kuyumcu, \u015e. \u00c7avu\u015flu ve M. G\u00f6kben, “Yo\u011fun bak\u0131m hastalar\u0131nda kullan\u0131lan iki farkl\u0131 santral ven\u00f6z kateterin infeksiyon geli\u015fim riskleri a\u00e7\u0131s\u0131ndan kar\u015f\u0131la\u015ft\u0131r\u0131lmas\u0131”, T\u00fcrk Anesteziyoloji ve Reanimasyon Cemiyeti Kongresi, Belek-Antalya, 6-30 Ekim 2002.<\/li>
                              • \u015eenkul T, N. Ard\u0131\u00e7, O. \u00d6nc\u00fcl, L. T\u00fct\u00fcnc\u00fc ve H. Altunay, “Ayaktan \u00fcriner sistem yak\u0131nmas\u0131 bulunan hastalarda klinik bulgular ve idrar k\u00fclt\u00fcr sonu\u00e7lar\u0131n\u0131n irdelenmesi*”, XI. T\u00fcrk Klinik Mikrobiyoloji ve \u0130nfeksiyon Hastal\u0131klar\u0131 Kongresi (KL\u0130M\u0130K)*, \u0130stanbul, 30 Mart-3 Nisan 2003.<\/li>
                              • Ereno\u011flu C, O. \u00d6nc\u00fcl, \u015e. Y\u0131ld\u0131z, T. \u00c7elenk ve \u015e. \u00c7avu\u015flu, “Fournier Gangreni: 4 olgunun irdelenmesi” XI. T\u00fcrk Klinik Mikrobiyoloji ve \u0130nfeksiyon Hastal\u0131klar\u0131 Kongresi (KL\u0130M\u0130K), \u0130stanbul, 30 Mart-3 Nisan 2003.<\/li>
                              • Ko\u00e7ak N, M. S\u00f6nmezo\u011flu, F. \u00c7etinkaya, \u015e. \u00d6zbayburtlu, S. Hepg\u00fcl, O. \u00d6nc\u00fcl, E. Ko\u015fan, Y. Aksu, M. Merdano\u011fullar\u0131, A.C. \u00dc\u00e7\u0131\u015f\u0131k, E. Erbil, G. Y\u0131lmaz, “\u0130stanbul’da farkl\u0131 kan merkezlerinde al\u0131nan don\u00f6r kanlar\u0131nda \u00fc\u00e7 y\u0131ll\u0131k HBV, HCV ve HIV seroprevalans oranlar\u0131n\u0131n kar\u015f\u0131la\u015ft\u0131r\u0131lmas\u0131”, XI. T\u00fcrk Klinik Mikrobiyoloji ve \u0130nfeksiyon Hastal\u0131klar\u0131 Kongresi (KL\u0130M\u0130K), \u0130stanbul, 30 Mart-3 Nisan 2003.<\/li>
                              • Ko\u00e7ak N, \u015e. \u00d6zbayburtlu, S. Hepg\u00fcl, O. \u00d6nc\u00fcl, E. Ko\u015fan ve G. Y\u0131lmaz, “Marmara depreminin \u0130stanbul b\u00f6lgesinde don\u00f6r say\u0131s\u0131 ve don\u00f6rlerdeki insan imm\u00fcn yetmezlik virusu (HIV), hepatit C virusu, hepatit B virusu ve sifiliz seroprevalans oranlar\u0131na etkisi”, XI. T\u00fcrk Klinik Mikrobiyoloji ve \u0130nfeksiyon Hastal\u0131klar\u0131 Kongresi (KL\u0130M\u0130K), \u0130stanbul, 30 Mart-3 Nisan 2003.<\/li>
                              • Karaka\u015f A, \u00d6nc\u00fcl O, \u00c7avu\u015flu \u015e. Toplu ya\u015fam merkezlerinde bulunan 2-6 ya\u015f grubu \u00e7ocuklar ile 20 ya\u015f grubu \u00e7ocuklar ile 20 ya\u015f grubu yeti\u015fkinlerin nazofarengeal streptococcus pneumoniae ta\u015f\u0131y\u0131c\u0131l\u0131k oranlar\u0131n\u0131n kar\u015f\u0131la\u015ft\u0131r\u0131lmas\u0131, 6. Antimikrobik Kemoterapi G\u00fcnleri, \u0130stanbul, 8-10 Nisan 2004.<\/li>
                              • \u00c7avu\u015flu \u015e, Yeniiz E, \u00d6nc\u00fcl O: Seksend\u00f6rt bruselloz olgusunun retrospektif olarak de\u011ferlendirilmesi, XXXI. T\u00fcrk Mikrobiyoloji Kongresi, Ku\u015fadas\u0131, 19-23 Eyl\u00fcl 2004.<\/li>
                              • \u00d6nc\u00fcl O, Keskin O, \u0130lhan H, Kalemo\u011flu M, \u00c7avu\u015flu \u015e. \u0130lkyard\u0131m servisinde merkezi sinir sistemi infeksiyonu \u015f\u00fcphesiyle lomber ponksiyon uygulanan elli d\u00f6rt olgunun irdelenmesi, XXXI. T\u00fcrk Mikrobiyoloji Kongresi, Ku\u015fadas\u0131, 19-23 Eyl\u00fcl 2004.<\/li>
                              • \u00c7avu\u015flu \u015e, \u00d6nc\u00fcl O, K\u0131z\u0131lkaya E, Karaka\u015f A. T\u00fcberk\u00fcloz menenjit: : otuzsekiz olgunun irdelenmesi, XXXI. T\u00fcrk Mikrobiyoloji Kongresi, Ku\u015fadas\u0131, 19-23 Eyl\u00fcl 2004.<\/li>
                              • \u00d6nc\u00fcl O, Y\u0131ld\u0131z \u015e, Yeniiz E, Qyrdedi, \u00c7avu\u015flu \u015e. Diyabetik ayak infeksiyonlar\u0131nda aerob kantitatif yara k\u00fclt\u00fcr sonu\u00e7lar\u0131. XXXI. T\u00fcrk Mikrobiyoloji Kongresi, Ku\u015fadas\u0131, 19-23 Eyl\u00fcl 2004.<\/li>
                              • \u00d6nc\u00fcl O, Baylan O, Mutlu H, \u00c7avu\u015flu \u015e, Do\u011fanc\u0131 L. \u00c7ok say\u0131da k\u00fc\u00e7\u00fck intrakraniyal nod\u00fcllerin e\u015flik etti\u011fi menenjitli dissemine akci\u011fer t\u00fcberk\u00fclozu olgusu, XXXI. T\u00fcrk Mikrobiyoloji Kongresi, Ku\u015fadas\u0131, 19-23 Eyl\u00fcl 2004.<\/li>
                              • \u00d6nc\u00fcl O, Ereno\u011flu C, Uluutku H, Akin ML, \u00c7avu\u015flu \u015e, \u00c7elenk T. Kontrol edilemeyen diabetes mellitus hastalar\u0131nda \u00f6l\u00fcmc\u00fcl bir klinik tablo; Fournier Gangreni. , XXXI. T\u00fcrk Mikrobiyoloji Kongresi, Ku\u015fadas\u0131, 19-23 Eyl\u00fcl 2004.<\/li>
                              • Top C, Er\u015fanl\u0131 D, \u00d6nc\u00fcl O, \u015eahan B, Danac\u0131 M. Serum Solubl E-Selektin d\u00fczeyleri ile diyabetik retinopati geli\u015fimi aras\u0131ndaki ili\u015fki. 41. Ulusal Diyabet Kongresi, 11-15 May\u0131s 2005, Kremlin Palace, Topkap\u0131 Palace, Antalya.<\/li>
                              • Yeniiz E, \u00d6nc\u00fcl O, Turhan V, \u00c7avu\u015flu \u015e. \u0130shal nedeniyle ba\u015fvuran hastalarda Escherichia coli O 157: H7 Enfeksiyon s\u0131kl\u0131\u011f\u0131n\u0131n ara\u015ft\u0131r\u0131lmas\u0131. IV.Ulusal Sindirim Yoli ile Bula\u015fan \u0130nfeksiyonlar Simpozyumu.16-20 May\u0131s 2005, Mersin.<\/li>
                              • Yeniiz E, \u00d6nc\u00fcl O, \u00c7avu\u015flu \u015e. Kesim hayvan\u0131 olarak kullan\u0131lan s\u0131\u011f\u0131rlarda Escherichia coli O 157: H7 Ta\u015f\u0131y\u0131c\u0131l\u0131\u011f\u0131n\u0131n ara\u015ft\u0131r\u0131lmas\u0131. IV.Ulusal Sindirim Yoli ile Bula\u015fan \u0130nfeksiyonlar Simpozyumu.16-20 May\u0131s 2005, Mersin.<\/li>
                              • \u00c7avu\u015flu \u015e, Turhan V, Kavruk U, \u00d6nc\u00fcl O, \u00d6zsoy MF. Akut viral hepatit A: 294 olgunun de\u011ferlendirilmesi. IV.Ulusal Sindirim Yolu ile Bula\u015fan \u0130nfeksiyonlar Simpozyumu.16-20 May\u0131s 2005, Mersin.<\/li>
                              • \u00d6nc\u00fcl O, G\u00fcl C, Turhan V, Ardi\u00e7 N, Diler M, Haznedaro\u011flu T, \u00c7avu\u015flu \u015e. \u00c7e\u015fitli ya\u015f gruplar\u0131nda hepatit A virus seroprevalans\u0131n\u0131n on y\u0131l arayla kar\u015f\u0131la\u015ft\u0131r\u0131lmas\u0131. IV.Ulusal Sindirim Yoli ile Bula\u015fan \u0130nfeksiyonlar Simpozyumu.16-20 May\u0131s 2005, Mersin.<\/li>
                              • \u00d6nc\u00fcl O, Yeniiz E, \u00d6zsoy MF, Turhan V, \u00c7avu\u015flu \u015e. Salmonelloz: 135 olgunun de\u011ferlendirilmesi. IV.Ulusal Sindirim Yolu ile Bula\u015fan \u0130nfeksiyonlar Simpozyumu.16-20 May\u0131s 2005, Mersin.<\/li>
                              • Temelatan \u015e, \u00d6nc\u00fcl O, Haznedaro\u011flu T, \u00c7avu\u015flu \u015e. Yo\u011fun bak\u0131m \u00fcnitelerinde \u00e7al\u0131\u015fan sa\u011fl\u0131k personelinde burun Staphylococcus aureus ta\u015f\u0131y\u0131c\u0131l\u0131\u011f\u0131n\u0131n trendi. II.Ulusal\/Uluslar aras\u0131 TSK Hem\u015firelik Kongresi, 25-27 May\u0131s 2005, Istanbul.<\/li>
                              • \u00d6nc\u00fcl O, K\u00fc\u00e7\u00fckardal\u0131 Y, \u00c7avu\u015flu \u015e, Danac\u0131 M, \u00c7alangu S, Akova M, Kaplan M, Solmazg\u00fcl E. Nedeni Bilinmeyen Ate\u015fte hastal\u0131\u011f\u0131n prognozuyla ilgili prediktif fakt\u00f6rler var m\u0131? \u00c7ok merkezli bir \u00e7al\u0131\u015fma. 7. Ulusal \u0130\u00e7 Hastal\u0131klar\u0131 Kongresi, 16-20 Eyl\u00fcl 2005, Pine Beach Resort-Belek, Antalya.<\/li>
                              • Turhan V, \u00c7arpraz H, Karacaer Z, \u00d6nc\u00fcl O. Brusella menenjiti: \u00fc\u00e7 olgu nedeniyle. XII. T\u00fcrk Klinik Mikrobiyoloji ve \u0130nfeksiyon Hastal\u0131klar\u0131 Kongresi, 12-16 Kas\u0131m 2005, Antalya.<\/li>
                              • \u00d6nc\u00fcl O, \u00c7arpraz H, \u00dclk\u00fcr E, Turhan V, \u00c7elik\u00f6z B, \u00c7avu\u015flu \u015e, Haznedaro\u011flu T. Yan\u0131k hastalar\u0131nda geli\u015fen infeksiyonlar\u0131n boyutu ve epidemiyolojik de\u011ferlendirilmesi. XII. T\u00fcrk Klinik Mikrobiyoloji ve \u0130nfeksiyon Hastal\u0131klar\u0131 Kongresi, 12-16 Kas\u0131m 2005, Antalya.<\/li>
                              • Haznedaro\u011flu T, Turhan V, Temelatan \u015e, Ard\u0131\u00e7 N, \u00d6nc\u00fcl O, \u00c7avu\u015flu \u015e. Koagulaz negatif stafilokoklar: yo\u011fun bak\u0131m \u00fcnitesinde yatan hastalar\u0131n kan k\u00fclt\u00fcrlerinde izole edilmi\u015f olmas\u0131 her zaman kan dola\u015f\u0131m infeksiyonlar\u0131 anlam\u0131na gelir mi? XII. T\u00fcrk Klinik Mikrobiyoloji ve \u0130nfeksiyon Hastal\u0131klar\u0131 Kongresi, 12-16 Kas\u0131m 2005, Antalya.<\/li>
                              • Haznedaro\u011flu T, \u00d6nc\u00fcl O, \u00c7avu\u015flu \u015e, Turhan V, \u00d6zyurt M, Ak\u0131n L, Karademir F, K\u00fc\u00e7\u00fckardal\u0131 Y, Ard\u0131\u00e7 N, \u00d6zsoy M, Temelatan \u015e. Bir y\u0131ll\u0131k s\u00fcrede 1000 yatakl\u0131 e\u011fitim hastanesinin yo\u011fun bak\u0131m \u00fcnitelerinde g\u00f6r\u00fclen hastane infeksiyonlar\u0131n\u0131n irdelenmesi: prospektif \u00e7al\u0131\u015fma. XII. T\u00fcrk Klinik Mikrobiyoloji ve \u0130nfeksiyon Hastal\u0131klar\u0131 Kongresi, 12-16 Kas\u0131m 2005, Antalya.<\/li>
                              • Ard\u0131\u00e7 N, \u00d6zyurt M, Haznedaro\u011flu T, \u00c7avu\u015flu \u015e, Turhan V, Ak\u0131n L, Karademir F, K\u00fc\u00e7\u00fckardal\u0131 Y, \u00d6nc\u00fcl O, \u00d6zsoy M, Temelatan \u015e. 1000 yatakl\u0131 bir e\u011fitim hastanesinde bir y\u0131l boyunca saptanan hastane infeksiyon etkenleri: prospektif \u00e7al\u0131\u015fma. XII. T\u00fcrk Klinik Mikrobiyoloji ve \u0130nfeksiyon Hastal\u0131klar\u0131 Kongresi, 12-16 Kas\u0131m 2005, Antalya.<\/li>
                              • \u00d6nc\u00fcl O, Kavruk U, Turhan V, Ereno\u011flu C. Kist hidatik: multipl organ tutulumu ile seyreden \u00fc\u00e7 olgunun irdelenmesi ve albendazol tedavisi. XII. T\u00fcrk Klinik Mikrobiyoloji ve \u0130nfeksiyon Hastal\u0131klar\u0131 Kongresi, 12-16 Kas\u0131m 2005, Antalya.<\/li>
                              • Turhan V, \u00c7oban M, \u00d6nc\u00fcl O, \u00c7avu\u015flu \u015e. Komplikasyonlu bir leptospiroz olgusanda geli\u015fen Strongyloidoz + Hipereuzinofilik Sendrom tablosu. XII. T\u00fcrk Klinik Mikrobiyoloji ve \u0130nfeksiyon Hastal\u0131klar\u0131 Kongresi, 12-16 Kas\u0131m 2005, Antalya.<\/li>
                              • Emekda\u015f G, \u00c7avu\u015flu \u015e, \u00d6nc\u00fcl O, Atuk \u00c7; Aksoy A. T\u00fcrkiye’de onalt\u0131 y\u0131ll\u0131k HBV ve on y\u0131ll\u0131k HCV trendi: Kan don\u00f6r verileri. XII. T\u00fcrk Klinik Mikrobiyoloji ve \u0130nfeksiyon Hastal\u0131klar\u0131 Kongresi, 12-16 Kas\u0131m 2005, Antalya.<\/li>
                              • \u00d6nc\u00fcl O, Emekda\u015f G, \u00c7avu\u015flu \u015e, Artuk \u00c7, Aksoy A. T\u00fcrkiye’de onalt\u0131 y\u0131ll\u0131k sifiliz trendi: Kan don\u00f6r verileri. XII. T\u00fcrk Klinik Mikrobiyoloji ve \u0130nfeksiyon Hastal\u0131klar\u0131 Kongresi, 12-16 Kas\u0131m 2005, Antalya.<\/li>
                              • Haznedaro\u011flu T, Ardi\u00e7 N, \u00d6zyurt M, \u00d6nc\u00fcl O, Kural M, \u015eahiner F. Hastanemizde saptanan baz\u0131 bakterilerde se\u00e7ili antibiyotiklere kar\u015f\u0131 2003-2005 y\u0131llar\u0131ndaki diren\u00e7 paterninin izlenmesi. 7.Antimikrobik Kemoterapi G\u00fcnleri13-15 Nisan 2006, Crowne Plaza, \u0130stanbul.<\/li>
                              • \u0130lhan H, Solmazg\u00fcl E, \u0130lhan A, Aldeniz SC, \u00d6nc\u00fcl O, \u00c7avu\u015flu \u015e. Bir b\u00f6lge hastanesinde Hepatit A virus infeksiyonlu eri\u015fkin olgular: 100 olgunun irdelenmesi. XXXII. T\u00fcrk Mikrobiyoloji Kongresi, 12-16 Eyl\u00fcl 2006, Antalya.<\/li>
                              • Haznedaro\u011flu T, \u00d6nc\u00fcl O, Ard\u0131\u00e7 N, \u00d6zyurt M, \u00c7avu\u015flu \u015e, K\u00fc\u00e7\u00fckardal\u0131 Y, Karademir F, Ak\u0131n L, Solmazg\u00fcl E, Turhan V, Temelatan \u015e. \u0130ki y\u0131ll\u0131k s\u00fcrede 1000 yatakl\u0131 e\u011fitim hastanesinin yo\u011fun bak\u0131m \u00fcnitelerinde g\u00f6r\u00fclen hastane infeksiyonlar\u0131n\u0131n irdelenmesi: Prospektif \u00e7al\u0131\u015fma. XXXII. T\u00fcrk Mikrobiyoloji Kongresi, 12-16 Eyl\u00fcl 2006, Antalya.<\/li>
                              • \u00c7arpraz H, Kavruk U, Turhan V, \u00dclk\u00fcr E, \u00d6nc\u00fcl O. Yan\u0131k infeksiyonlar\u0131nda tan\u0131: s\u00fcr\u00fcnt\u00fc k\u00fclt\u00fcr\u00fc m\u00fc? Kantitatif k\u00fclt\u00fcr m\u00fc? XXXII. T\u00fcrk Mikrobiyoloji Kongresi, 12-16 Eyl\u00fcl 2006, Antalya.<\/li>
                              • \u00d6zyurt M, Turhan V, Haznedaro\u011flu T, \u00d6nc\u00fcl O, Ard\u0131\u00e7 N, Temelatan \u015e. 1000 Yatakl\u0131 bir e\u011fitim hastanesinde 2 y\u0131l boyunca saptanan nozokomiyal etkenler: Prospektif \u00e7al\u0131\u015fma. XXXII. T\u00fcrk Mikrobiyoloji Kongresi, 12-16 Eyl\u00fcl 2006, Antalya.<\/li>
                              • \u00d6nc\u00fcl O, Haznedaro\u011flu T, \u00d6zyurt M, \u00c7avu\u015flu \u015e, Ak\u0131n L, Karademir F, K\u00fc\u00e7\u00fckardal\u0131 Y, Ard\u0131\u00e7 N, Solmazg\u00fcl E, Temelatan \u015e. \u0130nvaziv ayg\u0131t kullan\u0131m\u0131 ve bununla ili\u015fkili hastane infeksiyon oranlar\u0131: iki y\u0131ll\u0131k veriler. XXXII. T\u00fcrk Mikrobiyoloji Kongresi, 12-16 Eyl\u00fcl 2006, Antalya.<\/li>
                              • \u00dclk\u00fcr E, \u00d6nc\u00fcl O, Karag\u00f6z H, \u00c7elik\u00f6z B, \u00c7avu\u015flu \u015e. Pseudomonas aeruginosa ile konmtamine s\u0131\u00e7an tam kal\u0131nl\u0131kta yan\u0131k yaras\u0131nda g\u00fcm\u00fc\u015f i\u00e7eren pansuman (Acticoat TM), Klorheksidin asetat %0.5 (Bactigrass) ve G\u00fcm\u00fc\u015f S\u00fclfodiazin %1 (Silverdin)’in antibakteriyel etkilerinin kar\u015f\u0131la\u015ft\u0131r\u0131lmas\u0131. 28. T\u00fcrk Plastik Rekonstr\u00fcktif ve Estetik Cerrahi Ulusal Kongresi, 20-23 Eyl\u00fcl 2006, Ankara.<\/li>
                              • \u00c7avu\u015flu \u015e, Turhan V, \u00d6nc\u00fcl O, Budak S, Sa\u00e7ar S, Do\u011fru S, \u00c7oban M, Er\u015fanl\u0131 D. Homonim hemianopsi ile giden t\u00fcberk\u00fcloz otomastoidit ve menenjit; 3 olgu nedeniyle. XIII. T\u00fcrk Mikrobiyoloji ve \u0130nfeksiyon Hastal\u0131klar\u0131 Kongresi, 14-18 Mart 2007, Belek-Antalya.<\/li>
                              • Acar A, Turhan V, Akta\u015f H, \u00d6nc\u00fcl O, \u00c7avu\u015flu \u015e. Renal, kardiyolojik ve osteoartik\u00fcler kompilaksyonlarla seyreden bir brusolloz olgusu. XIII. T\u00fcrk Mikrobiyoloji ve \u0130nfeksiyon Hastal\u0131klar\u0131 Kongresi, 14-18 Mart 2007, Belek-Antalya.<\/li>
                              • Erdem H, \u00d6nc\u00fcl O, Ak \u00d6, KlimikAntibiyotik Alt \u00c7al\u0131\u015fma Grubu. Pn\u00f6mokok su\u015flar\u0131nda antibakteriyel diren\u00e7: 2002-2006. XIII. T\u00fcrk Mikrobiyoloji ve \u0130nfeksiyon Hastal\u0131klar\u0131 Kongresi, 14-18 Mart 2007, Belek-Antalya.<\/li>
                              • \u00d6zyurt M, Haznedaro\u011flu T, \u015eahiner F, \u00d6nc\u00fcl O, Ard\u0131\u00e7 N, Erdemo\u011flu A. Toplumsal k\u00f6kenli \u00fcropatojen E.coli izolatlar\u0131nda antibiyotik duyarl\u0131l\u0131klar\u0131ndaki de\u011fi\u015fim ve diren\u00e7 fenotiplerinin incelenmesi: 3 y\u0131ll\u0131k (2004-2006) tarama. XIII. T\u00fcrk Mikrobiyoloji ve \u0130nfeksiyon Hastal\u0131klar\u0131 Kongresi, 14-18 Mart 2007, Belek-Antalya.<\/li>
                              • \u00d6zyurt M, \u00d6nc\u00fcl O, Haznedaro\u011flu T, \u015eahiner F, Ard\u0131\u00e7 N. Yatan hastalara ait \u00fcropatojen E.coli izolatlar\u0131nda antibiyotik duyarl\u0131l\u0131klar\u0131ndaki de\u011fi\u015fim ve diren\u00e7 fenotiplerinin incelenmesi: 3 y\u0131ll\u0131k (2004-2006) tarama. XIII. T\u00fcrk Mikrobiyoloji ve \u0130nfeksiyon Hastal\u0131klar\u0131 Kongresi, 14-18 Mart 2007, Belek-Antalya.<\/li>
                              • \u00c7oban M, \u015eenol MG, Kavruk U, \u00d6nc\u00fcl O. Parkinson hastalar\u0131nda nedeni bilinmeyen ate\u015f sebebi olarak malign sendrom: bir olgu nedeniyle. XIII. T\u00fcrk Mikrobiyoloji ve \u0130nfeksiyon Hastal\u0131klar\u0131 Kongresi, 14-18 Mart 2007, Belek-Antalya.<\/li>
                              • Turhan V, Dikta\u015f H, \u00d6nc\u00fcl O. Akut bat\u0131n ve pansitopeni ile seyreden bruselloz olgusu. Antibiyotik ve Kemoterapi Kongresi kitap\u00e7\u0131\u011f\u0131, cilt 21, Ek-1. 29 Nisan-03 May\u0131s 2007, Antalya.<\/li>
                              • Acar A, Oncul O, K\u00fc\u00e7\u00fckardal\u0131 Y, Ozyurt M, Haznedaroglu T, Cavuslu S., Yo\u011fun bak\u0131mlarda kandida izole edilen hastalar\u0131n \u00f6zellikleri. III. Ulusal Yo\u011fun Bak\u0131m \u0130nfeksiyonlar\u0131 Simpozyum Kitab\u0131, 21-24 Haziran 2007, Trabzon.<\/li>
                              • Uygur F, Oncul O, Evin\u00e7 R, Dikta\u015f H, Acar A, \u00c7elik\u00f6z B. Acinetobacter baumanii ile kontamine s\u0131\u00e7an cildinde olu\u015fturulmu\u015f yan\u0131k alan\u0131nda pansuman malzemelerinin etkinli\u011finin ara\u015ft\u0131r\u0131lmas\u0131. 29. T\u00fcrk Plastik Rekonstruktif ve Estetik Cerrahi Ulusal Kongresi, 17-20 Ekim 2007, Eski\u015fehir.<\/li>
                              • Top C, Cing\u00f6zbay Y, \u00d6nc\u00fcl O, Demirel F, Karag\u00f6z B, \u00d6zt\u00fcrk A, G\u00fcrb\u00fcz AK. Tip 2 diyabetik olgularda cerrahi giri\u015fim sonras\u0131 n\u00f6trofil b2 (CD18) \u0130ntegrin ekspresyonunda art\u0131\u015f. 30. T\u00fcrkiye Endokrinoloji vc Metabolizma Hastal\u0131klar\u0131 Kongresi24-28 Ekim 2007, Belek-Antalya.<\/li>
                              • Top C, Cing\u00f6zbay Y, \u00d6nc\u00fcl O, Demirel F, Karag\u00f6z B, \u00d6zt\u00fcrk A, G\u00fcrb\u00fcz AK. Tip 2 diyabetik olgularda trombosit morfolojisi ile n\u00f6trofil \u03b22 (CD18) \u0130ntegrin ekspresyonu aras\u0131ndaki ili\u015fki. 30. T\u00fcrkiye Endokrinoloji vc Metabolizma Hastal\u0131klar\u0131 Kongresi24-28 Ekim 2007, Belek-Antalya.<\/li>
                              • Ho\u015fbul T, Haznedaro\u011flu T, \u00c7avu\u015flu \u015e, Bozdo\u011fan B, \u00d6nc\u00fcl O, \u00d6zyurt M. Bir e\u011fitim hastanesi yo\u011fun bak\u0131m\u0131nda ortaya \u00e7\u0131kan metisiline diren\u00e7li Staphylococcus aureus’a (MRSA) ba\u011fl\u0131 bir epideminin tan\u0131mlanmas\u0131. 5. Ulusal Molek\u00fcler ve Tan\u0131sal Mikrobiyoloji Kongresi, 24-28 Haziran 2008, Bilkent Otel ve Konferans Merkezi, Ankara.<\/li>
                              • Acar A, Rodop O, Yenilmez E, Baylan O, \u00d6nc\u00fcl O. Femoral adele (uyluk) yerle\u015fimli primer kist hidatik olgusu. XXXIII. T\u00fcrk Mikrobiyoloji Kongresi Kongre Kitab\u0131, S: 844, 21-25 Ekim 2008.<\/li>
                              • Acar A, Kutlay M, K\u00fc\u00e7\u00fckardal\u0131 Y, Ozyurt M, \u00d6nc\u00fcl O. Paicilomyces spp.’ ye ba\u011fl\u0131 intrakraniyal abse ve pn\u00f6moni. . T\u00fcrk Mikrobiyoloji Kongresi Kongre Kitab\u0131, S: 870, 21-25 Ekim 2008.<\/li>
                              • Haznedaro\u011flu T, \u00d6nc\u00fcl O, Ho\u015fbul T, Ard\u0131\u00e7 N, \u00c7avu\u015flu \u015e, Baylan O, \u00d6zyurt M. Yatan hastalardan izole edilen S. Aureus su\u015flar\u0131nda metisilin direnci: \u00dc\u00e7 y\u0131ll\u0131k trend. . T\u00fcrk Mikrobiyoloji Kongresi Kongre Kitab\u0131, S: 654, 21-25 Ekim 2008.<\/li>
                              • Turhan V, Acar A, K\u0131l\u0131\u00e7 A, Budak S, \u00d6nc\u00fcl O, Haznedaro\u011flu T, G\u00f6renek L. N.meningitidis su\u015funa ba\u011fl\u0131 akut fetal seyirli akut meningokoksemi olgusu. 14. T\u00fcrk Klinik Mikrobiyoloji ve \u0130nfeksiyon Hastal\u0131klar\u0131 Kongresi, 25-29 Mart 2009, Lara –Antalya.<\/li>
                              • Acar A, Yenilmez E, Turhan V, \u00d6nc\u00fcl O, \u00c7avu\u015flu \u015e, G\u00f6renek L. MMR A\u015f\u0131s\u0131ndan sonra g\u00f6r\u00fclen kabakulak infeksiyonlar\u0131. 14. T\u00fcrk Klinik Mikrobiyoloji ve \u0130nfeksiyon Hastal\u0131klar\u0131 Kongresi, 25-29 Mart 2009, Lara –Antalya.<\/li>
                              • Demirpek U, Haznedaro\u011flu T, \u00d6zyurt M, Ardic N, Sara\u00e7l\u0131 MA, \u00d6nc\u00fcl O, \u00c7avu\u015flu \u015e. Candida parapsilosis nedenli kan dola\u015f\u0131m\u0131 infeksiyonu salg\u0131n\u0131nda molek\u00fcler epidemiyolojik ara\u015ft\u0131rma. 14. T\u00fcrk Klinik Mikrobiyoloji ve \u0130nfeksiyon Hastal\u0131klar\u0131 Kongresi, 25-29 Mart 2009, Lara –Antalya.<\/li>
                              • Acar A, Dikta\u015f H, \u00d6nc\u00fcl O, \u00c7avu\u015flu \u015e. Steroid kullanan ve Salmonella enteriditis bakteriyemisi geli\u015fen bir olguda femur ba\u015f\u0131 avask\u00fcler nekrozu. 14. T\u00fcrk Klinik Mikrobiyoloji ve \u0130nfeksiyon Hastal\u0131klar\u0131 Kongresi, 25-29 Mart 2009, Lara –Antalya.<\/li>
                              • Acar A, Karabudak \u00d6, K\u00fc\u00e7\u00fckodac\u0131 Z, Dikta\u015f H, \u00d6nc\u00fcl O, G\u00f6renek L. Giardiasis enfestasyonuna ba\u011fl\u0131 geli\u015fen bir Wells (Euzinofilik Sel\u00fclit Sendromu) olgusu. 14. T\u00fcrk Klinik Mikrobiyoloji ve \u0130nfeksiyon Hastal\u0131klar\u0131 Kongresi, 25-29 Mart 2009, Lara –Antalya.<\/li>
                              • \u00c7oban M, Acar A, Erik\u00e7i A, \u00d6nc\u00fcl O, Turhan V, \u00c7avu\u015flu \u015e, G\u00f6renek L. Febril n\u00f6tropenik hastalarda g\u00f6r\u00fclen infeksiyonlar. \u0130ki y\u0131ll\u0131k verilerin irdelenmesi. 14. T\u00fcrk Klinik Mikrobiyoloji ve \u0130nfeksiyon Hastal\u0131klar\u0131 Kongresi, 25-29 Mart 2009, Lara –Antalya.<\/li>
                              • Acar A, \u00d6nc\u00fcl O, \u00c7avu\u015flu S, Okutan O, Kartalo\u011flu Z. Akut bakteriyel toplum k\u00f6kenli pn\u00f6moni klinigini taklit eden Ascaries lumbrocoiedse ba\u011fl\u0131 bir L\u00f6ffler’s Sendromu olgusu. 14. T\u00fcrk Klinik Mikrobiyoloji ve \u0130nfeksiyon Hastal\u0131klar\u0131 Kongresi, 25-29 Mart 2009, Lara –Antalya.<\/li>
                              • Ozsut H, Ba\u015faran S, \u00c7a\u011fatay AA, et al. Metronidazole Ba\u011fl\u0131 Bir Huzursuz Bacak Sendromu Olgusu. https:\/\/scholar.google.com\/citations?view_op=view_citation&hl=tr&user=HYc2sd0AAAAJ&cstart=200&pagesize=100&citation_for_view=HYc2sd0AAAAJ:9c2xU6iGI7YC.<\/li>
                              • Ba\u015faran S, Evlice O, Yavuz S, Ca\u011fatay A, Oncul M.O, Eraksoy H. Kafa Taban\u0131 Osteomyeliti: 7 Olgunun De\u011ferlendirilmesi. XIX. T\u00dcRK KL\u0130N\u0130K M\u0130KROB\u0130YOLOJ\u0130 VE \u0130NFEKS\u0130YON HASTALIKLARI KONGRES\u0130, T\u00fcrkiye, 28 Mart 2018.<\/li>
                              • Evlice O, Ozsut H, Ba\u015faran S, Yavuz S, \u00c7a\u011fatay A, Oncul MO, Eraksoy H. \u0130mm\u00fcnokompetan Bir Hastada D\u00f6k\u00fcnt\u00fc Olmadan Seyreden Varicella -Zoster Virusu Menenjiti. XIX. T\u00dcRK KL\u0130N\u0130K M\u0130KROB\u0130YOLOJ\u0130 VE \u0130NFEKS\u0130YON HASTALIKLARI KONGRES\u0130, T\u00fcrkiye, 28 Mart 2018.<\/li>
                              • \u00d6zmen C, Yavuz S, Ba\u015faran S, \u00c7a\u011fatay A.A, \u00d6nc\u00fcl MO, \u00d6zs\u00fct H, Eraksoy \u00d6H. Yo\u011fun Bak\u0131m \u00dcnitesi Hastalar\u0131nda Karbapeneme Diren\u00e7li Eneterobacteriaceae D\u0131\u015fk\u0131 Kolonizasyonu ve Kolonize Hastalarda \u0130nfeksiyon Geli\u015fimine Etki Eden Risk Fakt\u00f6rlerinin De\u011ferlendirilmesi. XXI. T\u00dcRK KL\u0130N\u0130K M\u0130KROB\u0130YOLOJ\u0130 VE \u0130NFEKS\u0130YON HASTALIKLARI KONGRES\u0130, 26 – 30 May 2021, pp.789-790.<\/li>
                              • Korkut D., Yavuz S., Ba\u015faran S., \u00c7a\u011fatay A. A., \u00d6nc\u00fcl M. O., \u00d6zs\u00fct H., Eraksoy \u00d6. H. Potent Antiretroviraller ve \u0130mm\u00fcn Rekonstit\u00fcsyon \u0130nflamatuar Sendromu: 2 Olgu Sunumu. XXI. T\u00dcRK KL\u0130N\u0130K M\u0130KROB\u0130YOLOJ\u0130 VE \u0130NFEKS\u0130YON HASTALIKLARI KONGRES\u0130, 26 – 30 May 2021, pp.789-790.<\/li>
                              • Ag\u00fclo\u011flu E., Ba\u015faran S., Yavuz S., \u00c7a\u011fatay A. A., \u00d6nc\u00fcl M. O., \u00d6zs\u00fct H., Eraksoy \u00d6. H. T\u00fcrkiye’de G\u00f6r\u00fclen Dermatobia Hominis’e Ba\u011fl\u0131 Bir Deri Miyaz\u0131 Olgusu. XVIII. T\u00dcRK KL\u0130N\u0130K M\u0130KROB\u0130YOLOJ\u0130 VE \u0130NFEKS\u0130YON HASTALIKLARI KONGRES\u0130, Antalya, Turkey, 22 – 25 March 2017, pp.189-190.<\/li>
                              • Sad\u0131\u00e7 B., Ba\u015faran S., Yavuz S., \u00c7a\u011fatay A. A., \u00d6nc\u00fcl M. O., \u00d6zs\u00fct H.,Eraksoy H. Kolistine Diren\u00e7li Klebsiella pneumoniae (KoDKP) \u0130le \u0130nfekte Olgular\u0131n Y\u00f6netimi. XVIII. T\u00dcRK KL\u0130N\u0130K M\u0130KROB\u0130YOLOJ\u0130 VE \u0130NFEKS\u0130YON HASTALIKLARI KONGRES\u0130, Antalya, Turkey, 22 – 25 March 2017, pp.192-3.<\/li>
                              • Ba\u015faran S, Yilmaz E, Ku\u015fkucu M, \u00c7a\u011fatay AA, Oncul MO, \u00d6zs\u00fct H, Eraksoy H. Ba\u011f\u0131\u015f\u0131kl\u0131\u011f\u0131 bask\u0131lanm\u0131\u015f hastalarda Nokardiyoz: 6 Olgu Bildirisi. XIX. T\u00dcRK KL\u0130N\u0130K M\u0130KROB\u0130YOLOJ\u0130 VE \u0130NFEKS\u0130YON HASTALIKLARI KONGRES\u0130 (KL\u0130M\u0130K 2018), 28 March 2018.<\/li>
                              • Aguloglu B.E, Ba\u015faran S, Eraksoy \u00d6H, Yavuz S, \u00c7a\u011fatay AA, \u00d6ncul MO, \u00d6zs\u00fct H. CMV \u0130nfeksiyonu ya da Hastal\u0131\u011f\u0131nda Risk Fakt\u00f6rleri, Tedavi ve Prognoz: 30 Hastan\u0131n Analizi. XXII. T\u00dcRK KL\u0130N\u0130K M\u0130KROB\u0130YOLOJ\u0130 VE \u0130NFEKS\u0130YON HASTALIKLARI KONGRES\u0130 (KL\u0130M\u0130K 2018), 28 March 2022.<\/li>
                              • Ayg\u00f6r B, Ba\u015faran S, Eraksoy \u00d6H, Yavuz S, \u00c7a\u011fatay AA, Oncul MO, Ozsut H. Listeria Rombensefaliti-\u0130ki Olgu Sunumu. XXII. T\u00dcRK KL\u0130N\u0130K M\u0130KROB\u0130YOLOJ\u0130 VE \u0130NFEKS\u0130YON HASTALIKLARI KONGRES\u0130 (KL\u0130M\u0130K 2018), 28 March 2022. 122. Aktas Z, Akcakaya H, Bilgili F, B\u00fcy\u00fckak\u0131nc\u0131 Y, Dal YF, D\u00f6\u015fler S, Tezcan E, Oncul MO. Medikal sekt\u00f6r i\u00e7in antimikrobiyal kuma\u015f \u00fcretimi. 06.03.2021<\/li>
                              • Aguloglu B.E, Ba\u015faran S, Eraksoy \u00d6H, Yavuz S, \u00c7a\u011fatay AA, \u00d6ncul MO, \u00d6zs\u00fct H. Komorbiditeleri Olan Hastalardan \u0130nfeksiyon Etkeni Olarak \u0130zole Edilmi\u015f Pn\u00f6mokok Su\u015flar\u0131nda Penisilin G ve Seftriakson MIC De\u011ferleri. XXII. T\u00dcRK KL\u0130N\u0130K M\u0130KROB\u0130YOLOJ\u0130 VE \u0130NFEKS\u0130YON HASTALIKLARI KONGRES\u0130 (KL\u0130M\u0130K 2018), 28 March 2022.<\/li>
                              • Ba\u015faran S, Eraksoy \u00d6H, Sad\u0131c SB, Yavuz S, \u00c7a\u011fatay AA, Oncul MO, Ozsut H. Yogun Bak\u0131m \u00dcnitesindeki Hastalar\u0131n Endotrakeal Aspiratlar\u0131ndan \u00dcretilen Bakteriler: Son Be\u015f Y\u0131ll\u0131k Veriler. XXII. T\u00dcRK KL\u0130N\u0130K M\u0130KROB\u0130YOLOJ\u0130 VE \u0130NFEKS\u0130YON HASTALIKLARI KONGRES\u0130 (KL\u0130M\u0130K 2018), 28 March 2022.<\/li>
                              • Ba\u015faran S, Eraksoy \u00d6H, Sad\u0131c SB, Yavuz S, \u00c7a\u011fatay AA, Oncul MO, Ozsut H. Metronidazole Ba\u011fl\u0131 Bir Huzursuz Bacak Sendromu Olgusu. XXII. T\u00dcRK KL\u0130N\u0130K M\u0130KROB\u0130YOLOJ\u0130 VE \u0130NFEKS\u0130YON HASTALIKLARI KONGRES\u0130 (KL\u0130M\u0130K 2018), 28 March 2022.<\/li>
                              • Ba\u015faran S, Eraksoy \u00d6H, Sad\u0131c SB, Yavuz S, \u00c7a\u011fatay AA, Oncul MO, Ozsut Ventilat\u00f6rle \u0130li\u015fkili Pn\u00f6monili Hastalarda Epidemiyolojik Verilerin Risk Fakt\u00f6rlerinin ve Prognozun De\u011ferlendirilmesi. XXI. T\u00dcRK KL\u0130N\u0130K M\u0130KROB\u0130YOLOJ\u0130 VE \u0130NFEKS\u0130YON HASTALIKLARI KONGRES\u0130, 26 – 30 May 2021, pp.789-790.<\/li>
                              • Ba\u015faran S, Benli A, Eraksoy \u00d6H, Evlice O, Yavuz S, \u00c7a\u011fatay AA, Oncul MO, Ozsut H. Kafa Taban\u0131 Osteomyelitleri ve Uzun D\u00f6nem Sonu\u00e7lar\u0131. XXI. T\u00dcRK KL\u0130N\u0130K M\u0130KROB\u0130YOLOJ\u0130 VE \u0130NFEKS\u0130YON HASTALIKLARI KONGRES\u0130, 26 – 30 May 2021.<\/li>
                              • Aguloglu B.E, Ba\u015faran S, Eraksoy \u00d6H, Yavuz S, \u00c7a\u011fatay AA, \u00d6ncul MO, \u00d6zs\u00fct H. Fosfomisin Direncini Saptamak \u0130\u00e7in Pratik Bir Y\u00f6ntem: Fosfomisin Diskleriyle T\u00fcpte Makrodilisyon XXII. T\u00dcRK KL\u0130N\u0130K M\u0130KROB\u0130YOLOJ\u0130 VE \u0130NFEKS\u0130YON HASTALIKLARI KONGRES\u0130 (KL\u0130M\u0130K 2018), 28 March 2022. 129. Aguloglu B.E, Ba\u015faran S, Eraksoy \u00d6H, Yavuz S, \u00c7a\u011fatay AA, \u00d6ncul MO, \u00d6zs\u00fct H. \u0130nfeksiy\u00f6z ensefalitler: HSV-1’e ba\u011fl\u0131 olan ve olmayan olgular\u0131n kar\u015f\u0131la\u015ft\u0131r\u0131lmas\u0131. XXII. T\u00dcRK KL\u0130N\u0130K M\u0130KROB\u0130YOLOJ\u0130 VE \u0130NFEKS\u0130YON HASTALIKLARI KONGRES\u0130 (KL\u0130M\u0130K 2018), 28 March 2022. 130. Aguloglu B.E, Ba\u015faran S, Eraksoy \u00d6H, Yavuz S, \u00c7a\u011fatay AA, \u00d6ncul MO, \u00d6zs\u00fct H. \u0130stanbul T\u0131p Fak\u00fcltesi Hastanesinde \u0130zole EdilenKarbapenemlere Diren\u00e7li Gram-Negatif Enterik\u00c7omaklarda Antibiyotik Diren\u00e7 Mekanizmalar\u0131n\u0131nAra\u015ft\u0131r\u0131lmas\u0131. XXII. T\u00dcRK KL\u0130N\u0130K M\u0130KROB\u0130YOLOJ\u0130 VE \u0130NFEKS\u0130YON HASTALIKLARI KONGRES\u0130 (KL\u0130M\u0130K 2018), 28 March 2022.<\/li>
                              • Ba\u015faran S, Eraksoy \u00d6H, Sad\u0131c SB, Yavuz S, \u00c7a\u011fatay AA, Oncul MO, Ozsut H. Farkl\u0131 antibiyotikler kullan\u0131lan hastalarda eozinofili say\u0131lar\u0131n\u0131n seyri ve klinik yans\u0131malar\u0131. XXII. T\u00dcRK KL\u0130N\u0130K M\u0130KROB\u0130YOLOJ\u0130 VE \u0130NFEKS\u0130YON HASTALIKLARI KONGRES\u0130 (KL\u0130M\u0130K 2018), 28 March 2022.<\/li>
                              • Ba\u015faran S, Eraksoy \u00d6H, Sad\u0131c SB, Yavuz S, \u00c7a\u011fatay AA, Oncul MO, Ozsut H. Kons\u00fcltan \u0130nfeksiyon Hastal\u0131klar\u0131 ve Klinik Mikrobiyoloji Hekiminin \u00dcreme Olan Kan K\u00fclt\u00fcr\u00fc \u015ei\u015felerinden Haz\u0131rlanan Gram Boyamas\u0131n\u0131 De\u011ferlendirmesi: Bakterilerin H\u0131zl\u0131 Tan\u0131mlanmas\u0131nda ve Uygun Tedavinin D\u00fczenlenmesinde Ne Kadar Yararl\u0131? XXII. T\u00dcRK KL\u0130N\u0130K M\u0130KROB\u0130YOLOJ\u0130 VE \u0130NFEKS\u0130YON HASTALIKLARI KONGRES\u0130 (KL\u0130M\u0130K 2018), 28 March 2022. 133. Aguloglu B.E, Ba\u015faran S, Eraksoy \u00d6H, Yavuz S, \u00c7a\u011fatay AA, \u00d6ncul MO, \u00d6zs\u00fct H. Kolistin Direncini Saptamak \u0130\u00e7in Pratik Bir Y\u00f6ntem: Kolistin Diskleriyle T\u00fcpte Makrodil\u00fcsyon. XXII. T\u00dcRK KL\u0130N\u0130K M\u0130KROB\u0130YOLOJ\u0130 VE \u0130NFEKS\u0130YON HASTALIKLARI KONGRES\u0130 (KL\u0130M\u0130K 2018), 28 March 2022. 134. Ba\u015faran S, Eraksoy \u00d6H, Sad\u0131c SB, Yavuz S, \u00c7a\u011fatay AA, Oncul MO, Ozsut H. HIV\/AIDS Hastas\u0131nda Rifabutin Kullan\u0131m\u0131na Ba\u011fl\u0131 Okuler Toksisite. XXII. T\u00dcRK KL\u0130N\u0130K M\u0130KROB\u0130YOLOJ\u0130 VE \u0130NFEKS\u0130YON HASTALIKLARI KONGRES\u0130 (KL\u0130M\u0130K 2018), 28 March 2022. 135. B\u00f6r\u00e7e AR, Ba\u015faran S, Eraksoy \u00d6H, Yavuz S, \u00c7a\u011fatay AA, \u00d6ncul MO, \u00d6zs\u00fct H. Kan K\u00fclt\u00fcr\u00fcnde G\u00f6rd\u00fc\u011f\u00fcn\u00fcz Mayalar Kriptokok Olabilir: HIV \u0130nfeksiyonlu Bir Olguda KriptokoksemiXXII. T\u00dcRK KL\u0130N\u0130K M\u0130KROB\u0130YOLOJ\u0130 VE \u0130NFEKS\u0130YON HASTALIKLARI KONGRES\u0130 (KL\u0130M\u0130K 2018), 28 March 2022. 136. Akta\u015f Z, Ba\u015faran S, Eraksoy \u00d6H, Yavuz S, \u00c7a\u011fatay AA, \u00d6ncul MO, \u00d6zs\u00fct H. Ventilat\u00f6rle \u0130li\u015fkili Pn\u00f6moni Etkeni Olan Bakterilerde Biyofilmin ve Antibiyotiklerin Biyofilm Tabakas\u0131na Olan Etkilerinin Ara\u015ft\u0131r\u0131lmas\u0131. XXII. T\u00dcRK KL\u0130N\u0130K M\u0130KROB\u0130YOLOJ\u0130 VE \u0130NFEKS\u0130YON HASTALIKLARI KONGRES\u0130 (KL\u0130M\u0130K 2018), 28 March 2022.<\/li>
                              • G\u00f6ker AE, Ba\u015faran S, Eraksoy \u00d6H, Yavuz S, \u00c7a\u011fatay AA, \u00d6ncul MO, \u00d6zs\u00fct H. \u0130nfektif Endokarditin Tan\u0131namamas\u0131, Tan\u0131s\u0131n\u0131n Gecikmesi ve Sonu\u00e7lar\u0131 XXII. T\u00dcRK KL\u0130N\u0130K M\u0130KROB\u0130YOLOJ\u0130 VE \u0130NFEKS\u0130YON HASTALIKLARI KONGRES\u0130 (KL\u0130M\u0130K 2018), 28 March 2022. 138. Aguloglu B.E, Ba\u015faran S, Eraksoy \u00d6H, Yavuz S, \u00c7a\u011fatay AA, \u00d6ncul MO, \u00d6zs\u00fct H. Ok\u00fcler Sifilis: Yeni bir Salg\u0131n m\u0131? XXII. T\u00dcRK KL\u0130N\u0130K M\u0130KROB\u0130YOLOJ\u0130 VE \u0130NFEKS\u0130YON HASTALIKLARI KONGRES\u0130 (KL\u0130M\u0130K 2018), 28 March 2022. 139. Ba\u015faran S, Eraksoy \u00d6H, Sad\u0131c SB, Yavuz S, \u00c7a\u011fatay AA, Oncul MO, Ozsut H. Klebsiella pneumoniae ve Pseudomonas aeruginosa’da Karbapenemaz \u00dcretiminin Saptanmas\u0131nda Fenotipik Y\u00f6ntemlerin G\u00fcvenilirli\u011fi. XXII. T\u00dcRK KL\u0130N\u0130K M\u0130KROB\u0130YOLOJ\u0130 VE \u0130NFEKS\u0130YON HASTALIKLARI KONGRES\u0130 (KL\u0130M\u0130K 2018), 28 March 2022. 140. Aliyev A, Aliyev V, Ba\u015faran S, Eraksoy \u00d6H, Poyanl\u0131 A, Yavuz S, \u00c7a\u011fatay AA, \u00d6nc\u00fcl MO, \u00d6zden \u0130, \u00d6zs\u00fct H. S\u00fcrekli Bakteriyemi Nedeni Olan Kolistine Diren\u00e7li Klebsiella pneumoniae’ye Ba\u011fl\u0131 Pileflebit: Giri\u015fimsel Radyolojik Y\u00f6ntemle Tedavi Edilen Bir Olgu. XXII. T\u00dcRK KL\u0130N\u0130K M\u0130KROB\u0130YOLOJ\u0130 VE \u0130NFEKS\u0130YON HASTALIKLARI KONGRES\u0130 (KL\u0130M\u0130K 2018), 28 March 2022.<\/li>
                              • G\u00f6ker AE, Ba\u015faran S, Eraksoy \u00d6H, Yavuz S, \u00c7a\u011fatay AA, \u00d6ncul MO, \u00d6zs\u00fct H. \u0130nfektif Endokardit Tan\u0131s\u0131na Serolojik \u0130ncelemelerin ve PET\/BT’nin Katk\u0131lar\u0131 XXII. T\u00dcRK KL\u0130N\u0130K M\u0130KROB\u0130YOLOJ\u0130 VE \u0130NFEKS\u0130YON HASTALIKLARI KONGRES\u0130 (KL\u0130M\u0130K 2018), 28 March 2022.<\/li>
                              • Ba\u015faran M, Eraksoy \u00d6H, Sad\u0131c SB, Yavuz S, \u00c7a\u011fatay AA, Oncul MO, Ozsut H. S\u00fcrekli Bakteriyemi Nedeni Olan Kolistine Diren\u00e7li Klebsiella pneumoniae’ye Ba\u011fl\u0131 Pileflebit: Giri\u015fimsel Radyolojik Y\u00f6ntemle Tedavi Edilen Bir Olgu XXII. T\u00dcRK KL\u0130N\u0130K M\u0130KROB\u0130YOLOJ\u0130 VE \u0130NFEKS\u0130YON HASTALIKLARI KONGRES\u0130 (KL\u0130M\u0130K 2018), 28 March 2022.<\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t
                                \n\t\t\t\t
                                \n\t\t\t\t\t\r\n
                                \r\n\r\n

                                Book Chapters and Book Translations<\/h3> \r\n\r\n <\/div>\r\n\r\n \t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
                                \n\t\t\t\t\t\t\t\t\t
                                  \n \t
                                • Oncul O, Akta\u015f Z. M\u00fcsilajda Bulunan Patojen Mikroorganizmalar\u0131n Klinik A\u00e7\u0131dan Potansiyel Tehlikeleri. Marmara’da M\u00fcsilaj Sorunu. Istanbul University Press, 2023. DOI: 10.26650\/B\/LS32.2023.002.02<\/li>\n \t
                                • \u00d6nc\u00fcl O, “Antibiyotikler I”, Tabak F, \u00d6zt\u00fcrk R, Aktu\u011flu Y eds*. Ak\u0131lc\u0131 Antibiyotik Kullan\u0131m\u0131 ve Eri\u015fkinde Toplumdan Edinilmi\u015f Enfeksiyonlar*. \u0130.\u00dc. Cerrahpa\u015fa T\u0131p Fak\u00fcltesi S\u00fcrekli T\u0131p E\u011fitimi Etkinlikleri Sempozyum Dizisi, \u0130stanbul, 23-38 (2002).<\/li>\n \t
                                • \u00d6nc\u00fcl O, (Kitap \u00e7evirisi) “Streptococcus pneumoniae”, (B\u00f6l\u00fcm 47) \u00c7eviri Edit\u00f6r\u00fc: D\u00fcndar \u0130.H. In: Current \u0130nfeksiyon Hastal\u0131klar\u0131 Tan\u0131 ve Tedavi. Nobel T\u0131p Kitabevi, \u0130stanbul, 2003; 489-501.<\/li>\n \t
                                • \u00d6nc\u00fcl O, (Kitap \u00e7evirisi) “Akut \u0130nfeksiy\u00f6z ishaller ve Besin zehirlenmesi”. In: Harrison \u0130\u00e7 Hastal\u0131klar\u0131 Prensipleri, Cilt 1. B\u00f6l\u00fcm Yazar\u0131: Stephen B. Calderwood. Nobel Matbaac\u0131l\u0131k ve Yay\u0131n & Mc Grow-Hill, s: 834-9, 2001-Istanbul.<\/li>\n \t
                                • \u00d6nc\u00fcl O. (Kitap \u00e7evirisi) ” Infections due to Fungi, Actinomyces, and Nocardia”. In: Reese & Bettis’s A Pratical Approach to Infectious Diseases, \u00c7eviri Ed. Prof. Dr. Fehmi Tabak, OHAN Matbaac\u0131l\u0131k, \u0130stanbul Medikal Yay\u0131nc\u0131l\u0131k Ltd. Sti. 5. Bask\u0131, 2005- \u0130stanbul.<\/li>\n \t
                                • \u00d6nc\u00fcl O. (Kitap \u00e7evirisi) “Hastane kaynakl\u0131 stafilokok infeksiyonlar\u0131”. Hastane \u0130nfeksiyonlar\u0131 Kitab\u0131, Edit\u00f6rler: Prof. Dr. Mesut Pek\u00e7an, Prof. Dr. Alaaddin Pahsa, Do\u00e7. Dr. Levent G\u00f6renek, Do\u00e7. Dr. B\u00fclent A Be\u015firbellio\u011flu. S: 329-43, GATA Bas\u0131mevi, 2003-Ankara.<\/li>\n \t
                                • \u00d6nc\u00fcl O. (Kitap \u00e7evirisi) “Travmal\u0131 hastalarda proflaksi”, Afet T\u0131bb\u0131, Ed: Mehmet Ery\u0131lmaz, Ufuk Dizer, s: 565-73, I.Cilt, 1. Bask\u0131, \u00dcnsal Yay\u0131nlar\u0131, 2005-Ankara.<\/li>\n \t
                                • \u00d6nc\u00fcl O. (Kitap b\u00f6l\u00fcm\u00fc) “Sepsis tan\u0131m\u0131, etiyoloji ve epidemiyoloji”, Ed. K\u00fc\u00e7\u00fckardal\u0131 Y, GATA Bas\u0131mevi, Ankara 2006.<\/li>\n \t
                                • \u00d6nc\u00fcl O. Clostridium difficile infeksiyonlar\u0131ndan korunma. Yeni ve Yeniden G\u00fcndeme Gelen \u0130nfeksiyonlar. Ed. Prof. Dr. Recep \u00d6zt\u00fcrk. Bilimsel T\u0131p Yay\u0131nevi, Ankara-2005.<\/li>\n \t
                                • \u00d6nc\u00fcl O. (Kitap B\u00f6l\u00fcm\u00fc) Hastane enfeksiyonlar\u0131n\u0131n kontrol\u00fc. Enfeksiyon Hastal\u0131klar\u0131 ve Mikrobiyoloji. Edit\u00f6rler:Prof. Dr. Ay\u015fe Willke-Topcu, Prof. Dr. G\u00fcner S\u00f6yletir, Prof. Dr. Mehmet Do\u011fanay. 3. Bask\u0131, s: 1039-47 Nobel T\u0131p Yay\u0131nevi, \u0130stanbul-2007.<\/li>\n \t
                                • \u00d6nc\u00fcl O. Hepatit B Virus\u00fc Epidemiyolojisi. A\u015f\u0131 Serisi, Ed. Prof. Dr. Selim Badur, Bilimsel T\u0131p Yay\u0131nevi, Ankara 2007; 7-18.<\/li>\n \t
                                • \u00d6nc\u00fcl O. Yan\u0131k Enfeksiyonlar\u0131, Korunma ve Kontrol. Hastane Enfeksiyonlar\u0131: Korunma ve Kontrol. Ed: Prof. Dr. Recep \u00d6zt\u00fcrk, Prof. Dr. Ne\u015fe Salto\u011flu, Do\u00e7. Dr. G\u00f6khan Ayg\u00fcn, Aksu Bas\u0131m Yay\u0131n, Ocak 2008; 105-21.<\/li>\n \t
                                • \u00d6nc\u00fcl O. Ventilat\u00f6rle ili\u015fkili pn\u00f6moni. III. Ulusal Yo\u011fun Bak\u0131m \u0130nfeksiyonlar\u0131 Sempozyumu. Sempozyum Kitab\u0131, Edit\u00f6r, Prof. Dr. Haluk Eraksoy, 2007; 35-8.<\/li>\n \t
                                • \u00d6nc\u00fcl O. Diyabette n\u00f6trofil fonksiyon bozukluklar\u0131. I. Ulusal Diyabetik Ayak \u0130nfeksiyonlar\u0131 Sempozyumu. Sempozyum Kitab\u0131, Edit\u00f6rler, Yrd. Do\u00e7. Dr. M.B\u00fclent Ertu\u011frul, Do\u00e7. Dr. Nur Yapar, 2008; 4-5.<\/li>\n \t
                                • \u00d6nc\u00fcl O. Yo\u011fun bak\u0131mda infeksiyonu olan ya\u015fl\u0131 hastalarda sorunlar. Yo\u011fun Bak\u0131mda Ya\u015fl\u0131 Hasta Sorunlar\u0131, Ed. Do\u00e7. Dr. Ya\u015far K\u00fc\u00e7\u00fckardal\u0131, Yrd. Do\u00e7. Dr. Hakan Terekeci, 55-69, Nobel T\u0131p Kitabevi, \u0130stanbul, 2008.<\/li>\n \t
                                • \u00d6nc\u00fcl O: Antibiyotik direnci ile ilgili ulusal ve uluslararas\u0131 \u00e7al\u0131\u015fmalar. XXXIII. T\u00fcrk Mikrobiyoloji Kongre Kitab\u0131, 2008-Istanbul: 423-9.<\/li>\n \t
                                • \u00d6nc\u00fcl O. Yan\u0131k \u0130nfeksiyonlar\u0131. Yara Bak\u0131m\u0131 ve Tedavisi Kitab\u0131. Edit\u00f6rler: Kartal Erdost \u015e, \u00c7etinkale O. \u0130stanbul \u00dcniversitesi Cerrahpa\u015fa T\u0131p Fak\u00fclteasi S\u00fcrekli T\u0131p E\u011fitimi Etkinlikleri, s: 129-144, Aksu Bas\u0131m, 2008- \u0130stanbul.<\/li>\n \t
                                • Oncul O, Mert A. Nedeni bilinmeyen ate\u015fli bir olguya yakl\u0131\u015f\u0131m. 14. T\u00fcrk Klinik Mikrobiyoloji ve Infeksiyon Hastal\u0131klar\u0131 Kongre Kitab\u0131. 2009-Istanbul: 12-5.<\/li>\n \t
                                • Oncul O. Nozokomiyal Viral Hepatit Sorunu. 3.Ulusal Viroloji Kongresi \u00f6zet kitab\u0131, 2008-Istanbul.<\/li>\n \t
                                • \u00d6nc\u00fcl O. Yo\u011fun Bak\u0131m \u00fcnitesinde ate\u015fli hastaya yakla\u015f\u0131m. Yo\u011fun Bak\u0131m \u00dcnitesinde \u0130nfeksiyonlar. Eds. Prof. Dr. Ata Nevzat Yal\u00e7\u0131n, Do\u00e7. Dr. R\u0131za Hakan Erbay, Nobel Matbaac\u0131l\u0131k, \u0130stanbul, 2009.<\/li>\n \t
                                • \u00d6nc\u00fcl O. Hepatit B Virus infeksiyonlar\u0131ndan korunma. Eri\u015fkin A\u015f\u0131lama El Kitab\u0131, Ed: Prof. Dr. Selim Badur. Mart\u0131 Ofset, \u015ei\u015fli \u0130stanbul, 2009.<\/li>\n \t
                                • \u00d6nc\u00fcl O. HCV A\u015f\u0131s\u0131. Eds, Badur S, Bak\u0131r M. A\u015f\u0131 Kitab\u0131, Akademi Yay\u0131nlar\u0131, 2012, \u0130stanbul, 406-418.<\/li>\n \t
                                • Oncul O. Yan\u0131k Hastalar\u0131na Yakla\u015f\u0131m ve Yara Bak\u0131m\u0131. \u0130stanbul \u00dcniversitesi Cerrahpa\u015fa S\u00fcrekli T\u0131p Yay\u0131nlar\u0131. Yara Bak\u00fdm\u00fd ve Tedavisi Sempozyum Dizisi No:67 s.129-143.<\/li>\n \t
                                • \u00c7elik MM\u00d6, \u00d6zg\u00fclnar N, Canbaz S ve ark. Covid-19 Olgular\u0131n\u0131n (Ayaktan-Yatarak) Telesa\u011fl\u0131k \u0130zlem Verilerinin De\u011ferlendirilmesi. T\u0131p Bili\u015fimi III, Istanbul Universtiy Press, 2023, DOI:10.26650\/B\/ET07.2023.005.27 IUP :10.26650\/B\/ET07.2023.005.27.<\/li>\n \t
                                • Bozbuga N, Ta\u015f F, Huri PY, Oncul MO. Medical Informatics III. T\u0131p Bili\u015fimi III, Istanbul University, 2023, Istanbul.<\/li>\n \t
                                • Oncul MO, Ramazono\u011flu S, Adali E, Kolat A, Bozbuga N, G\u00fclse\u00e7en S. T\u00fcrkiyede ilk Bilgisayar ve Kazan\u0131mlar: T\u0131p Bili\u015fimi ve Tele-T\u0131p. T\u0131p Bili\u015fimi III, Istanbul University, 2023, Istanbul.<\/li>\n \t
                                • Guloglu R, Bozbuga N, Kurtulmu\u015f K, Oncul MO, et al. T\u0131pta Dijitalle\u015fme I. T\u0131p Bili\u015fimi III, Istanbul University, 2023, Istanbul.<\/li>\n \t
                                • Oncul O, Akta\u015f Z. Ba\u011f\u0131rsak Mikrobiyotas\u0131n\u0131n Beslenme ve Sa\u011fl\u0131ktaki Rol\u00fc. 2024. DOI: 10.26650\/B\/LS34CH11CH22\/2024.011.001.<\/li>\n \t
                                • Bozbuga N, Ta\u015f F, Huri PY, Oncul MO. Bioinks and 3D Bioprinting. Medical Informatics III. Istanbul University Press, 2023. DOI :10.26650\/B\/ET07.2023.005.16.<\/li>\n \t
                                • \u00d6ren MM, \u00d6zg\u00fclnar N, Canbaz S, \u015eim\u015fek KO, Karabey S, \u00d6nal AE, Medetalibeyoglu A, Oncul MO. Evaluation of Telehealth Follow-up Monitoring Data of Covid-19 Patients (Outpatient-\u0130npatient). Medical Informatics III. Istanbul University Press, 2023DOI :10.26650\/B\/ET07.2023.005.27.<\/li>\n \t
                                • Bozbuga N, Kosif FK, Oncul MO. Sa\u011fl\u0131kta Digital D\u00f6n\u00fc\u015f\u00fcm, B\u00f6l\u00fcm 26. Pp: 1-30. DOI: 10.26650\/B\/ET07.2021.003.26.<\/li>\n \t
                                • Bozbuga N, Ta\u015f F, Huri PY, Oncul MO. Biyom\u00fcrekkepler ve \u00fc\u00e7 boyutlu biyobask\u0131. B\u00f6l\u00fcm 16. Pp: 1-20. DOI: 10.26650\/B\/ET07.2023.005.16.<\/li>\n \t
                                • \u00d6nc\u00fcl O. (Kitap B\u00f6l\u00fcm\u00fc) Hastane enfeksiyonlar\u0131n\u0131n kontrol\u00fc. Enfeksiyon Hastal\u0131klar\u0131 ve Mikrobiyoloji. Sistemlere G\u00f6re \u0130nfeksiyonlar. Edit\u00f6rler:Prof. Dr. Ay\u015fe Willke-Topcu, Prof. Dr. G\u00fcner S\u00f6yletir, Prof. Dr. Mehmet Do\u011fanay. 4. Bask\u0131, s: 1039-47 Nobel T\u0131p Yay\u0131nevi, \u0130stanbul-2017.<\/li>\n \t
                                • Ak\u0131nc\u0131 E, Alt\u0131ndi\u015f M, Ataman HC, Oncul O, et al. Viral Hepatit 2018, Ankara 2018.<\/li>\n \t
                                • Oncul O. Risk Y\u00f6netimi. Eds, Bozbuga N, Yak\u0131nc\u0131 C. Hasta G\u00fcvenli\u011fi ve Risk Y\u00f6netimi. \u0130n\u00f6n\u00fc \u00dcniversitesi Yay\u0131nevi. Aral\u0131k 2020.<\/li>\n<\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t
                                  \n\t\t\t\t
                                  \n\t\t\t\t\t\r\n
                                  \r\n\r\n

                                  Edited Volumes<\/h3> \r\n\r\n <\/div>\r\n\r\n \t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
                                  \n\t\t\t\t\t\t\t\t\t
                                  • T\u00fcrk Klinik Mikrobiyoloji ve \u0130nfeksiyon Hastal\u0131klar\u0131 Derne\u011fi Kongre Kitab\u0131, Eds, \u015eaban \u00c7AVU\u015eLU, Mustafa Oral \u00d6NC\u00dcL, 2005, Istanbul<\/li>
                                  • Mikrobiyotan\u0131n \u0130nsan Sa\u011fl\u0131\u011f\u0131 \u00dczerine Etkileri, Eds, Mustafa Oral \u00d6NC\u00dcL, Zerrin AKTA\u015e, \u0130stanbul \u00dcniversitesi Press, 2013, Istanbul<\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t
                                    \n\t\t\t\t
                                    \n\t\t\t\t\t\r\n
                                    \r\n\r\n

                                    Books and Book Chapters (International)<\/h3> \r\n\r\n <\/div>\r\n\r\n \t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
                                    \n\t\t\t\t\t\t\t\t\t
                                    • Oncul O, Aktas Z. Potential Clinical Hazards of Pathogenic Microorganisms in Mucilage. In: Mucilage Problem in the Sea of Marmara, Istanbul University Press, 2023, Istanbul.<\/li>
                                    • Bozbuga N, Ta\u015f F, Huri PY, Oncul MO. Bioinks and 3D Bioprinting. Medical Informatics III. Istanbul University Press, 2023, Istanbul. DOI :10.26650\/B\/ET07.2023.005.16 IUP :10.26650\/B\/ET07.2023.005.16.<\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t
                                      \n\t\t\t\t
                                      \n\t\t\t\t\t\r\n
                                      \r\n\r\n

                                      Editorships, Editorial Boards, and Peer Review<\/h3> \r\n\r\n <\/div>\r\n\r\n \t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
                                      \n\t\t\t\t\t\t\t\t\t
                                      • International Scholars Journal (Editor in Chief) (https:\/\/www.internationalscholarsjournals.com\/international-journal-microbiology-research-reviews\/editorial-board.html)<\/li>
                                      • International Research Journal of Microbiology (Editor in Chief) (https:\/\/www.interesjournals.org\/microbiology\/editorial-board.html).<\/li>
                                      • Journal of Turkish Clinical Microbioloyg and Infectious Diseases (KL\u0130M\u0130K) (https:\/\/www.klimikdergisi.org\/wp-content\/uploads\/2021\/01\/cover_vol_25_issue_3.pdf)<\/li>
                                      • Turkish Journal of Trauma and Emergency Surgery (https:\/\/tjtes.org\/editorial_board)<\/li>
                                      • Journal of Medical Clinics (Scientific Referee Board) (https:\/\/dergipark.org.tr\/en\/pub\/atk\/board).<\/li>
                                      • Turkiye Klinikleri Journal of Medical Sciences (https:\/\/www.turkiyeklinikleri.com\/journal\/journal-of-medical-sciences\/1300-0292\/editorial-board\/en-index.html)<\/li>
                                      • Istanbul Ayd\u0131n Universitesi T\u0131p Fak\u00fcltesi Klinikleri Dergisi (Scientific Board) (https:\/\/tipfakultesiklinikleri.aydin.edu.tr\/wp-content\/uploads\/2020\/03\/10.17932IAU.TFK_.2018.0082018.103.pdf).<\/li>
                                      • The Open Access Journal of Science and Technology (https:\/\/www.agialpress.com\/open-access-science-and-technology\/editorial-board.html)<\/li>
                                      • World Journal of Clinical Infectious Diseases (https:\/\/www.wjgnet.com\/2220-3176\/SeniorScholars?pageNumber=7)<\/li>
                                      • Peak Journal of Public Health Management(PJPHM) (Editorial Board Member) (2012-2022).<\/li>
                                      • International Journal of Medical Science (Editorial Board Member) (2010-2020).<\/li>
                                      • Translational Biomedicine (TBM) Journal (Editorial Board Member) (2015-2020).<\/li>
                                      • Journal of Pamukkale University Medical Science (Editorial Board Member) (2010-2015).<\/li>
                                      • Anatolian Journal of Infectious Diseases (Editorial Board Member) (2010-2015).<\/li>
                                      • The Open Diabetes Journal (TODIAJ), (Editorial Board Member) (2012-2015).<\/li>
                                      • Interdisciplinary Perspectives on Infectious Diseases (Editorial Board) (2012-2017).<\/li>
                                      • Gulhane Military Medical Academy Journal (Editorial Board Member) (2008-2012). Editorial Board and Advisory Commitee \u00d6nc\u00fcl O. The Open Diabetes Journal, 2008 (Editorial Board Member) \u00d6nc\u00fcl O. American Journal of Infection Control, 2006 (AJIC-d-06-00093) \u00d6nc\u00fcl O. Head and Neck, 2005 (HED-05-0372) \u00d6nc\u00fcl O. Tropical Medicine and Health, 2007 (2007-27) \u00d6nc\u00fcl O. Clinical and Experimental Dermatology 2008 (CED-2008-0230) \u00d6nc\u00fcl O. World Journal of Clinical Infectious Diseases (WJCID) (Editorial Board Member) \u00d6nc\u00fcl O. Annals of Clinical Microbiology and Antimicrobials. \u00d6nc\u00fcl O. African Journal of Microbiology Research (AJMR 11-157). Oncul O. The Journal of Turkish Clinical Microbiology and Infectious Diseases (KLIMIK) Oncul O. Journal of Turkish Medcial Science (T\u00fcrkiye Klinikleri T\u0131p Bilimleri Dergisi) Oncul O. Anataloian Journal of Infectious Diseases Oncul O. Journal of Pamukkale University Medical Science \u00d6nc\u00fcl O.: Translational Biomedicine (TBM) Journal \u00d6ncul O. Indian Journal of Medical Research (IJMR) \u00d6nc\u00fcl O. Wold journal of Translational Medicine Oncul O. International Research Journal of Microbiology (Editors-in-Chief)(2010). Oncul O. Interdisciplinary Perspectives on Infectious Diseases (Editorial Board) (2014). Oncul O. Turkish Journal of Trauma and Emergency Surgery (2015). \u00d6nc\u00fcl O. The Open Diabetes Journal (TODIAJ), (2012-2014). Oncul O. The Wolrd J of Clin Infect Dis (2013). Oncul O. The Journal of Turkish Clinical Microbiology and Infectious Diseases (KLIMIK) Oncul O. Journal of Turkish Medcial Science (T\u00fcrkiye Klinikleri T\u0131p Bilimleri Dergisi) Oncul O. Anataloian Journal of Infectious Diseases. (2012-2015). Oncul O. Journal of Pamukkale University Medical Science (2011-2014). \u00d6nc\u00fcl O.: Translational Biomedicine (TBM) Journal (2014-2015). Oncul O. International Journal of Medical Science. (Editorial Board Member) (2011-2015) Oncul O Peak Journal of Public Health Management(PJPHM) (Editorial Board Member) Oncul O. The Open Access Journal of Science and Technology. (2015). Oncul O. Ankem Dergisi (2010-2020 Oncul O. Journal of Advanced Biomedical Engineering (2024) Oncul O. Journal of Curare (Honorary Editor) (2024). Oncul O. Journal of Clinical and Medical Reviews PEER REV\u0130EW<\/li>
                                      • The Journal of Life and Environmental Sciences (Article: COVID-19 and Elevation: an Analysis of the effect of elevation on COVID-19 fatality rate), (2021).<\/li>
                                      • Frontiers in Microbiology (Article: Molecular Characterization of Carbapenemases and Hypermucoviscous Traits of Carbapenem-Resistant Klebsiella pneumoniae Clinical Isolates in a Tertiary Hospital in China), (2022).<\/li>
                                      • Frontiers in Microbiology (Article: ST11 Carbapenem-resistant Klebsiella pneumoniae Clone Harboring blaNDM replaced a blaKPC Clone in a Tertiary Hospital in China), (2022).<\/li>
                                      • Infection and Drug Resistance (Article: Risk factors and drug resistanceanalysis of multidrug-resistant organisms infection in diabetic foot ulcer), (2022).<\/li>
                                      • Journal of Pharmaceutical Research International (Article: Awareness of Emergencey Drugs and Their Usage Among Dental Professionals), (2021).<\/li>
                                      • Hindawi Journal (Article: Nurses knowledge and associated factors regarding prevention of surgical site infection in Ethiopian Hospitals), (2021).<\/li>
                                      • Microbiology Researh Journal International (Article: First detection of the plasmid-mediated quinolone resistance determinants qnrB, qnrS, and aac(6′)-1b-cr in extended spectrum beta lactamases producing Klebsiella pneumoniae in Bouake, Cote d’Ivoire), (2020).<\/li>
                                      • Journal of Medical and Biologyical Science Research (Article: Associated factors for Helicobacter pylori infection in eastern of Minas Gerais, Brazil), (2020).<\/li>
                                      • International Journal of Infectious Diseases (Article: Sphingomonas Paucimobilis Related Bone and Soft Dissue Infections: A Systemic Review), (2020).<\/li>
                                      • Time Journal of Biological Sciences and Technology (Article: The Prevalance of Antimicrobial Resistance in Mycobacterium Tuberculosis to commonly used anti-tuberculosis drugs in the Tuberculosis Reference Laboratory in Khartoum Durign the year 2013), (2016).<\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t
                                        \n\t\t\t\t
                                        \n\t\t\t\t\t\r\n
                                        \r\n\r\n

                                        International Representations and Board Memberships<\/h3> \r\n\r\n <\/div>\r\n\r\n \t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
                                        \n\t\t\t\t\t\t\t\t\t
                                        • M8 Alliance Govermance – World Health Summit (https:\/\/www.worldhealthsummit.org\/m8-alliance\/governance.html)<\/li>
                                        • CEOTEKMER Technology City – Istanbul Turkey (https:\/\/www.ceotekmer.com\/eng\/mentors-advisory-board)<\/li>
                                        • Istanbul Technopark -Entertech Board of Directors (https:\/\/www.entertech.com.tr\/tr\/yonetim-kurulu)<\/li>
                                        • Istanbul Development Agency Development Board List (https:\/\/www.istka.org.tr\/media\/133567\/kalk%C4%B1nma-kurulu-listesi.pdf).<\/li>
                                        • International Nosocomial Infection Control Consortium ( https:\/\/www.inicc.org\/site\/)<\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

                                          Prof. Dr. Mustafa Oral \u00d6NC\u00dcL Prof. Dr. Mustafa Oral \u00d6nc\u00fcl is a physician who has combined patient care, academic teaching, and scientific research in infectious diseases and clinical microbiology for more than thirty years. He is recognized nationally and internationally for his expertise in managing difficult-to-treat infections, particularly hospital-acquired infections, antibacterial resistance, and infections in […]<\/p>\n","protected":false},"featured_media":7815,"parent":0,"comment_status":"open","ping_status":"closed","template":"","class_list":["post-7246","team","type-team","status-publish","has-post-thumbnail","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/oncomsi.com\/en\/wp-json\/wp\/v2\/team\/7246","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/oncomsi.com\/en\/wp-json\/wp\/v2\/team"}],"about":[{"href":"https:\/\/oncomsi.com\/en\/wp-json\/wp\/v2\/types\/team"}],"replies":[{"embeddable":true,"href":"https:\/\/oncomsi.com\/en\/wp-json\/wp\/v2\/comments?post=7246"}],"version-history":[{"count":4,"href":"https:\/\/oncomsi.com\/en\/wp-json\/wp\/v2\/team\/7246\/revisions"}],"predecessor-version":[{"id":7255,"href":"https:\/\/oncomsi.com\/en\/wp-json\/wp\/v2\/team\/7246\/revisions\/7255"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/oncomsi.com\/en\/wp-json\/wp\/v2\/media\/7815"}],"wp:attachment":[{"href":"https:\/\/oncomsi.com\/en\/wp-json\/wp\/v2\/media?parent=7246"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}